Traumatic Brain Injury Epidemiology, risk factors and decision making by Brand, C.L. (Crispijn) van den
Tra
um
a
tic Bra
in Injury      Ep
id
em
iolog
y, risk fa
ctors a
nd
 d
ecision m
a
king
          C
risp
ijn va
n d
en Bra
nd
Traumatic Brain Injury
Epidemiology, risk factors and decision making
Crispijn van den Brand
Traumatic Brain Injury
Epidemiology, risk factors and decision making
Crispijn van den Brand
COLOFON
Traumatic Brain Injury, epidemiology, risk factors and decision making; C.L. van den 
Brand. 
ISBN 978-94-6416-381-0
Copyright © 2021 C.L. van den Brand. 
All rights reserved. No part of this thesis may be reproduced, stored or transmitted in 
any way or by any means without prior permission of the author, or when applicable, 
of the publishers of the scientific papers.
Cover design and layout by Evelien Jagtman, © evelienjagtman.com 
Printed by Ridderprint | www.ridderprint.nl
Financial support for this thesis by the St Jacobus Foundation is gratefully 
acknowledged. 
The publication of this thesis was also generously supported by the Erasmus 
University Rotterdam and the Dutch Society of Emergency Physicians
Traumatic Brain Injury
Epidemiology, risk factors and decision making
Traumatisch hersenletsel
Epidemiologie, risicofactoren en beslismodellen 
Proefschrift
ter verkrijging van de graad van doctor aan de
Erasmus Universiteit Rotterdam
op gezag van de
rector magnificus
Prof. dr. F.A. van der Duijn Schouten
en volgens besluit van het College voor Promoties.
De openbare verdediging zal plaatsvinden op 
woensdag 24 maart 2021 om 15.30 uur
door
Crispijn Lennart van den Brand
geboren te Rotterdam
Promotiecommissie:
Promotor:  Prof. dr. M.G.M. Hunink
Overige leden:  Prof. dr. J. van der Naalt
  Prof. dr. M. Smits
  Prof. dr. E.W. Steyerberg  
Copromotor: Dr. K. Jellema
Trust in dreams for in them is hidden the gate to eternity (Kahlil Gibran)
In herinnering aan mijn ouders
Voor Joanne, Josephine en Mathilde

Table of contents
General introduction
1. General introduction 9
Part I Changing trends in traumatic brain injury
2. Traumatic brain injury in the Netherlands, trends in emergency 
department visits, hospitalization and mortality between 1998 and 2012
21
3. Effect of the implementation of a new guideline for minor head 
injury on computed tomography-ratio and hospitalizations in the 
Netherlands
41
Part II Prevention of- and risk factors for traumatic brain injury
4. Systematic review and meta-analysis: is pre-injury antiplatelet 
therapy associated with traumatic intracranial hemorrhage?
59
5. Bicycle helmets and bicycle-related traumatic brain injury in the 
Netherlands
77
Part III Decision rules for patients with minor head injury and mild traumatic 
brain injury
6. External validation of computed tomography decision rules for minor 
head injury: prospective, multicenter cohort study in the Netherlands
95
7. Update of the CHIP (CT in Head Injury Patients) decision rule for 
patients with minor head injury based on a multicenter consecutive 
case series
131
Part IV Conclusions
8. General discussion 161
9. Summary 175
10. Dutch summary (Nederlandse samenvatting) 185
Appendices
Abbreviations
List of publications
Curriculum vitae
PhD portfolio
Dankwoord
197
203
211
215
221

CHAPTER 1
General introduction

1
11
General introduction
General introduction
Traumatic Brain Injury (TBI) is a major health and socio-economic problem worldwide. 
Although society is largely unaware of the magnitude of the problem, TBI is a growing 
epidemic.[1,2] Each year over 50 million people will have a TBI and it is estimated that 
approximately 50% of the world’s population will have at least one TBI in their lifetime. 
TBI is a leading cause of mortality and disability in all age groups, for young adults it 
is even the leading injury-related cause of death. Not only the health impact of TBI is 
huge, also the economic impact is substantial. An estimate of total costs of TBI for 
the global economy is about US$ 400billion annually, which is approximately 0.5% of 
the entire global output.[3,4]
TBI severity classification
Fortunately, not all head trauma leads to TBI. Only patients with head trauma and 
evidence of brain pathology are classified as TBI.[5] The exact percentage of patients 
with head trauma that have TBI is unknown because many individuals with head injury 
do not seek medical care. 
The Glasgow Coma Scale (GCS) is the most widely used score to classify the severity 
of TBI. The GCS was originally published in 1974 to objectively describe the extent 
of impaired consciousness.[6] Nowadays the GCS is, in combination with other 
factors, also used to assess TBI severity. However, the GCS has some limitations, 
mainly because other factors such as alcohol intoxication may alter consciousness 
regardless of TBI. 
Based on GCS on arrival at hospital TBI is classified as follows:[7]
• Mild TBI: GCS 13-15; mortality ~ 0.2-0.4%
• Moderate TBI: GCS 9-12; mortality ~ 10%
• Severe TBI: GCS 3-8; mortality ~ 40%
The vast majority of TBI can be classified as mild TBI and this thesis will mainly focus 
on that group. However, this is actually a misnomer because a substantial part of 
patients with mild TBI still have complaints 6-12 months after the trauma, moreover 
some (0.2-0.4%) individuals even die as a result of ‘mild’ TBI.[8-11]
Epidemiology 
The incidence of TBI is rising globally, both in low- and middle-income countries and 
in high income countries.[1,3] Although rough estimates of the incidence of TBI exist, 
the exact incidence is unknown.[1] Causes of uncertainty and poor comparability 
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of incidence estimates are various. First, many individuals with mild TBI probably 
do not seek medical help and may not be registered as such. Second, definitions 
of TBI and head trauma are subject of debate and different definitions are used in 
different registries, complicating international use and comparison. Third, the source 
of information may cause substantial variation in incidence estimates. Sources of 
information can be either routinely registered information, such as International 
Classification of Disease (ICD) codes, or specifically collected data such as national 
trauma registries, which may result in differences in estimates. 
The incidence of TBI is not only rising, the epidemiology of TBI is also changing. A 
distinction has to be made between low- and middle-income countries and high-
income countries. Globally, two leading causes of TBI can be identified: motor vehicle 
accidents and falls. In low- and middle- income countries motor vehicle accidents are 
the leading cause of TBI and the increasing use of motorized vehicles in combination 
with poor road safety leads to more TBI.[3,12] In contrast, in high income countries, 
with an ageing population and increased road safety, falls are the main cause of TBI 
nowadays.[13-15] For example in the USA falls are the leading cause of TBI-related 
emergency department (ED) visits (48% in 2014) and hospitalizations (52% in 2014). 
However, in the USA intentional self-harm (33% in 2014, mostly due to fire arms) 
followed by falls (28% in 2014) were the overall leading causes of death from TBI.[2,16] 
Guidelines for diagnostics
The large majority of individuals with head injury have no intracranial complications 
and many do not even need professional care. Nonetheless, a small but important 
group does have traumatic (intra)cranial lesions and these lesions can lead to severe 
disability or even death. The most used technique to reliably rule out (intra)cranial 
lesions is head computed tomography (CT), which is available in all Dutch hospitals. 
However, there are important disadvantages of scanning all patients with head injury. 
First and most important, scanning all patients with head trauma would lead to many 
more ED visits and prolonged ED throughput times and crowding as result.[17] Second, 
CT scanning exposes the patient to (a limited) radiation risk.[18,19] Third, the price of 
CT varies substantially and can be up to US$2200 for a non-contrast head CT.[19,20] 
Therefore, CT should be used selectively for those patients that benefit most and 
several guidelines have been developed for this purpose. Globally, the guidelines that 
are most widely used are the Canadian CT Head Rule (CCHR) and the New Orleans 
Criteria (NOC).[21,22] These guidelines are suitable for patients with mild traumatic 
brain injury that have loss of consciousness, amnesia or confusion. However, many 
patients with head trauma do not have any of these and are still at risk for (intra)
cranial lesions.[23,24] Therefore the CT in Head Injury Patients (CHIP) decision rule 
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was developed in the Netherlands.[25] The CHIP decision rule is applicable for almost 
all patients with head injury and a GCS between 13 and 15. However, until the study 
included in this thesis, the CHIP had not been externally validated. 
The Dutch situation
In the Netherlands the general practitioner is traditionally the gatekeeper for secondary 
healthcare and is available 24/7. However, in emergency situations patients can come 
directly to the ED or (in more serious situations) call the national emergency number 
‘112’. For head trauma, as for many other conditions, there is a grey area which patient 
should call 112, who should come to the ED, who should go to the general practitioner 
and who does not need any medical care. Some EDs have a joint triage with the out-
of-hours general practitioners service. The triage determines which patients should 
be seen in the ED or by the general practitioner. This thesis will focus on ED care for 
patients with head injury.
In the ED patients with (minor) head trauma can, depending on local agreements, 
be treated by either emergency physicians or neurologists or residents of other 
specialties. 
The Dutch guideline for minor head injury (MHI) was introduced in 2010 and partially 
revised in 2017.[26-28] According to the current Dutch guideline, minor head injury 
is defined as:
Head injury is any trauma to the head, other than superficial injuries to the face. For 
minor head injury the following criteria apply:
• GCS at first examination 13-15
• In case of loss of consciousness: no more than 30 minutes
• In case of posttraumatic amnesia: no more than 24 hours
The guideline formulated criteria for adults and children with minor head injury 
regarding: referral to a hospital; examination at the ED; performance of a CT; and 
admission to a hospital. Regarding indications for CT scanning in MHI, the guideline 
is with some adjustments based on the CHIP decision rule. The guideline has major 
and minor criteria for a head CT. In case of at least 1 major or 2 minor criteria a CT-
scan of the head is indicated. 
In the 2017 update antiplatelet therapy was added as a major risk factor and criteria 
for minimal head injury were formulated, for which a CT scan is, under circumstances, 
not indicated.[26] 
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Table 1. The Dutch guideline for CT scanning following MHI in adults 
Major criteria Minor Criteria
Pedestrian or cyclist versus vehicle
Ejected from vehicle
Vomiting
Posttraumatic amnesia (PTA) ≥ 4h
Clinical signs of skull(base) fracture
GCS < 15 on presentation (including persisting 
PTA)
GCS deterioration ≥ 2 points (1 hour after 
presentation)
Use of anticoagulants*
Posttraumatic seizure
Focal neurologic deficit
Suspicion of intracranial injury after focal “high 
impact” injury
Fall from any elevation
Posttraumatic amnesia 2-4 hours
Visible injury to the head, excluding the face 
(without signs of fracture)
Loss of consciousness
GCS deterioration of 1 point (1 hour after 
presentation)
Age ≥ 40
*In 2017 antiplatelet therapy, other than acetylsalicylic acid monotherapy, was added as a major 
risk factor.
After introduction of the guideline in 2010 the authors expected a decrease in the 
number of CTs with approximately 30%.[27] However, several healthcare professionals 
feared that the guideline would lead to more rather than less diagnostics and 
referrals.[29-31] The evaluation of the guideline was the starting point of this thesis. 
We performed a simple ‘before-after’ study and concluded that the number of CTs 
increased in our hospital after the introduction of the guideline.[32] An extended 
version of that study has been included in this thesis in chapter 3. Another Dutch 
study that was subsequently published confirmed the conclusion of our before-after 
study: “The number of CTs performed for head trauma gradually increased over two 
decades, while the yield decreased. In 2011, despite implementation of a guideline 
aiming to improve selective use of CT in minor head injury, utilization significantly 
increased.”[33]
Aim of the thesis
This thesis aims to study changing trends, risk factors, preventive measures and 
decision rules for diagnostics in patients with head trauma and TBI in emergency 
departments in the Netherlands. 
1
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Outline of the thesis
Part I Changing trends in traumatic brain injury
In Chapter 2 epidemiological changes in TBI related ED visits, hospitalizations and 
mortality in the Netherlands are assessed. The results are put into context of the 
ageing population and increased traffic safety. In Chapter 3 the association between 
implementation of the minor head injury guideline in 2010 and CT and hospital 
admission rate is described. 
Part II Prevention of- and risk factors for traumatic brain injury
Chapter 4 reviews the association between the pre-injury use of antiplatelet therapy 
and traumatic intracranial hemorrhage. The association between the use of bicycle 
helmets and (prevention of) traumatic brain injury in the Netherlands is presented 
in Chapter 5. 
Part III Decision rules for patients with minor head injury and mild traumatic brain injury
In Chapter 6 several decision rules for minor head injury are validated and compared 
in a multicenter study in the Netherlands. The evaluated decision rules are the CHIP-
rule, the NOC, the CCHR and the National Institute for Health and Care Excellence 
(NICE) clinical guideline for head injury. Chapter 7 describes a possible adjustment of 
the CHIP-rule. This update aims to improve the identification of patients that require 
a head CT to identify traumatic lesions.
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PART I
Changing trends in traumatic brain injury

Traumatic brain injury in the Netherlands
Trends in emergency department visits, 
hospitalization and mortality between 1998 and 2012
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ABSTRACT
Background 
Traumatic brain injury (TBI) is a major cause of morbidity and mortality worldwide. The 
effects of epidemiological changes such as ageing of the population and increased 
traffic safety on the incidence of TBI are unknown. 
Objective 
The objective of this study was to evaluate trends in TBI related emergency department 
(ED)-visits, hospitalization and mortality in the Netherlands between 1998 and 2012. 
Design This was a retrospective observational, longitudinal study.
Main outcome measures
The main outcome measures were TBI-related ED-visits, hospitalization and mortality.
Results 
Between 1998 and 2012 there were 500,000 TBI related ED visits in the Netherlands. 
In the same period there were 222,000 TBI related admissions and 17,000 TBI related 
deaths. During this period there was a 75% increase in ED visits for TBI, a 95% increase 
for TBI related hospitalization; overall mortality due to TBI did not change significantly. 
Despite the overall increase in TBI related ED visits this increase was not evenly 
distributed among age groups or trauma mechanisms. In patients younger than 65 
years, a declining trend in ED visits for TBI caused by road traffic accidents was 
seen. Among patients 65 years or older, ED visits for TBI caused by a fall increased 
markedly. TBI related mortality shifted from mainly young (67%) and middle-aged 
people (< 65 years) to mainly elderly (63%) individuals (≥65 years) between 1998 and 
2012. The conclusions of this study did not change when adjusting for changes in age, 
gender and overall population growth. 
Conclusions 
The incidence of TBI-related ED visits and hospitalization increased markedly between 
1998 and 2012 in the Netherlands. TBI-related mortality occurred at an older age. 
These observations are probably the result of a change in aetiology of TBI, specifically 
a decrease in traffic accidents and an increase in falls in the ageing population. This 
hypothesis is supported by our data. However, ageing of the population is not the only 
cause of the changes observed; the observed changes remained significant when 
correcting for age and sex. The higher incidence of TBI with a relative stable mortality 
rate highlights the importance of clinical decision rules to identify patients with a high 
risk of poor outcome after TBI. 
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Introduction
Traumatic brain injury (TBI) is a major cause of mortality and morbidity worldwide 
affecting ~ 10 million individuals annually.[1,2,3] Although several definitions of TBI 
exist, the most frequently used definition is ‘an alteration in brain function, or other 
evidence of brain pathology, caused by an external force’.[1,4,5]
In the USA TBI accounts for ~2.5 million emergency department (ED) visits, 
hospitalizations and deaths annually; of these, ~ 53,000 individuals die as a result of 
TBI.[1] The exact incidence for the Netherlands and many other European countries 
is unknown.[5]
TBI used to be most prevalent in young men. However, in most industrialized countries, 
TBI is predominantly a disease of the elderly nowadays. [1,5] This presumed shift in 
the epidemiology of TBI in the last decades is most likely the result of two important 
changes that affect the incidence and epidemiology of TBI: first ageing of the 
population; increasing age is associated with an absolute increase of TBI. [6,7,8] In 
the Netherlands the percentage of the population aged 65 years or older was 12.8% 
in 1990, increased to 17.8% in 2015 and it is estimated to be 26.5% in 2040. [9,10] For 
other parts of the western world, similar trends are to be expected. Another important 
development is the decrease in traffic accidents. During the last decades, traffic 
safety increased and the number of traffic deaths in the Netherlands decreased 
substantially from 1149 in 1998 to 650 in 2012. [9] Subsequently, falls have surpassed 
traffic accidents as most important cause of TBI-related deaths. [9] The effects of 
this presumed shift from mainly young traffic accident victims to elderly fall victims 
on ED visits and hospitalizations in the Netherlands is unknown.
This study evaluates trends in epidemiology of TBI patients in the Netherlands 
between 1998 and 2012. 
We hypothesize that the ageing population in the Netherlands is associated with an 
increased incidence of TBI despite a decrease of traffic accidents.
24
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Methods
Data sources
In this observational, longitudinal study all patients with ED visits, hospitalization or 
mortality because of TBI in the period 1998-2012 were included using the Dutch Injury 
Surveillance System (Letsel Informatie Systeem; LIS), the National Medical Register 
(Landelijke Medische Registratie; LMR), and Statistics Netherlands (Centraal Bureau 
voor de Statistiek; CBS), respectively. 
The cause-of-death statistic by CBS is a registration based on all causes of death 
(ICD-10) from all deceased individuals registered in the Netherlands. The information 
is based on the compulsory notification of cause of death by the physician treating 
the deceased at the time of death or by a pathologist. For every deceased a cause-of-
death certificate is completed, which is used exclusively for statistical purposes, and 
is sent to CBS. The reliability of registration of causes of death is generally reasonable 
to good. [9,11] 
The National Medical Register (LMR) has been set up by the hospitals in the 
Netherlands for the benefit of research and policy. The LMR contains data of admitted 
patients on demographics (age, sex), hospital, date of admission and injury diagnosis 
(ICD-9CM). 
All general and academic hospitals have statutory obligations to participate in the 
LMR. Hence, using the LMR data approximates the true number of admissions 
throughout the Netherlands.[12] The reliability and completeness of LMR data are 
high.[13,14]
ED visits were extracted from the LIS database; participation in LIS is not compulsory. 
The LIS database is a continuous monitoring system in which next to demographics, 
injury diagnoses and injury mechanisms are registered. LIS is based on 13 
geographically distributed EDs in The Netherlands, resulting in a representative 12-
15% sample of injury-related ED visits that can be extrapolated to national estimates. 
For extrapolation of the sample, a factor was calculated in which the number of 
trauma-related ED treatments in LIS hospitals was multiplied by the quotient of all 
trauma related hospital admissions in the Netherlands divided by trauma related 
hospital admissions in LIS hospitals. [15,16] In addition, a data set was created to 
standardize (with 2012 as standard) for differences in distribution of sex and age. This 
data set was used to perform supplementa analysis. Because of a certain measure 
of uncertainty, numbers are rounded to thousands in this manuscript. 
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Inclusion
All patients who attended a Dutch ED for any trauma, were discharged from a Dutch 
hospital for any trauma or died because of any non-natural cause between 1 January 
1998 and 31 December 2012 were included. The study groups comprise all patients 
who visited the ED for TBI, were admitted for TBI or died from TBI. TBI was defined 
using the ICD-9CM codes for LMR; the ICD-10 codes for CBS and the LIS codes for 
ED visits. All patients with intracranial injury and/or a fracture of the skull (ICD9-CM 
codes 800-804 and 850–854; ICD10 codes S01.0; S02.0;S02.1; S02.3; S02.7-9; S04.0; 
S06; S07; S09.7-9; T90.1-2; T90.4-5; T90.8-9) were included in this group, irrespective 
of age and sex. The study groups were compared with all ED patients with non-TBI 
trauma, all admitted patients with non-TBI-trauma or all deaths from non-natural 
causes other than TBI. 
Data and statistical analysis
SPSS for windows (IBM SPSS Statistics, SPSS Inc, Chicago, Illinois, USA) was used 
for statistical analyses. The data set was subdivided into TBI patients and non-TBI 
patients, and was deliberately not standardized for age as the effects of ageing of 
the population on TBI epidemiology are one of the research questions of this study. 
Cumulative incidence is shown as number of new cases throughout the population 
of the Netherlands per year. Incidence proportions (per 100,000 per year) were 
calculated using Statistics Netherlands data [9]. A Poisson regression was used to 
determine the difference in the increase in incidence over time using a generalized 
linear model. As the Poisson distribution was used to describe this population, the 
same method was used to analyze the change in incidence proportions over time. To 
determine a significant change of cumulative incidence proportions between 1998 
and 2012, MedCalc statistical software (version 16.4.3; MedCalc Software, Ostend, 
Belgium) was used to compare proportion using a c2-test. Statistical significance was 
determined by a P-value of less than 0.001. The study was approved by the medical 
ethical review board (METC Zuidwest Holland, number 15-072). 
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Results
Incidence measures in total population
Between 1998 and 2012 there were ~13,651,000 trauma-related ED visits, of which 
500,000 (3.7%) were because of TBI. The total number of hospital admissions for 
trauma during the study period was 1,958,000, of which 222,000 (11%) were for TBI. 
The total mortality due to non-natural causes was 86,000, of which 17,000 (20%) 
were caused by TBI (Table 1). 
Between 1998 and 2012, according to the Poisson regression model without correction 
for age and sex, there was a significant increase in ED visits for TBI, from 153/100,000 
in 1998 to 267/100,000 in 2012 (75% increase, P < 0.001); in hospital admissions for 
TBI from 64/100,000 per year to 125/100,000 per year (95% increase, P < 0.001); 
and a nonsignificant change in mortality because of TBI from 6.8/100,000 per year 
to 7.2/100,000 per year (6% increase, P = 0.17).
In comparison with other trauma, the ED visits increased significantly more for TBI 
(P < 0.001). According to the Poisson regression model, ED visits for TBI increased 
with 4.6% each year versus a decrease of 2.1% for ED visits for other injury types. 
There was a significant increase (P < 0.001) in admissions for TBI (5.5% increase 
per year) compared with admissions for other injury (3.3% increase per year). The 
TBI related mortality did not change compared with overall mortality by non-natural 
causes (TBI related mortality increased 0.8% per year, mortality by other non-natural 
causes increased 0.9% per year, P = 0.78) 
Comparing TBI-related admissions with TBI-related ED visits and mortality, the 
increase in TBI-related hospital admissions (5.5% per year) increased significantly 
(P < 0.001) more than the TBI related ED visits (4.6% per year). Moreover, TBI-related 
mortality increased significantly less than TBI-related admissions (0.8% vs. 5.5% 
per year) (P < 0.001). The changes in the crude incidence of TBI in the Netherlands 
between 1998 and. 2012 are shown in Figures 1 and 2.
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Figure 1
The cumulative incidence of TBI and other injury: ED-visits, admissions and mortality in the Netherlands. 
A Poisson regression model estimates the best linear fit on logarithmic scale (dotted lines). 
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Incidence proportions on a logarithmic scale of TBI and other injury ED-visits, admissions and 
mortality in the Netherlands, 1998 and 2012 compared. 
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Table 1. Key figures on traumatic brain injury and other injury between 1998 and 2012 in the 
Netherlands: emergency department visits, admissions and mortality.
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Total
ED TBI (total) 24,053 25,499 28,415 27,124 29,764 27,555 27,604 31,439 35,047 35,917 39,391 41,912 38,907 42,516 44,818 499,961
ED other injury (total)  1,025,522  1,072,796  1,009,383  961,552  878,253  841,291  803,445  809,001  831,327  881,374  862,701  834,107  782,246  796,245  761,553 13,150,796
Admissions TBI (total) 10,928 11,049 11,284 10,608 11,667 12,575 13,799 13,978 14,542 15,897 16,771 19,289 20,022 21,022 19,055 222,486
Admissions other injury (total) 96,773 99,688 98,016 99,708 101,038 105,291 108,769 111,519 111,667 117,512 121,627 133,218 141,844 146,406 142,693 1,735,769
Death TBI (total) 1,032 1,071 1,063 1,137 1,097 1,133 1,142 1,141 1,117 1,150 1,075 1,157 1,102 1,197 1,292 16,906
Death other non natural causes (total) 4,300 4,434 4,407 4,707 4,600 4,599 4,381 4,531 4,533 4,312 4,612 4,747 4,910 4,900 5,312 69,285
ED TBI (65+)  2,270  2,844  3,190  3,196  3,971  4,014  3,834  4,253  5,357  5,659  7,049  7,958  8,351  9,264  10,274 81,484
ED other injury (65+) 96,793 103,817 97,048 96,312 93,059 94,644 91,886 94,285 99,633 105,508 105,383 106,745 108,388 115,338 117,514 1,526,353
Admissions TBI (65+) 1,899 1,907 1,932 1,980 2,295 2,606 2,933 3,096 3,416 3,880 4,192 5,374 5,942 6,109 5,395 52,956
Admissions other injury (65+) 30,658 31,317 30,739 31,404 31,900 33,942 34,917 36,150 36,284 38,276 40,360 44,528 49,339 51,202 51,387 572,403
Death TBI (65+) 349 381 358 399 416 438 498 520 526 564 535 591 632 708 809 7,724
Death other non natural causes (65+) 1,837 1,977 1,969 2,237 2,062 2,137 1,988 2,191 2,351 2,280 2,473 2,535 2,646 2,693 3,000 34,376
population (total) 15,654,192 15,760,225 15,863,950 15,987,075 16,105,285 16,192,572 16,258,032 16,305,526 16,334,210 16,357,992 16,405,399 16,485,787 16,574,989 16,655,799 16,730,348
population (65+) 2,109,719 2,130,934 2,152,442 2,174,501 2,198,714 2,220,456 2,251,154 2,288,670 2,330,459 2,368,352 2,414,826 2,471,815 2,538,328 2,594,946 2,716,368
% population 65+ 13.5% 13.5% 13.6% 13.6% 13.7% 13.7% 13.8% 14.0% 14.3% 14.5% 14.7% 15.0% 15.3% 15.6% 16.2%
% ED TBI 65+/ED TBI total 9.4% 11.2% 11.2% 11.8% 13.3% 14.6% 13.9% 13.5% 15.3% 15.8% 17.9% 19.0% 21.5% 21.8% 22.9%
% Admissions TBI 65+/Admissions TBI total 17.4% 17.3% 17.1% 18.7% 19.7% 20.7% 21.3% 22.1% 23.5% 24.4% 25.0% 27.9% 29.7% 29.1% 28.3%
% Death TBI 65+/Death TBI total 33.8% 35.6% 33.7% 35.1% 37.9% 38.7% 43.6% 45.6% 47.1% 49.0% 49.8% 51.1% 57.4% 59.1% 62.6%
Effects of age
During the study period, the total number of ED visits for TBI by patients aged 65 
and older increased from 2270 in 1998 to 10274 in 2012. Besides this absolute 
increase, there was also a relative increase in ED visits for TBI among those aged 
65 and older from 115/100,000 to 388/100,000 per year (P < 0.001). For the 
population younger than 65 years of age, we also observed an increase in TBI-
related ED visits; this increase was significantly less (3.1 vs. 9.1% per year; P < 
0.001) than that in the elderly (from 160/100,000 to 247/100,000 per year; P < 
0.001). Therefore, the percentage of elderly among patients visiting the ED for TBI 
increased between 1998 and 2012 (from 9 to 23%). 
For TBI-related admissions, the percentage of elderly (≥65) increased from 
17 to 28%. Incidence proportions for admissions in the elderly increased from 
81/100,000 to 242/100,000 per year (P < 0.001). For the population younger than 
65 years of age, we also observed an increase in TBI related admissions; this 
increase was significantly less (3.9 vs. 8.2% per year; P < 0.001) than that in the 
elderly (from 61/100,000 to 104/100,000 per year; P < 0.001).
Between 1998 and 2012, the proportion of individuals aged 65 years and older 
among TBI-related deaths increased from 34% in 1998 to 63% in 2012. In absolute 
numbers this increase was from 349 in 1998 to 809 in 2012; meanwhile, there 
was a decrease in TBI-related mortality in the young and middle aged (< 65 years) 
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Table 1. Key figures on traumatic brain injury and other injury between 1998 and 2012 in the 
Netherlands: emergency department visits, admissions and mortality.
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Total
ED TBI (total) 24,053 25,499 28,415 27,124 29,764 27,555 27,604 31,439 35,047 35,917 39,391 41,912 38,907 42,516 44,818 499,961
ED other injury (total)  1,025,522  1,072,796  1,009,383  961,552  878,253  841,291  803,445  809,001  831,327  881,374  862,701  834,107  782,246  796,245  761,553 13,150,796
Admissions TBI (total) 10,928 11,049 11,284 10,608 11,667 12,575 13,799 13,978 14,542 15,897 16,771 19,289 20,022 21,022 19,055 222,486
Admissions other injury (total) 96,773 99,688 98,016 99,708 101,038 105,291 108,769 111,519 111,667 117,512 121,627 133,218 141,844 146,406 142,693 1,735,769
Death TBI (total) 1,032 1,071 1,063 1,137 1,097 1,133 1,142 1,141 1,117 1,150 1,075 1,157 1,102 1,197 1,292 16,906
Death other non natural causes (total) 4,300 4,434 4,407 4,707 4,600 4,599 4,381 4,531 4,533 4,312 4,612 4,747 4,910 4,900 5,312 69,285
ED TBI (65+)  2,270  2,844  3,190  3,196  3,971  4,014  3,834  4,253  5,357  5,659  7,049  7,958  8,351  9,264  10,274 81,484
ED other injury (65+) 96,793 103,817 97,048 96,312 93,059 94,644 91,886 94,285 99,633 105,508 105,383 106,745 108,388 115,338 117,514 1,526,353
Admissions TBI (65+) 1,899 1,907 1,932 1,980 2,295 2,606 2,933 3,096 3,416 3,880 4,192 5,374 5,942 6,109 5,395 52,956
Admissions other injury (65+) 30,658 31,317 30,739 31,404 31,900 33,942 34,917 36,150 36,284 38,276 40,360 44,528 49,339 51,202 51,387 572,403
Death TBI (65+) 349 381 358 399 416 438 498 520 526 564 535 591 632 708 809 7,724
Death other non natural causes (65+) 1,837 1,977 1,969 2,237 2,062 2,137 1,988 2,191 2,351 2,280 2,473 2,535 2,646 2,693 3,000 34,376
population (total) 15,654,192 15,760,225 15,863,950 15,987,075 16,105,285 16,192,572 16,258,032 16,305,526 16,334,210 16,357,992 16,405,399 16,485,787 16,574,989 16,655,799 16,730,348
population (65+) 2,109,719 2,130,934 2,152,442 2,174,501 2,198,714 2,220,456 2,251,154 2,288,670 2,330,459 2,368,352 2,414,826 2,471,815 2,538,328 2,594,946 2,716,368
% population 65+ 13.5% 13.5% 13.6% 13.6% 13.7% 13.7% 13.8% 14.0% 14.3% 14.5% 14.7% 15.0% 15.3% 15.6% 16.2%
% ED TBI 65+/ED TBI total 9.4% 11.2% 11.2% 11.8% 13.3% 14.6% 13.9% 13.5% 15.3% 15.8% 17.9% 19.0% 21.5% 21.8% 22.9%
% Admissions TBI 65+/Admissions TBI total 17.4% 17.3% 17.1% 18.7% 19.7% 20.7% 21.3% 22.1% 23.5% 24.4% 25.0% 27.9% 29.7% 29.1% 28.3%
% Death TBI 65+/Death TBI total 33.8% 35.6% 33.7% 35.1% 37.9% 38.7% 43.6% 45.6% 47.1% 49.0% 49.8% 51.1% 57.4% 59.1% 62.6%
Effects of age
During the study period, the total number of ED visits for TBI by patients aged 65 
and older increased from 2270 in 1998 to 10274 in 2012. Besides this absolute 
increase, there was also a relative increase in ED visits for TBI among those aged 
65 and older from 115/100,000 to 388/100,000 per year (P < 0.001). For the 
population younger than 65 years of age, we also observed an increase in TBI-
related ED visits; this increase was significantly less (3.1 vs. 9.1% per year; P < 
0.001) than that in the elderly (from 160/100,000 to 247/100,000 per year; P < 
0.001). Therefore, the percentage of elderly among patients visiting the ED for TBI 
increased between 1998 and 2012 (from 9 to 23%). 
For TBI-related admissions, the percentage of elderly (≥65) increased from 
17 to 28%. Incidence proportions for admissions in the elderly increased from 
81/100,000 to 242/100,000 per year (P < 0.001). For the population younger than 
65 years of age, we also observed an increase in TBI related admissions; this 
increase was significantly less (3.9 vs. 8.2% per year; P < 0.001) than that in the 
elderly (from 61/100,000 to 104/100,000 per year; P < 0.001).
Between 1998 and 2012, the proportion of individuals aged 65 years and older 
among TBI-related deaths increased from 34% in 1998 to 63% in 2012. In absolute 
numbers this increase was from 349 in 1998 to 809 in 2012; meanwhile, there 
was a decrease in TBI-related mortality in the young and middle aged (< 65 years) 
from 683 in 1998 to 483 in 2012. When looking at the incidence proportion for TBI 
mortality, it did not change significantly either for the elderly (from 16/100,000 
to 28/100,000 per year; P = 0.08) or for the population younger than 65 years of 
age (from 5/100,000 to 3/100,000 per year; P = 0.50). However, the change (3.9% 
increase per year) in mortality in the population over 65 was significantly more 
than the change (3.2% decrease per year) in mortality in the population younger 
than 65 years (P < 0.001) (Table 1, Figure 3 and Supplementary Figure 1).
Trauma mechanism
When analyzing different trauma mechanisms in various age groups, it is observed 
that the increase in TBI-related ED visits is not evenly distributed; road traffic 
accidents (RTAs) seem to decrease and falls increase as the cause of TBI. Among 
young and middle aged (< 65 years), Poisson predicted TBI ED visits caused by 
RTAs decreased from 2682 in 1998 to 2112 in 2012. Translating this into incidence 
proportion means a decrease from 20 to 15 per 100,000 annually in, respectively, 
1998 and 2012. This decrease did not reach statistical significance (P = 0.39). The 
incidence proportion of non-TBI ED visits because of RTAs in the same age group 
and study period remained more or less stable (from 60 per 100,000 in 1998 to 
64 per 100,000 in 2012) (P = 0.72). In contrast, Poisson predicted TBI-related ED 
visits among elderly patients (≥ 65 years) with a fall as the trauma mechanism 
increased from 853 in 1998 to 4704 in 2012. These figures, translated to incidence 
proportion, mean an increase from 40 to 173 per 100,000 per year (P < 0.001). 
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The incidence proportion of non-TBI ED visits due to falls in the same age group 
and study period increased as well but this change was not as impressive; from 
1034 to 1436 per 100,000 per year (P < 0.001) (Figure 4). 
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Figure 3
Incidence proportions on a linear scale of TBI ED-visits, admissions and mortality in the Netherlands, 
population younger than 65 years and 65 years or older compared. 
Adjustment for age and gender
When the study population was standardized for age and sex, the TBI-related ED visits 
and admissions per 100,000 still increased significantly (P < 0.001) between 1998 
and 2012. The increase was 3.9% for ED visits and 4.6% for admissions annually. With 
this standardization TBI-related mortality still did not change significantly during the 
study period (P = 0.88) (Supplementary Figure 2).
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Figure 4 
Incidence proportions on a logarithmic scale of ED-visits for TBI and for other injury in the 
Netherlands. Left: road traffic accidents in population younger than 65 years in 1998 and 2012 
compared. Right: falls in population 65 years or older in 1998 and 2012 compared.
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Discussion
From 1998 to 2012, there was a significant increase in TBI-related ED visits and 
hospitalization, whereas TBI-related mortality remained relatively stable. The increase 
in ED visits and hospital admissions was significantly higher for TBI patients compared 
with other trauma patients; no such difference was observed for TBI-related deaths 
compared with other non-natural causes of death. Although the overall TBI-related 
mortality remained stable there was a change in the demographics of TBI-related 
mortality. TBI-related deaths in the elderly (≥ 65 years) more than doubled during the 
study period; TBI related death in the young and middle aged (< 65 years) decreased 
in contrast. 
The observed absolute increase in TBI related ED visits and hospitalizations without a 
significant increase in mortality rate may be the result of a variety of factors. 
First, there is probably an absolute increase of TBI in the population because of ageing 
of the population and hence more falls and increased use of antiplatelet therapy and 
anticoagulants. This is also reflected by the observed shift in mortality from mainly 
young and middle aged to mainly elderly individuals. 
Second, a possible explanation for the relative increase in TBI-related ED visits and 
hospital admissions compared with TBI-related mortality is the increased incidence 
of less severe TBI. This may be caused by a decrease in traffic accidents and an 
increase in ground level falls during the study period. This is supported by our finding 
of a decrease in TBI caused by RTA in the young and middle-aged individuals and a 
major increase in TBI caused by falls in the elderly. In the late 1990s, traffic accidents 
caused over 600 TBI-related deaths annually in the Netherlands; by the end of our 
study period, this number had decreased to about 300.[2] In the same period the 
number of TBI-related deaths because of falls increased from about 300 to over 650 
per year.[2] TBI caused by motorized vehicle accidents result in death approximately 
four times more often than TBI caused by low-energy falls (6.4 vs. 1.7%).[1] Hence, it 
makes sense that the number of ED visits and hospitalizations increased much more 
than the mortality rate during the study period, despite the fact that older patients 
have a higher TBI mortality than young patients for a given Glasgow Coma Scale 
score.[17] This is also in line with the result of a recent study from the UK.[18] They 
studied major trauma patients between 1990 and 2013 and reported a shift in the 
predominant trauma mechanism from RTAs to falls from less than 2 meter. They 
also reported a change in the mean age of major trauma patients from 36.1 in 1990 
to 53.8 in 2013. 
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There are several other possible explanations for the increase in TBI-related ED visits 
and (subsequent) increased admissions that is observed even when correcting for 
ageing of the population. First, there is probably increased awareness for TBI among 
the general public, paramedics and general practitioners. Second, the indications for 
anticoagulant and antiplatelet therapy have expanded in recent years, while these 
drugs are potential risk factors for traumatic intracranial hemorrhage. This is likely 
to affect TBI ED visits and admissions even when standardizing for ageing of the 
population. [6-8, 19-22] Third, fall rates among the elderly may increase and exceed 
what would be expected merely by ageing of the population. A recent study does support 
this hypothesis. [23] However, this seems to be in contradiction with the decrease 
in non-TBI-related ED visits that we observed. Better treatment for osteoporosis 
could, to some extent, explain this apparent contradiction.[24] Fourth, the change in 
minor head injury guidelines in the Netherlands in 2010 should be mentioned. Since 
introduction of the new guidelines an increase in both CT- and hospitalization rate 
was observed; this could lead to better identification and hence earlier treatment of 
traumatic intracranial findings.[25,26] Besides better identification and treatment, 
the threshold for hospitalization might have been lowered during the study period. 
Our finding that TBI-related admissions increased significantly compared with both 
TBI-related ED visits and mortality could support this hypothesis. Finally it is possible 
that the treatment of TBI patients has improved between 1998 and 2012, this could 
contribute towards a stable TBI-related mortality despite an increasing incidence and 
is in line with a global trend of decreasing injury-related mortality relative to injury 
incidence.[27] However, it is not possible to support or refute that conclusion on the 
basis of our study.
Besides strengths such as size and long duration, this study also has several 
limitations and the results should be interpreted in the light of these limitations. In 
contrast to the data on TBI admissions and TBI-related mortality that are (almost) 
complete, the data regarding TBI-related ED visits are an extrapolation from a limited 
number (12-15%) of EDs and are indicative only. 
The observational nature of this study makes it impossible to draw firm conclusions 
on the causes of observed changes in TBI-related ED visits, admissions or 
mortality. 
We used existing databases and had to rely on the registered data. Unfortunately, 
the different databases used did not use the same version of the ICD classification 
during the study period; the TBI hospitalization and mortality rates were based 
on ICD9-CM and ICD-10 codes, respectively. This is a limitation when comparing 
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the different strata of our study. Miscoding cannot be excluded; nonetheless, we 
do not expect considerable changes in miscoding throughout the years and the 
changes observed were substantial and consistent and are therefore unlikely to 
result from miscoding. The TBI hospitalization and mortality rates were based 
on ICD9-CM and ICD-10 codes; this may result in both false-positive as false-
negative cases [5]. An international comparison of absolute numbers mentioned 
in this article should be done with caution because of the lack of international 
standardization. 
Conclusions
Between 1998 and 2012, the incidence of TBI-related ED visits and hospitalization 
increased markedly, both in absolute numbers, as compared with other trauma. 
Despite a 41% reduction in traffic-related deaths in the same period, no reduction in 
TBI-related deaths was observed. The demographics of TBI-related deaths changed 
from mainly young and middle-aged individuals (< 65 years) to mainly elderly 
individuals (≥65 years). These observations are probably caused by a shift in the 
causative trauma mechanism from mainly traffic accidents (high-energetic trauma) 
to mainly fall accidents (low-energetic trauma). This hypothesis is supported by 
our data. However, ageing of the population is not the only cause of the changes 
observed; the changes observed remained significant when correcting for age and 
sex. Both policy makers and medical personnel should be aware of these changes 
in epidemiology. The higher incidence of TBI with a relative stable mortality rate 
highlights the importance of clinical decision rules to identify patients with a high 
risk of poor outcome after TBI. 
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Incidence proportions of TBI: ED-visits, admissions and mortality in the Netherlands, population 
< 65 years and ≥ 65 years compared. A Poisson regression model estimates the best linear fit on 
logarithmic scale (dotted lines).
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ABSTRACT
Objective
A new nationwide guideline for minor head injury was introduced in the Netherlands 
in 2010. The effect on CT ratio and hospital admission ratio after introduction of the 
guideline is unknown. The aim was to reduce these numbers as part of cost-effective 
health care. Therefore, we assessed the effect on these variables after introduction 
of the guideline. 
Methods
We used an interrupted time series study design. Data selection was done three 
years before (2007-2009) and several years after (2012, 2014, 2015) introduction 
of the guideline. 
Results 
Data collection was performed for 3880 patients. Introduction of the new guideline 
was associated with an increase in CT ratio from 24.6% before to 55% after introduction 
(P < 0.001). This increase is the result of both the new guideline and a secular trend. 
Besides this, hospital admissions increased from 14.7% to 23.4% (P < 0.001) during 
the study period. This increase was less clearly associated with the new guideline. 
After introduction of the guideline there was no significant difference in (intra)cranial 
traumatic findings (2.6% vs. 3.4%; P = 0.13) and neurosurgical interventions (0.1% vs. 
0.2%; P = 0.50).
Conclusions
Between 2007 and 2015, a marked increase in CT ratio and hospital admissions has 
been observed. The increase in CT ratio seems to be caused both by the new guideline 
and by a secular trend to perform more CT scans. Adaptations to the guideline should 
be considered to improve patient care and cost-effectiveness in patients with minor 
head injury.
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Introduction
Minor head injury (MHI) is an everyday problem in emergency departments (EDs). 
Exact numbers for the Netherlands are lacking, but a distinct increase in ED visits for 
traumatic brain injury (TBI) has been observed over the past decades.[1] Traumatic 
intracranial findings occur in 7-10 % of MHI patients and less than 1% will require 
neurosurgical intervention.[2-4] Computed Tomography (CT) of the head is the 
most used imaging modality, because it is a fast and reliable method for detecting 
traumatic findings.[5]
Obtaining a CT-scan for every head trauma is undesirable, because of various reasons 
such as cost-effectiveness, overdiagnosis, ED crowding and radiation exposure.[6,7] 
There are various guidelines to determine for which patients a CT-scan is indicated. 
Many guidelines are derived from the Canadian CT Head Rule (CCHR) and the New 
Orleans Criteria (NOC).[8,9] These decision rules are externally validated and have a 
high sensitivity for both clinically important brain injury and neurosurgical intervention.
[10-13] Nevertheless, the applicability of these decision rules is limited to patients who 
experienced loss of consciousness (LOC), post-traumatic amnesia (PTA) or confusion.
[8,9] However, intracranial complications occur both in patients with and without 
LOC and PTA.[14] Therefore, a major disadvantage of these guidelines is the lack of 
recommendations in case of the absence of LOC and/or PTA. 
A decision rule that is applicable to all MHI patients, was established later on by a 
Dutch research group: the CHIP prediction rule.[3] A recent validation study showed 
a performance comparable to the CCHR and NOC.[2] The CHIP prediction rule, with 
some adjustments, led to the development of the current Dutch guideline for MHI 
in 2010.[15] Although the sensitivity of the guideline is expected to be very high, 
implications for clinical practice, like the total number of CT-scans performed, are 
uncertain. The purpose of this study is to determine the impact of the introduction of 
a new guideline for MHI. We compared CT ratio before and after introduction of the 
new guideline, and simultaneously the effect on hospital admission rates.
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Methods
Study setting and patients
We used an interrupted time series (ITS) study design. All data were collected from a 
Dutch non-academic hospital with two separate ED locations. One location concerns 
a level-1 trauma centre with an annual number of visitors to the ED of 46,500 (2007) 
– 52,000 (2015); level-1 meaning that all possible traumas can be treated there. The 
other location is a level-3 trauma centre with an annual number of ED-visitors of 
20,000 (2007) – 17,500 (2015). The declining number of visitors to this last ED is due 
to reallocation of patients to other EDs. 
The study periods involved the first three months of six different years: 2007; 2008; 
2009; 2012; 2014 and 2015. The ‘after period’ was intentionally chosen some years 
after 2010, to guarantee that all hospitals were familiar with the new Dutch guidelines. 
There is no specific reason for the lack of data concerning the year 2013, other than 
the data collection being performed in two different time frames. 
All patient records concerning MHI were selected manually from the electronic 
patient records. Data extraction from these records was performed by physicians 
under supervision of the corresponding author (CvdB). In case no abnormalities or 
symptoms were specified, these were assumed to be absent. In case of discrepancies 
or doubt about the information in the patient record the record was reviewed by CvdB.
Patients were included when they met the criteria for MHI as described later in 
this section. Other inclusion criteria were presentation to the ED within 24 hours of 
injury, and age of at least 16 years. Exclusion criteria were ‘reassessed patients’ and 
‘transferred patients’. 
All CT-scans were performed according to standard trauma protocol. Assessment of 
the CT-scans was carried out by a (neuro)radiologist, and by the treating neurologist. 
In case of disagreement, a second (neuro)radiologist and neurologist reached 
consensus.
Data collection
We collected the following data from the electronic patient record: demographic 
data, Glasgow Coma Scale (GCS) on entry, whether a CT-scan of the head was made, 
CT findings, hospital admissions and neurosurgical interventions. A neurosurgical 
intervention is defined as any neurocranial operation for the sustained head trauma 
carried out by a neurosurgeon within 30 days after the trauma, including the 
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placement of an intracranial pressure monitoring device. We concurrently verified 
the presence of major and minor CT-criteria for each patient, according to the 2010 
guideline, so that guideline adherence could be measured [15]. 
The 2010 Dutch MHI guideline
The Dutch guideline for MHI was introduced nationwide in 2010 and was based on 
the CHIP decision rule [3,15]. It is applicable to all patients with MHI. MHI was defined 
as: Head injury is any trauma to the head, other than superficial injuries to the face. 
For minor head injury the following criteria apply:
• GCS at first examination 13-15
• In case of loss of consciousness: no more than 30 minutes
• In case of posttraumatic amnesia: no more than 24 hours
The guideline has major and minor criteria for a head CT. In case of 1 major or 2 minor 
criteria a CT-scan of the head is indicated. 
Major criteria: GCS < 15 on presentation; signs of skull fracture; vomiting; posttraumatic 
amnesia ≥ 4h; GCS deterioration ≥ 2 points (1 hour after presentation); pedestrian or 
cyclist versus vehicle; ejected from vehicle; coumarin use, focal neurologic deficit1; 
posttraumatic seizure; suspicion of intracranial injury after focal “high impact” injury2. 
Minor criteria: fall from any elevation; posttraumatic amnesia 2-4 hours; visible injury 
to the head, (excluding the face); loss of consciousness; GCS deterioration of 1 point 
(1 hour post presentation); age ≥ 403.
Indications for admission according to the guideline are: new clinically significant 
findings on CT-scan; GCS < 15; focal neurologic deficit; indication for CT-scan, but 
CT-scan not (yet) performed; alarming signs for the clinician such as intoxication with 
alcohol and/or drugs; other injuries that require admission4.
Outcome measures
The primary outcome measure is the change in level and trend in the percentage of 
head CT-scans for MHI performed: the crude CT ratio and the standardized CT ratio. 
1 Focal neurologic deficit was a minor criterium in the original CHIP rule. 
2 Suspicion of intracranial injury after focal “high impact” injury was no criterium in the original 
CHIP rule.
3 Age 40-60 was a minor criterium and age ≥60 was a major criterium in the original CHIP rule.
4 The CHIP rule does not formulate indications for admission.
46
Chapter 3
The crude CT ratio is the percentage of patients with head CT. The standardized CT 
ratio is the quotient of the number of cases with a head CT and the number of cases 
with an indication for head CT according to the 2010 guideline.[15] 
Secondary outcome measures are the changes in level and trend in the percentage 
of patients admitted to the hospital and in the number of neurosurgical interventions 
within 30 days after the trauma. Another secondary outcome measure is guideline 
adherence. The study was approved by the regional medical research ethics 
committee and informed consent was waived (IRB Southwest Holland, nr. 13-054).
Statistical analysis
Data were analyzed using descriptive statistics, c2 tests and Mann-Whitney U tests 
where appropriate. The impact of the new guideline on CT ratio and admission 
percentage was analyzed with an interrupted time series approach, hereby controlling 
for the observed level and trend in the data before the intervention.[16] The following 
regression model was used: 
Ut = b0 + b1T + b2Ct + b3TCt where b0 represents the baseline level before implementation 
of the new guideline, b1 represents the change in outcome associated with a time 
unit increase (representing the underlying trend, slope), b2 is interpreted as the level 
change following the intervention and b3 represents the slope change following the 
intervention. The time unit used in the model is months. 
Significance threshold was set at P < 0.05. The statistical package for the social 
sciences (IBM Corp., IBM SPSS Statistics for Windows, version 22.0. Armonk, New 
York USA) was used for analyses. 
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Results
During the study periods a total of 3880 eligible patients were seen at one of the 
two EDs and were included in our study. Of those patients, 1823 (47.0%) visited the 
hospital before- and 2057 (53.0%) did so after introduction of the guideline. Patient 
characteristics are shown in Table 1. Notably, the median age and specifically the 
proportion of patients over 40 years of age was higher in the group of patients seen 
after the introduction of de guideline. 
Table 1. Basic demographic characteristics and hospital location
2007-2009
(before group)
(n=1823)
2012-2014-2015
(after group)
(n=2057)
P-value1
Demographics
• Median age y (IQR) 
• Age ≥40y n (%)
• Male gender n (%)
40 (25-60)
917 (50.3)
1116 (61.2)
46 (28-67)
1211 (58.9)
1215 (59.1)
< 0.001
< 0.001
0.172
Hospital location
• Trauma centre 1293 (70.9) 1611 (78.3) < 0.001
1Difference between before-group (2007-2009) and after-group (2012, 2014, 2015).
Traumatic (intra)cranial CT findings were present in 2.6% of patients in the ‘before’ 
group and 3.4% of patients in the ‘after’ group. However, this difference was not 
significant, as shown in Table 2. Four patients with at the first visit missed (intra) 
cranial traumatic findings (or possible intracranial findings) were identified, two 
before introduction of the guideline and two after introduction of the guideline 
(Supplementary Table 1). Facial fractures were found on CT in merely 0.9% of the 
‘before’ group, and in 4.0% of the ‘after’ group, this difference was statistically 
significant. In line with these findings, there was no noteworthy increase in the number 
of neurosurgical interventions between the ‘before’ and ‘after’ group, which was 0.1% 
in the before group and 0.2% in the after group (Table 2).
Before introduction of the guideline the crude CT ratio was on average 24.6%. After 
introduction of the guideline, the crude CT ratio increased to 55%. A sensitivity analysis 
of the period 2012-2015, including only those patients in which the guideline was 
adhered, showed a similar crude CT ratio of 55.8%. The ITS analysis showed a (non-
significant) positive time trend (slope) in crude CT ratio, a significant increase in 
level after introduction of the new guideline and a slight (non-significant) change of 
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slope following the introduction of the guideline (Table 3). The standardized CT ratio5 
increased each year and was on average 51.9% before introduction of the guideline 
and 100.5% after introduction of the guideline (Table 2, Supplementary Table 2). The 
ITS analysis for standardized CT ratio showed similar results as for the crude CT 
ratio; a (non-significant) positive time trend (slope) (b1 = 0.48, p = 0.08), a significant 
increase in level after introduction of the new guideline (b2 = 31.85, p = 0.05) and a 
slight (non-significant) change of slope following the introduction of the guideline (b3 
= -0.21, p = 0.50) (Table 3, Figure 1). Hospital admissions have increased from 14.7% 
before- to 23.4% after introduction of the guideline. However, there was no significant 
deviation from the secular trend after introduction of the guideline (Table 2, Table 3). 
Table 2. (Standardized) CT ratio, traumatic CT findings, hospital admission and neurosurgical 
intervention
2007-2009 
(n=1823)
2012-2014-2015
(n=2057)
P value1
Head CT-scans n (%) 448 (24.6) 1131 (55) < 0.001
Standardized CT ratio 51.9 100.5 < 0.001
(Intra) cranial traumatic CT findings n (%)
• Hemorrhagic intracranial traumatic findings2
• Isolated skull fracture3
• Intracranial traumatic findings plus fracture
Isolated facial fracture(s) on CT n (%)
47 (2.6)
24 (1.3)
9 (0.5)
14 (0.8)
16 (0.9)
70 (3.4)
38 (1.8)
9 (0.4)
23(1.1)
83 (4.0)
0.13
< 0.001
Hospital admission n (%) 268 (14.7) 481 (23.4) < 0.001
Neurosurgical intervention n (%) 2 (0.1) 4 (0.2) 0.50
1 Difference between before-group (2007-2009) and after-group (2012, 2014, 2015).
2 hemorrhagic intracranial traumatic findings means all traumatic intracranial findings: subdural 
hematoma, epidural hematoma, traumatic subarachnoid hemorrhage and parenchymal contusion.
3 Isolated skull fractures means all fractures to the neurocranium.
Guideline adherence, since the introduction of the guideline, was good; when a CT 
was indicated according to the guideline, a CT-scan was performed in 85.7% of the 
patients. In addition, a CT-scan was performed in merely 17.9% of the patients when the 
guideline dictated not to perform a CT-scan (Supplementary Table 3). That equalizes 
84.1% overall guideline adherence. 
5 The standardized CT ratio is the quotient of the number of cases with a head CT and the number 
of cases with an indication for head CT according to the 2010 guidelines. 
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Table 3. Interrupted time series analysis changes in slope and level of crude and standardized CT 
ratio and hospital admissions
Slope 2007-2009
(p value)
Change in level after 
introduction of new 
guideline 
(p value)
Change in slope 
2012-2015
(p value)
Crude CT ratio 0.18 (0.27) 19.84 (0.04) -0.01 (0.94)
Standardized CT ratio 0.48 (0.08) 31.85 (0.05) -0.21 (0.50)
Hospital admissions 0.29 (0.13) 8.32 (0.43) -0.23 (0.31)
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Figure 1. 
Interrupted time series analysis changes in slope and level of standardized CT ratio.
This figure shows the standardized CT ratio per month before (triangles) and after (rounds) 
introduction of the guideline. It also shows the secular trend (slope) in standardized CT ratio before 
(dotted line) and after (striped line) introduction of the guideline.
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Discussion
In this study we found an increase in both the use of CT-scans as well as hospital 
admissions in patients with MHI, not sufficiently explained by the increase in (intra)
cranial traumatic findings. 
This is in contrast with the expectation that introduction of the guideline would reduce 
the number of CT scans as well as the number of hospital admission. A CT reduction of 
20-32% was estimated beforehand. Instead of confirming this reduction, we found an 
increase of 30.4%. A major cause of this increase seems to be the implementation of 
the new guideline as was demonstrated in the ITS analysis. However, this is probably 
not the only cause as we also observed a (not statistically significant) secular trend 
of an increasing standardized CT ratio each year. Easy access to CT scans, more 
defensive healthcare in general, and emergency department crowding are possible 
causes of this secular trend. Besides this the CT ratio in the Netherlands is still 
relatively low in international perspective, where CT ratios for MHI are generally 
around 65-80%.[7,17,18] Remarkably the implementation trial after introduction of 
the Canadian CT Head Rule showed similar results, an increase in CT ratio.[17,19] 
The authors argued this effect was, for the most part, attributable to poor physician 
adherence to the guideline.[17] However, in our study lack of guideline adherence does 
not seem to be an important contributing factor with an adherence of 84.1% and an 
average standardized CT ratio of 100.5% after implementation of the guideline. This is 
a better guideline adherence than other proposed guidelines for MHI.[17,20]
The increase in CT ratio did not result in less hospitalization, on the contrary. Besides 
more CT-scans performed, also the proportion of patients admitted to the hospital 
increased between 2007 and 2015. This was also an unexpected result, since the new 
guideline dictates that hospitalization is (generally) no longer necessary when the CT-
scan shows no traumatic abnormalities. The observed increase in hospital admission 
ratio may be partially explained by the abandonment of home waking advice in the 
new guideline. Before introduction of the guideline home waking advice used to be 
daily routine in certain patients, also when the CT-scan was normal. Home waking 
advice comprises of regularly waking the patient in the home setting, to make sure he 
or she is doing well. Because of lack of evidence this advice is no longer part of the 
new guideline. It is possible that Dutch physicians, instead of discharging the patient, 
chose for hospitalization for clinical observation. 
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From the viewpoint of cost-effectiveness there seems to be a lot to gain. The number 
of CT-scans performed has risen significantly. Moreover, costs are piling up even 
more with the growth in hospitalizations. Careful evaluation of each admission and 
CT-scan is therefore needed. A multimodal intervention focusing on physicians could 
be of importance to reduce CT ratio, as was shown in community hospitals in the USA.
[21] Furthermore, adjustment of the guideline should be considered. Examples of such 
adjustments that could be considered are a higher threshold for performing a CT-
scan, more emphasis on clinical judgement or the implementation of other diagnostic 
modalities such as biomarkers to reduce CT ratio. 
The retrospective study design has certain limitations. Missing data were presumed 
to be absent. For example: if vomiting was not mentioned in the electronic patient 
record, we presumed absence. This could introduce bias while determining the major 
and minor criteria for performing a CT-scan. However, this bias would be present in all 
years studied, and should not be of noteworthy effect for our primary and secondary 
outcomes. Demonstrating a causal link is also impossible with the retrospective 
design. Another limiting factor is the possibility of missing traumatic findings in 
patients who did not undergo a CT. Subsequently it is not possible to draw conclusions 
about whether too few CT-scans were performed in 2007-2009, or too many were 
performed in 2012-2015. In line with these limitations, our study was not designed to 
prove which situation (2007-2009 or 2012-2015) was better in the context of patient 
safety.
Between 2007 and 2015, a marked increase in CT ratio for MHI as well as hospitalizations 
has been observed. Several factors seem to contribute to this increase. Most likely, 
introduction of the MHI guideline is an important contributor at least to the increase 
in CT ratio. Since health care is getting more expensive and cost-effectiveness more 
important, an adjustment to the guideline should be considered. 
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Supplementary Material 
Supplementary Table 1. Patients with (possible) missed traumatic findings 
Patient Year PTA, LOC, 
confusion1
GCS1 CT indication2 CT on first ED visit CT on repeat ED visit (within 
30 days)
Clinical course
A 2007 Yes LOC, PTA 15 No3 No CT on first visit Day 2: epidural hematoma 
with midline shift, skull 
fracture
Neurosurgical intervention, full 
recovery
B 2009 No 15 Yes4 No CT on first visit Day 3: parenchymal contusion, 
acute subdural hematoma
Conservative treatment, 
patient died of a non-
neurologic cause on day 16
C 2012 Yes LOC, PTA 14 Yes5 Yes, no traumatic findings on 
first CT
Day 10: acute subdural 
hematoma with midline shift
Several neurosurgical 
interventions, patient died of 
a non-neurologic cause on 
day 27
D 2014 No 15 Yes6 No CT on first visit No repeat ED visit Patient died of an unknown 
cause on day 7
PTA: post traumatic amnesia; LOC: loss of consciousness; GCS: Glasgow Coma Scale score
2 According to the guideline introduced in 2010.
3 Age < 40 years, no external injury to the head, LOC, PTA < 2 hours, no other risk factors.
4 Age ≥ 40 years, external injury to the head, anticoagulants.
5 Age ≥ 40 years, external injury to the head, LOC, GCS 14, PTA < 2 hours.
6 Age ≥ 40 years, external injury to the head, anticoagulants. A CT head was not performed for 
unclear reasons. 
Supplementary Table 2. Crude and standardized CT ratio per year, hospital admission per year 
2007 2008 2009 2012 2014 2015
Crude CT ratio % 24.2 22.2 27.0 51.6 55.6 57.8
CT indication % 52.5 41.0 49.0 54.3 54.1 55.7
Standardized CT ratio % 46.2 54.2 55.1 94.9 102.9 103.8
Hospital admissions % 10.3 16.0 16.9 23.1 19.8 27.4
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Supplementary Table 1. Patients with (possible) missed traumatic findings 
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day 27
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PTA: post traumatic amnesia; LOC: loss of consciousness; GCS: Glasgow Coma Scale score
2 According to the guideline introduced in 2010.
3 Age < 40 years, no external injury to the head, LOC, PTA < 2 hours, no other risk factors.
4 Age ≥ 40 years, external injury to the head, anticoagulants.
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ABSTRACT
The objective of this systematic review and meta-analysis is to evaluate whether 
the pre-injury use of antiplatelet therapy (APT) is associated with increased risk of 
traumatic intracranial hemorrhage (tICH) on CT scan. Pubmed, Medline, Embase, 
Cochrane Central, reference lists and national guidelines on traumatic brain injury 
were used as data sources.
Eligible studies were cohort studies and case-control studies that assessed the 
relationship between APT and tICH. Studies without control group were not included. 
The primary outcome of interest was tICH on CT. Two reviewers independently 
selected studies, assessed methodological quality and extracted outcome data. 
This search resulted in ten eligible studies with 20,247 patients with head injury 
that were included in the meta-analysis. The use of APT in head injury patients was 
associated with significant increased risk of tICH compared to control (odds ratio 
1.87, 95% confidence interval 1.27 to 2.74). There was significant heterogeneity in the 
studies (I2 84%), although almost all showed an association between APT use and tICH. 
This association could not be established for patients on aspirin monotherapy. When 
considering only patients with mild traumatic brain injury (mTBI) the odds ratio is 2.72 
(95% CI 1.92-3.85). The results were robust to sensitivity analysis on study quality. 
In conclusion APT in head injury patients is associated with increased risk of tICH, 
this association is most relevant in patients with mTBI. Whether this association is the 
result of a causal relationship, and whether this relationship also exists for patients 
on aspirin monotherapy cannot be established with the current review and meta-
analysis. 
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Introduction
Traumatic brain injury is a major cause for morbidity and mortality worldwide.[1,2] 
Approximately 5% of emergency department (ED) visits are because of traumatic 
brain injury (TBI), and in the United States there are approximately 2.5 million TBI 
related ED visits annually.[1,3] For patients with severe (GCS 3-8) or moderate 
TBI (GCS 9-12) intracranial complications are frequent and a CT head is indicated 
in all patients.[4] In contrast, for patients with mild TBI (GCS 13-15) intracranial 
complications are infrequent (< 10%), and rarely require neurosurgical intervention 
(< 1%).[5] Nonetheless intracranial complications after head injury do occur and are 
potentially life threatening. To enhance efficiency without compromising on patient 
safety various decision rules and guidelines have been developed to identify patients 
with increased risk of intracranial complications.[4-9]
Whereas many decision rules and guidelines consider the use of vitamin K antagonists 
(e.g. warfarin) as risk factor for intracranial complications after minor head injury, 
antiplatelet therapy (APT) is not generally considered to be an independent risk 
factor for intracranial complications after minor head injury.[4-9] Recent publications 
however raised the question whether APT increases the risk of brain injury after head 
trauma.[10-20] Both the American ACEP (American College of Emergency Physicians) 
clinical policy on this subject as the British NICE (National Institute for Health and 
Care Excellence) guidelines stressed the need for research on this subject and the 
Scandinavian guidelines included antiplatelet therapy as a risk factor.[4,9,21] With 
the ageing population and hence the increasing use of aspirin, ticagrelor, clopidogrel 
and other antiplatelets the need to establish whether the pre-injury use of APT is 
associated with traumatic intracranial hemorrhage (tICH) becomes more and more 
urgent.[1,22]
This meta-analysis aims to quantitatively assess the available data from various 
studies regarding direct (< 24h) tICH on CT following head injury in relationship to 
APT use. 
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Methods
Identification of studies
We used the Preferred Reporting Items for Systematic Reviews and Meta-Analysis 
(PRISMA) to conduct our review and meta-analysis and also adhered to the Meta-
analysis Of Observational Studies in Epidemiology (MOOSE) guidelines.[23,24] A 
search of the databases Pubmed, Medline, Embase, Cochrane Central from inception 
to 29-09-2015 was made. The following combinations of search terms were used to 
search all databases: head trauma; brain injury; cerebral injury; brain trauma; cerebral 
trauma; brain contusion; cerebral contusion; brain concussion; cerebral concussion; 
anticoagulant; antithrombotic; platelet aggregation inhibitor; vitamin K antagonist; 
carbasalate calcium; aspirin; acetylsalicylic acid; clopidogrel; ticagrelor; dipyridamole; 
prasugrel; marcoumar; phenprocoumon; acenocoumarol; noac; doac; apixaban; 
rivaroxaban; dabigatran; heparin; enoxaparin nadroparin. 
We also searched the most important relevant guidelines for references and we 
searched the reference list of appropriate studies.[4,8,9,21]
Selection criteria, data extraction, quality assessment
We included retrospective as well as prospective observational cohort studies and 
case-control studies that evaluated the relationship between (any type of) APT 
use and tICH following head injury on CT in an ED setting. Studies without control 
group or studies outside the ED were excluded. Studies that only included patients 
with tICH were also excluded. Severity of the brain injury was no selection criteria 
for inclusion of the study. The main outcome measure was tICH on head-CT, other 
outcome measures of interest were neurosurgical intervention and mortality within 
six months, for studies to be eligible we had to be able to extract data on at least one 
of these outcomes. No limits were placed on characteristics of participants, date of 
publication or language of publication. 
Three authors (CB, TT, AR) selected articles and extracted data; each step in 
selection and data extraction was done independently by two of these authors. Any 
disagreements were resolved by discussion and consensus. We extracted data 
regarding: study design, study location, sample sizes, characteristics of participants 
(including age and GCS), intervention (type of APT), control group, outcome measure, 
measures of effect (including Odds Ratio) and quality of methods. Methodological 
quality of the studies was assessed independently by two authors (CB, TT, AR) with the 
Newcastle-Ottawa assessment scale (NOS).[25] Any disagreements were resolved 
by discussion and consensus. The NOS consists of three components assessing the 
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studies on selection (four items), comparability (one item) and exposure (three items). 
Each item is scored with a maximum of one star, except the item comparability, that 
could be scored two stars; therefore a maximum of nine stars can be scored. We 
rated studies as low risk of bias if they received nine stars, moderate risk of bias 
if they received seven or eight stars and high risk of bias if they received less than 
seven stars. 
Several attempts were made to contact all authors of included studies for additional 
information. The review was registered in the PROSPERO register as number 
CRD42015025458.
Statistical analysis
The pooled odds ratio and 95% confidence interval were calculated for the relationship 
between APT use and tICH. Pre-specified subgroup analyses were performed for 
severity of TBI (GCS > 13 or GCS ≥ 13), type of APT (aspirin; clopidogrel; other) and 
type of control group (no medication; warfarin). A random effects model was used.
We evaluated heterogeneity with the I2 test, which represents the proportion of 
variability not explained by chance alone. The likelihood of publication bias was 
assessed graphically with a funnel plot.[26]
All analyses were made with RevMan (version 5.3) from The Cochrane Collaboration 
(2014). 
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Results
Study selection
The search of Pubmed, Medline, Embase and Cochrane Central returned 831, 1099, 
2480, 117 results respectively. After correction for duplicates 3193 articles remained. 
After selection on title and abstract 3165 articles were excluded, leaving 28 articles. 
These 28 articles were analyzed in more detail to assess suitability. After this 
assessment another 17 articles were excluded, leaving eleven articles. Of these eleven 
articles two were based on the same study results, these results were only used once 
for this meta-analysis (Figure 1).[15,16]
Study characteristics
Ten studies (eleven publications) with a total of 20,247 participants met the inclusion 
criteria.[10-20] One study is a retrospective case-control study, the nine other study 
are cohort studies.[13] Eight cohort studies have a retrospective design and one has 
a prospective design. All studies are published in English since 2003, and conducted 
in three different Western countries in level I and II trauma centers (Table 1). Four 
studies looked specifically at the use of clopidogrel.[13-16, 20] One study assessed 
specifically the use of aspirin [18]. All other studies included different types and 
combinations of APT’s.[10-12,17,19] The control groups consisted of TBI-patients 
without (a type of) APT; in the study by Nishijima and in the study by Brewer the 
control group were TBI-patients on warfarin therapy. The age of included patients 
and severity of trauma varied between studies as is outlined in Table 1. 
Risk of bias within studies
Using the NOS, one study was rated as low risk of bias, while seven studies were rated 
as moderate risk of bias and two studies were rated as high risk of bias. The NOS 
ratings are included in Table 1. 
In the study by Cull et al selection bias was a major concern. The study included only 
patients registered in the trauma registry. This trauma registry only includes patients 
admitted to the hospital.[27] Admitted TBI-patients are not a random selection of all 
ED TBI patients and both tICH and the use of APT in itself can be reasons for hospital 
admission. The effect of the possible bias is reflected in the fact that the APT group 
had relatively less patients with severe TBI compared to the non-APT group (4.7% 
versus 10.2%) hence the APT-group might not be comparable with the non-APT group.
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Figure 1
Flow diagram of included studies
Bias in the studies by Ahmed and Dunham encompassed the same selection bias as 
the study by Cull (admitted patients only) besides this comparability between groups 
(GCS, age) was not reported in the manuscripts, although we did get this information 
from the Dunham study group. 
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Table 1. included studies
Source Design Setting Single/
Multicentre
Country Age GCS No of 
pts
APT Control Selection Compari-
bility
Outcome Risk of 
bias
Ahmed 2015 Retrospective cohort ED, level I Singlecentre U.S.A. >17 3-15 163 clopidogrel, ASA No APT ** ** *** Moderate 
risk
Brewer 2011 Retrospective cohort ED, level II Singlecentre U.S.A. >17 15 141* clopidogrel VKA ** * *** High risk
Cull 2015 Retrospective cohort ED, level I Multicentre U.S.A. >40 3-15 1547 clopidogrel, ASA No APT/VKA ** ** *** Moderate 
risk
Dunham 
2014
Retrospective cohort ED, level I Singlecentre U.S.A. >59 3-15 148 clopidogrel, ASA No APT/VKA ** ** *** Moderate 
risk
Fabbri 2010 Retrospective cohort ED, level I Singlecentre Italy >9 14.15 14228 ASA, ticlopidine, 
indobufen
No APT **** ** ** Moderate 
risk
Jones 2006 Retrospective case-
control
ED, level II Singlecentre U.S.A. >50 3-15 86† clopidogrel No clopidogrel - * ** High risk
Levine 2013 Retrospective cohort ED, level I Singlecentre U.S.A. >14 15 658 clopidogrel No 
clopidogrel/
VKA
*** ** *** Moderate 
risk
Nishijima 
2012
Prospective cohort ED, level 
I/II
Multicentre U.S.A. >17 3-15 1064* clopidogrel VKA **** ** *** Low risk
Riccardi 
2013
Retrospective cohort ED, level II Singlecentre Italy >65 15 2149 clopidogrel, ASA, 
ticlopidine
No APT/VKA **** * *** Moderate 
risk
Spektor 
2003
Retrospective cohort ED, level I Multicentre Israel >59 9-15 231 ASA No APT/VKA ** ** *** Moderate 
risk
* Patients with concomitant VKA and ASA use were excluded from analysis (Brewer 21 patients, 
Nishijima 107 patients)
† Not all patients sustained a head trauma, patients without head trauma were excluded from 
analysis (40 patients)
In the study by Brewer selection bias was also a major concern, the study only 
included trauma registry patients. This trauma registry only included patients 
admitted to or consulted by the trauma service [20]. These patients likely suffered 
from greater overall trauma compared to the non-trauma registry patients as 
stated by the authors. No information regarding comparability between groups 
was reported. 
The most important bias in the study by Fabbri was detection bias, as only in 63.3% 
of patients a CT scan was made.
The case-control study by Jones had very limited information in the manuscript 
and we were not able to get in contact with the authors. The study included both 
patients with head injury as patients without head injury and patients were matched 
for age, sex, mechanism of injury and Injury Severity Score. Because patients were 
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APT Control Selection Compari-
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Cull 2015 Retrospective cohort ED, level I Multicentre U.S.A. >40 3-15 1547 clopidogrel, ASA No APT/VKA ** ** *** Moderate 
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Dunham 
2014
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risk
Fabbri 2010 Retrospective cohort ED, level I Singlecentre Italy >9 14.15 14228 ASA, ticlopidine, 
indobufen
No APT **** ** ** Moderate 
risk
Jones 2006 Retrospective case-
control
ED, level II Singlecentre U.S.A. >50 3-15 86† clopidogrel No clopidogrel - * ** High risk
Levine 2013 Retrospective cohort ED, level I Singlecentre U.S.A. >14 15 658 clopidogrel No 
clopidogrel/
VKA
*** ** *** Moderate 
risk
Nishijima 
2012
Prospective cohort ED, level 
I/II
Multicentre U.S.A. >17 3-15 1064* clopidogrel VKA **** ** *** Low risk
Riccardi 
2013
Retrospective cohort ED, level II Singlecentre Italy >65 15 2149 clopidogrel, ASA, 
ticlopidine
No APT/VKA **** * *** Moderate 
risk
Spektor 
2003
Retrospective cohort ED, level I Multicentre Israel >59 9-15 231 ASA No APT/VKA ** ** *** Moderate 
risk
* Patients with concomitant VKA and ASA use were excluded from analysis (Brewer 21 patients, 
Nishijima 107 patients)
† Not all patients sustained a head trauma, patients without head trauma were excluded from 
analysis (40 patients)
In the study by Brewer selection bias was also a major concern, the study only 
included trauma registry patients. This trauma registry only included patients 
admitted to or consulted by the trauma service [20]. These patients likely suffered 
from greater overall trauma compared to the non-trauma registry patients as 
stated by the authors. No information regarding comparability between groups 
was reported. 
The most important bias in the study by Fabbri was detection bias, as only in 63.3% 
of patients a CT scan was made.
The case-control study by Jones had very limited information in the manuscript 
and we were not able to get in contact with the authors. The study included both 
patients with head injury as patients without head injury and patients were matched 
for age, sex, mechanism of injury and Injury Severity Score. Because patients were 
not matched for GCS and no information is provided regarding GCS we do not know 
if the groups are comparable in this regard, GCS is known to be the most important 
predictor of tICH.[5,6]
In the retrospective study by Levine only patients that underwent a CT-head were 
included, this may have caused selection bias. 
The study by Nishijima is the only prospective trial in this review, it was generally well 
set up, unfortunately patients on clopidogrel were only compared to warfarin and not 
to a control group without antithrombotic medication. This may underestimate the 
risk of clopidogrel as warfarin is generally regarded as a risk factor for tICH.[4,8,9]
The study by Riccardi did not report comparability of baseline characteristics between 
the APT group and the non-APT group.
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Finally in the study by Spektor it was not clear from the manuscript in which way the 
selection of patients was done and if consecutive patients were included. 
Outcomes
Combining all data for a summary OR we found an increased risk for tICH in patients 
with APT versus patients without APT. The overall OR was 1.87 (95% CI 1.27-2.74) 
(Table 2, Figure 2) 
Risk of bias across studies
Strong evidence of heterogeneity (I2 84%) was observed. To explore this heterogeneity 
a funnel plot was drawn, which showed only minor asymmetry with no indication for 
publication bias. (Supplementary Figure 1)
Additional analysis
Based on the risk of bias a sensitivity analysis was performed, excluding all studies 
with a high risk of bias. The odds ratio for APT as a risk factor for the development of 
intracranial traumatic complications was 2.02 (95% CI 1.33-3.08; I2 87%) for the low-
intermediate risk of bias studies. We also performed a sensitivity analysis excluding 
the study by Spektor, which only included patients with aspirin use. The result of that 
analysis was an OR of 2.02 (95% CI 1.35-3.03; I2 85%). Finally we did a sensitivity 
analysis that only included studies with patients with mild TBI (GCS 13-15), which 
resulted in an OR of 2.72 (95% CI 1.92-3.85; I2 53%).
Table 2. study outcomes
Source tICH APT-group tICH non-APT-group
Ahmed (2015) 35/52 (67.3%) 56/111 (50.5%)
Brewer (2011) 15/36 (41.7%) 23/84 (27.4%)
Cull (2015) 198/422 (46.9%) 504/1125 (44.8%)
Dunham (2014) 35/76 (46.1%) 23/72 (31.9%)
Fabbri (2010) 180/1366 (13.2%) 700/12862 (5.4%)
Jones (2006) 9/25 (36.0%) 10/21 (47.6%)
Levine (2013) 3/10 (30%) 14/648 (2.2%)
Nishijima (2012) 29/252 (11.5%) 36/705 (5.1%)
Riccardi (2013) 22/617 (3.6%) 25/1532 (1.6%)
Spektor (2003) 27/110 (24.5%) 31/121 (25.6%)
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Figure 2
Forrest plot of included studies.
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Discussion
We conducted a systematic review and meta-analysis of the literature to assess the 
association between the use of APT and tICH. 
Evidence from the nine available studies suggests that pre-injury APT use is 
associated with an increased incidence of tICH. However, this conclusion should be 
interpreted with caution given the high heterogeneity and methodological flaws of 
several included studies in this review. To our knowledge the current meta-analysis 
is the only quantitative analysis of pooled data on this topic. 
The use of APT seems to be most relevant in patients with mild TBI, it is in these 
patients that APT use may direct the clinical decision whether to scan or admit the 
patient or not. 
Important to mention, but outside the scope of this review, there are indications that 
patients on APT not only have a higher risk of tICH, but those with tICH also do have 
a higher risk of unfavorable outcome.[13,28-32]
Studies comparing APT and VKA therapy are limited, the limited studies available 
mainly included patients with clopidogrel and patients with warfarin therapy.[15,16,20] 
These studies do not show that the tICH risk associated with clopidogrel use is lower 
than that associated with warfarin use. Hence it could be advisable to use the same 
guidelines for scanning and disposition for clopidogrel therapy as apply for VKA 
therapy in (mild) TBI patients. Whether this is also advisable for other antiplatelet 
therapy cannot be answered based on the current review.
Another consideration, which is also outside the scope of this review, is whether 
routine administration of platelets in patients with tICH and APT is useful. There is only 
low quality evidence from observational studies, and the results of these studies are 
contradictory.[31-36] Both a systematic review and a recent guideline by the AABB 
(formerly American Association of Blood Banks) conclude that there is insufficient 
evidence to recommend for or against platelet transfusion in patients with tICH while 
receiving APT.[37,38] Routine administration of platelets in TBI patients receiving APT 
without evidence of hemorrhage on CT does not seem to be indicated.[38]
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Limitations
This review and meta-analysis has a number of limitations and the results of this 
review should be interpreted in the light of these limitations. First, the patient 
population, APT use, control group and outcome definitions are not the same across 
studies. This resulted in significant heterogeneity across studies. Second, the overall 
quality of the included studies was low. All the original studies were observational 
studies and almost all studies had a retrospective design with consequently a 
higher risk of bias. Especially selection bias was a concern in many of the included 
studies. Because of the design of the studies it is impossible to establish a causal 
relationship of APT use and the risk of tICH. Confounding, as in any meta-analysis 
of observational studies, may introduce considerable bias. Another limitation is that 
in this review APT is considered as a group, it is unlikely however that all different 
antiplatelet medications will have the same risk of tICH, there were insufficient studies 
on different antiplatelet medications to specify the risk of different APT’s. Especially 
for patients on low-dose aspirin monotherapy it is uncertain if the risk for tICH is 
increased, the only included study that assessed aspirin as risk factor for tICH did 
not find an increased risk. Finally although tICH is generally regarded as important in 
the disposition and treatment of TBI patients, this is in fact a surrogate outcome for 
mortality and morbidity following TBI. 
Clinical implications
Considering the observed association between APT use and tICH, APT use should 
be considered as a potential risk factor for tICH in future guidelines regarding (mild) 
TBI. Whether patients on low-dose aspirin monotherapy do have an increased risk 
of tICH as well cannot be concluded based on the current review and meta-analysis 
because of limited literature. 
Conclusions
Although the estimates of the association between APT and tICH are clinically relevant, 
they are still somewhat preliminary and do not prove that APT use increases the risk 
of tICH. Additional prospective studies are needed to confirm and quantify findings 
further. These studies could also give an indication whether a causal relationship 
between APT and tICH is probable, and explore the risks of different types of APT’s. 
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ABSTRACT
The aim of this study was to determine the association between bicycle helmet use in 
adults (16 years and older) and traumatic brain injury (TBI) in emergency departments 
(EDs) in the Netherlands
The conducted research was a retrospective case-control study in patients aged 16 
years and older that sustained a bicycle accident and therefore visited the EDs of 
participating hospitals throughout 2016. Cases were patients with TBI; controls were 
patients without TBI but with other trauma. Exposure was defined as helmet wearing 
during the accident. 
In total 2133 patients were included in the study, 361 case patients and 1772 controls. 
Within the TBI group (cases) 3.9% of the patients wore a helmet compared to 7.7% of 
patients in the control (non-head injury) group (odds ratio [OR] 0.49, 95% confidence 
interval [CI] 0.28-0.86). No difference in helmet wearing was observed in patients that 
sustained accidents which involved motorized vehicles (OR 0.91; 95% CI 0.29-2.83).
In conclusion adult patients (≥ 16 years of age) with TBI had a significantly lower 
odds of wearing a bicycle helmet than adult patients with other trauma, adding more 
evidence that wearing a bicycle helmet effectively protects against TBI. 
79
Bicycle helmets and traumatic brain injury in the Netherlands
5
Introduction
Worldwide cycling is a popular form of recreation and a cheap and environmentally 
friendly mode of transportation. In the Netherlands, a small and densely populated 
country, cycling is very popular. In fact, the Netherlands could be called the number 
one cycling country in the world. An average of approximately 900 kilometers per 
inhabitant is cycled each year, this is by far the most in the world and about 20 
times as much as in the United States{Stichting BOVAG-RAI mobiliteit, #4}.[1-3] This 
translates to 27% of all trips in the Netherlands being done by bicycle, again more 
than in any other country in the world.[4] 
{Stichting BOVAG-RAI mobiliteit, #4}Cycling is also a relative safe mode of 
transportation compared to other modes of transportation and the health benefits 
of cycling are substantially higher than the risks associated with cycling. [5,6] 
Moreover, there is a correlation between bicycle use in a country and the fatality 
rate among cyclists. Higher bicycle use in a country is associated with lower 
fatalities with the Netherlands having the lowest fatality rate per kilometer cycled.
[3] However, despite investments in road safety and overall decreasing incidence of 
traffic fatalities, injuries and fatalities among cyclists did not significantly decrease 
in the last 20 years in the Netherlands. Currently, bicycle accidents are responsible 
for over 70% of all severely injured traffic participants in the Netherlands.[7] Severe 
injury as a result of bicycle accidents has increased by 35% in the last 10 years 
and. Especially in elderly traffic participants this increase is significant even when 
correcting for ageing of the population, one possible explanation is that the elderly 
do cycle a lot more nowadays than they used to in the past, for example because 
of the introduction of e-bikes.[7,8] The rise of traumatic brain injury (TBI) is not 
only responsible for the growing incidence of persons with bicycle related injury 
presenting at the emergency department (ED), but TBI is also the most important 
cause of death and long-term disability from bicycle injury.[9-13] Hence, it is crucial 
to reduce TBI incidence among cyclists. 
An obvious way to realize less TBI in cyclists could be by promoting bicycle helmets. 
However, both public opinion and the scientific literature are divided about bicycle 
helmets. Some claim that bicycle use decreases after helmets became obligatory 
in different countries and as a result the health benefits of helmets were negated. 
For example, bicycle use in New Zealand declined by 51% after it became obligatory 
to wear a bicycle helmet. [14] Other authors question whether there is any causality 
between the decline in cycling and the bicycle helmet law.[15,16] Regarding the 
protective value of bicycle helmets two meta-analysis that included mostly case-
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control studies both concluded that bicycle helmets reduce serious and fatal head 
injury by approximately 60-70%.[17,18] However, some other studies question (the 
magnitude of) this protective effect of bicycle helmets.[19-22]
Although many studies have been done to examine the effectiveness of bicycle 
helmets, remarkably no such study has been performed in the Netherlands. In 
contrast to other countries, in the Netherlands bicycle helmets are not mandatory or 
common and bicycle helmet use is fiercely debated.[23-25] 
In the current study we examine the association between bicycle helmet use in adults 
(16 years of age and older) and TBI cases in EDs in the Netherlands. 
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Methods
Data sources and inclusion
In this retrospective case-control study patients aged 16 years and older who 
sustained a bicycle accident and therefore visited the EDs of participating hospitals 
throughout 2016 were included using the Dutch Injury Surveillance System (Letsel 
Informatie Systeem; LIS). Cases were defined as patients with TBI who visited the ED 
of one of the participating hospitals; controls were defined as patients without TBI 
but with other trauma who visited these EDs. Exposure was defined as (self-reported) 
helmet-wearing during the accident. 
The LIS database is a continuous monitoring system in which in addition to 
demographics, injury diagnoses and injury mechanisms are registered. LIS is based 
on 13 geographically distributed EDs in the Netherlands, resulting in a representative 
12%-15% sample of injury-related ED visits that can be extrapolated to national 
estimates. For extrapolation of the sample a factor was calculated in which the number 
of trauma-related ED treatments in LIS hospitals was multiplied by the quotient of 
all trauma-related hospital admissions in the Netherlands divided by trauma-related 
hospital admissions in LIS hospitals.[26-29]
To study bicycle-related accidents, extra information was gathered in all LIS hospitals 
in 2016. Patients who sustained a bicycle accident received a questionnaire within two 
months after their visit to the ED. Patients were asked to complete the questionnaire 
online or to fill out a paper questionnaire. Ultimately, a sensitivity analysis was 
conducted in which the study population was corrected for selective (non-)response 
by a weighing factor, using the age and gender distribution from the total patient 
population for bicycle accident-related ED treatments from the LIS database. 
The study was submitted to the medical ethics review committee (reference number 
W16_151#16.175) which concluded that the Medical Research Involving Human 
Subjects Act (WMO) was not applicable. Therefore, official approval of this study by 
the medical ethics review committee and was not required.
Exclusion
All participants who were not driving on public roads (i.e. parcourse, dirt track, private 
property) were excluded. Because we focused on the risk on TBI in normal traffic, 
we also excluded cyclists who were travelling at a self-reported speed of 25 km/h 
or more. 
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Patients with isolated injury to the eyeball and/or to the scalp were excluded from the 
control group because helmet wear possibly protects against these injuries. Patients 
with a combination of injuries that included scalp or eyeball injury were not excluded 
from the study. 
Data and statistical analysis
Data were analyzed using descriptive statistics, χ2 tests and Mann-Whitney U tests 
where appropriate. Significance threshold was set at P < 0.05. The Statistical Package 
for the Social Sciences (IBM Corp., IBM SPSS Statistics for Windows, version 22.0. 
Armonk, New York, USA) was used for statistical analysis.
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Results
Between January 1, 2016 and December 31, 2016, 9013 patients were treated for a 
bicycle accident in the ED of participating LIS hospitals. Of these 9013 patients 3146 
returned a usable questionnaire. After exclusion of patients under 16 years of age, or 
with other exclusion criteria, 2133 patients were included in the analysis (Figure 1). 
These 2133 patients were 361 cases (patients with TBI) and 1772 controls (patients 
without TBI). Of the entire group 60.4% were female. The mean age was 58.5 years. 
To assess comparability of cases (patients with TBI) and controls (patients without 
TBI), patients without helmet wear were compared between cases and controls. 
It appeared that patients with TBI were more often male than controls; no other 
significant differences were observed between cases and controls (Table 1).
Figure 1. 
Overview of cases included in analysis
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Table 1a. Baseline characteristics of cases and controls all patients.
Cases (TBI) 
n=361
Controls (non-TBI) 
n=1772
Missing P-value
Age, years (mean) 58.7 58.5 0 0.63
Male sex (n, %) 161 (44.6%) 684 (38.6%) 0 0.03
Helmet wear (n, %) 14 (3.9%)1 135 (7.7%)1 16 (0.8%) 0.03
Motorized vehicle collision (n, %) 70 (40.9%)2 242 (32.4%)2 1214 (56.9%)# 0.03
Bicycle type (n, %) 26 (1.2%)
Commuter bicycle 205 (57.7%)3 951 (54.3%)3 0.23
Mountain bike 8 (2.3%)3 46 (2.6%)3 0.69
Racing bike 18 (5.1%)3 125 (7.1%)3 0.16
Bike with pedal support 117 (33.0%)3 602 (34.4%)3 0.61
Other 7 (2.0%)3 28 (1.6%)3 0.62
1 Unknows and missings (for helmet wear) are excluded: cases (TBI) n=359, controls (non-TBI) 
n=1758
2 Unknows and missings (for cause of accident) are excluded: cases (TBI) n=171, controls (non-TBI) 
n=748
3 Unknowns and missings (for bike types) are excluded: cases (TBI) n=355, controls (non-TBI) 
n=1752
Table 1b, Baseline characteristics of cases and controls only patients without helmet wear
Cases (TBI) 
n=345
Controls (non-TBI) 
n=1623 
Missing P-value
Age, years (mean) 59.0 58.7 0 0.71
Male sex (n, %) 149 (43.2%) 566 (34.9%) 0 < 0.01
Motorized vehicle collision (n, %) 66 (40.5%)1 225 (33.4%)1 1131 (57.5%)# 0.09
Bicycle type (n, %) 26 (1.2%)
Commuter bicycle 202 (59.6%)2 935 (58.3%)2 0.67
Mountain bike 7 (2.1%)2 23 (1.4%)2 0.39
Racing bike 6 (1.8%)2 31 (1.9%)2 0.84
Bike with pedal support 117 (34.5%)2 589 (36.7%)2 0.44
Other 7 (2.1%)2 25 (1.6%) 0.51
1 Unknows and missings (for cause of accident) are excluded: cases (TBI) n=163, controls (non-
TBI) n=674
2 Unknowns and missings (for bicycle types) are excluded: cases (TBI) n=339, controls (non-TBI) 
n=1603 
# The high number of missings is probably caused by the nature of the question “what did you collide 
with?” in many cases this was unknown or not applicable. 
85
Bicycle helmets and traumatic brain injury in the Netherlands
5
Within the TBI group (cases) 3.9% of patients wore a helmet compared to 7.7% of 
patients in the control (non-TBI) group (odds ratio [OR] 0.49, 95% confidence interval 
[CI] 0.28-0.86). These differences were clearly visible in patients with accidents that 
did not involve motorized vehicles (OR 0.27; 95% CI: 0.08-0.87). In contrast, in patients 
with accidents that involved motorized vehicles no difference was found between the 
groups (OR 0.91; 95% CI: 0.29-2.83; Table 2). 
Table 2. Odds for traumatic brain injury in cyclists 
Odds 
ratio
95% confidence 
interval
p-value
Odds for TBI wearing a helmet 0.49 0.28 0.86 0.01
Odds for TBI in a motorized vehicle collision wearing a 
helmet
0.91 0.29 2.83 0.87
Odds for TBI in an accident without motorized vehicle 
wearing a helmet
0.27 0.08 0.87 0.03
Odds for mild traumatic brain injury wearing a helmet 0.47 0.25 0.88 0.02
Odds for severe traumatic brain injury wearing a helmet 0.54 0.17 1.74 0.30
For all different types of bicycles patients were less likely to have worn a helmet in 
the TBI group compared to the control (other injury) group. However, this difference 
did not reach statistical significance in any of the bicycle types (Table 3).
Table 3. Odds for traumatic brain injury per bicycle type (helmet wearing vs not helmet wearing)
Odds ratio 95% confidence interval p-value
Commuter bicycle 0.58 0.07 4.65 0.61
Mountain bike 0.15 0.02 1.32 0.09
Racing bike 0.67 0.23 1.93 0.45
Bike with pedal support 0.26 0.02 4.57 0.36
A sensitivity analysis was performed to correct for selective (non)-response to the 
questionnaire. This additional analysis did not essentially change the results of the 
study. The odds of wearing a bicycle helmet in TBI compared with other trauma was 
0.52 (95% CI: 0.29-0.94) in the sensitivity analysis. 
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Discussion
Adult patients (≥ 16 years of age) who presented to the ED with TBI wore a bicycle 
helmet significantly less often than adult patients that presented with other trauma. 
Therefore, wearing a bicycle helmet appears to effectively protect against TBI. 
However, when focusing on adult cyclists who experienced a motorized vehicle 
collision (MVC) we found no indication for a reduced risk of TBI because of bicycle 
helmet use. 
In recent years there has been a fierce discussion about the use, active promotion, or 
even obligation of bicycle helmets. On one side of the spectrum are the promotors of 
bicycle helmets who claim that it is a good way to halt the growing incidence of bicycle 
related TBI especially in vulnerable groups such as children and elderly.[22,25,30-
32] On the other end of the spectrum there is fierce opposition to active promotion 
or obligatory use of bicycle helmets. Opponents of (obligatory) helmet use doubt the 
protection offered by helmets and fear that obligatory helmet use will lead to decline 
in cycling.[13,24,33,34] 
In our control group 7.7% of patients wore a helmet, which is comparable to results of 
a survey conducted in 2008, in which 7.5% of all cyclists with a self-reported speed 
of less than 25km/h without head injury wore a helmet (unpublished data, obtained 
from VeiligheidNL).[35] In our control group helmet use is still very infrequent on 
commuter bicycles (0.8%), but high on racing bikes (75%) and mountain bikes (49%). 
These results are all comparable to those in the 2008 survey. 
The results of this study appear to show that helmet use in cyclists reduces the risk 
of TBI. However, the case-control design of the study makes it impossible to draw 
firm conclusions regarding a causal relationship or magnitude of this relationship. 
Opponents of this theory point out that another explanation for the observed OR is that 
cyclists with helmet-use are more often sports cyclists (mountain bikers and racing 
cyclists) who according to some might have relatively more non-TBI trauma than 
other cyclists.[36] Our results do not support this explanation, as the ratio between 
TBI and non-TBI was not different for (non-helmet wearing) sports cyclists compared 
to those on normal bicycles. 
We found no significant relationship between bicycle helmet use and (reduced) risk 
of TBI when bicyclists were involved in MVCs. This could be explained by the fact 
that bicycle helmets are designed to protect against an impact of approximately 
20km/h, in most MVCs the impact is likely to be (much) higher.[37] The assumed 
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larger protective effect in one-sided bicycle crashes compared with bicycle-MVCs is 
in line with an earlier study.[38] However, this does not have to discredit the bicycle 
helmet use because motorized vehicles were involved in a minority of TBIs in our 
study. This is in line with other research on this subject that also shows that in the 
majority of the patients with TBI no motorized vehicles were involved.[25] 
Strengths and limitations
The current study is the first study of its kind in the Netherlands. Strengths of the 
study are the large number of participants and the detailed information obtained. 
Limitations of our study include the lack of exact information about the bicycle 
helmet use in the Netherlands in non-injured cyclists. Therefore, we used patients 
who presented to the ED without head injury as a control group as we had exact 
information about helmet use in that group. In addition, bicycle helmet use in our study 
(7.7% in the control group) was comparable to a survey in 2008 that showed a bicycle 
helmet use of 7.5% in patients without head injury.[35] Another related limitation 
is the case-control design of the study; therefore only association and no causal 
relationship between helmet use and TBI can be proven. Also, the response rate of 
37% is an additional limitation of this study. The primary analysis was conducted using 
the unweighted results, hence not corrected for selective non-response. Therefore, 
these results may not be representative for the entire LIS population. To take this 
into account a sensitivity analysis, corrected for selective non-response in certain 
demographic groups, was also performed. 
Possible selective non-response based on injury severity is not known and could not 
be corrected for. However, we have no indication that this affected patients with or 
without helmets unevenly.
Conclusions
In this study we found that patients with TBI due to bicycle accidents did not wear 
helmets as often as a comparable control group. This association could not be 
established for patients with TBI as a result of a collision between a bicycle and a 
motorized vehicle. This study has some limitations, but the results strongly suggest 
that TBI in adult cyclists could be reduced if cyclists in the Netherlands would 
wear a helmet more often. Future research should focus on establishing the exact 
frequency of bicycle helmet use in the Netherlands and ways to promote this without 
discouraging cycling.
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CHAPTER 6
External validation of computed tomography 
decision rules for minor head injury: 
prospective, multicentre cohort study 
in the Netherlands
ABSTRACT
Objective
To externally validate four commonly used computed tomography (CT) decision rules 
for minor head injury (MHI). 
Design and Setting
Prospective multicenter cohort study in three university and six non-university 
hospitals in the Netherlands.
Participants
Consecutive adult patients aged 16 years and over who presented with MHI at the 
emergency department with a Glasgow Coma Scale score of 13-15 between March 
2015 and December 2016.
Main outcome measures
The primary outcome was any intracranial traumatic finding on CT; the secondary 
outcome was a potential neurosurgical lesion on CT. We compared the sensitivity, 
specificity and clinical usefulness, (defined as net benefit, a weighted sum of true 
positive classifications) of four CT decision rules: CT in Head Injury Patients (CHIP) 
rule; New Orleans Criteria (NOC); Canadian CT Head Rule (CCHR); and National 
Institute for Health and Care Excellence (NICE) guideline for head injury. 
Results
For the primary analysis, only six centers that included patients with and without CT 
were selected. Of 4557 eligible patients who presented with minor head injury, 3742 
(82%) received a CT scan; 384 (8%) had a intracranial traumatic finding on CT, and 74 
(2%) had a potential neurosurgical lesion. The sensitivity for any intracranial traumatic 
finding on CT ranged from 73% (NICE) to 99% (NOC); specificity ranged from 4% (NOC) 
to 61% (NICE). Sensitivity for a potential neurosurgical lesion ranged between 85% 
(NICE) and 100% (NOC); specificity from 4% (NOC) to 59% (NICE). Clinical usefulness 
depended on thresholds for performing CT scanning: the NOC rule was preferable at 
a low threshold, the NICE rule was preferable at a higher threshold, whereas the CHIP 
rule was preferable for an intermediate threshold.
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Conclusions
Application of the CHIP, NOC, CCHR, or NICE decision rules can lead to a wide variation 
in CT scanning among patients with minor head injury, resulting in many unnecessary 
CT scans and some missed intracranial traumatic findings. Until an existing decision 
rule has been updated, any of the four rules can be used for patients presenting minor 
head injuries at the emergency department. Use of the CHIP rule is recommended 
because it leads to a substantial reduction in CT scans while missing few potential 
neurosurgical lesions.
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Introduction
Minor head injury (MHI) or mild traumatic brain injury is a common injury increasingly 
seen in emergency departments.[1,2] Possible causes for this increase are ageing of 
the population and increased awareness of the potential intracranial complications 
of MHI among general practitioners and paramedics.[3,4] Although the risk of 
intracranial complications after MHI is low, the consequences are important as these 
patients require close observation and sometimes even neurosurgical intervention.
[5] Several clinical decision rules exist that aim to identify those patients with MHI 
who are at high risk for intracranial complications and need computed tomography 
(CT) of the head. Examples of frequently used decision rules are: the New Orleans 
Criteria (NOC); Canadian CT Head Rule (CCHR); and the National Institute for Clinical 
Excellence (NICE) guideline for Head injury (Supplementary Table 1).[6-8] 
The purpose of these rules is to detect all relevant intracranial traumatic lesions 
while minimizing the number of unnecessary CT scans. Relevant lesions are those 
that need neurosurgical intervention or prolonged clinical observation because of 
a risk of neurological deterioration. Although the number of patients that present 
at the emergency departments with MHI has increased substantially, the overall 
incidence of disease specific mortality after head injury has remained fairly stable.
[9] An increased number of patients leads to more CT scans, longer waiting times at 
the emergency department, burden for the patients, radiation risks, and higher costs.
[10] The need for reliable CT decision rules for MHI to reduce unnecessary CT scans 
is therefore even more apparent. 
Two of the decision rules have been developed for patients who had had blunt trauma 
to the head, have a Glasgow Coma Scale (GCS) of 13-15 at presentation, and have 
experienced loss of consciousness (LOC) and/or posttraumatic amnesia (PTA).[6,7] 
However, these rules cannot be applied to patients without LOC or PTA.[11,12] Therefore 
a new decision rule was developed, the CT in Head Injury Patients (CHIP) rule, which 
includes patients with and without LOC or PTA.[13] The potential reduction of CT scans 
by use of the CHIP rule was estimated at 23% compared to scanning of all patients.[13]
The NOC, CCHR and NICE guideline were externally validated in previous studies, but 
there has been no external validation of the CHIP rule, even though this is necessary 
to determine whether the rule is generally applicable.[14-21] Our aim was to perform 
an external validation of frequently used CT decision rules for MHI (CHIP, NOC, CCHR, 
NICE) and compare their performance in a multicenter study in the Netherlands in 
university and non-university hospitals.
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Methods
Study design
We conducted a prospective, multicenter cohort study between March 2015 and 
December 2016 in the Netherlands. Three university emergency departments (all level 
1 trauma centers) and six non-university emergency departments (trauma level 1 (two 
centers), trauma level 2 (two centers) and trauma level 3 (two centers)) participated 
in this study. The emergency departments were all situated at an urban location. 
Institutional ethics and research board approval was obtained and informed consent 
was waived.
Inclusion criteria were age 16 years and over, presentation within 24 hours after 
blunt trauma to the head and a GCS score of 13-15 at presentation at the emergency 
department. Patients with and without LOC or PTA were included. We excluded all 
patients with a GCS score less than 13, patients younger than 16 years, transferred 
from other hospitals or with any contra-indication for CT. 
Definition of risk factors
Clinical data concerning risk factors for intracranial complications used in the 
CCHR, NOC, NICE and CHIP decision rules were collected.[6-8,13] These clinical risk 
factors were: age, history of coagulopathy, use of anticoagulants, dangerous trauma 
mechanism (pedestrian/cyclist versus vehicle, ejected from vehicle, fall from elevation 
(more than 1 meter or 5 stairs) or an equivalent mechanism), fall from any elevation, 
loss of consciousness reported by patient or witness (presence and duration), 
retrograde amnesia (presence and duration), posttraumatic amnesia (presence and 
duration), headache, vomiting (frequency), intoxication with drugs or alcohol (history or 
suggestive findings on examination), posttraumatic seizure, GCS score on presentation, 
significant injury above clavicles, suspected open or depressed skull fracture, contusion 
of skull, clinical signs of skull base fracture (for example: raccoon eyes, battle sign, 
hemotympanum, CSF otorrhea, CSF rhinorrhea, palpable discontinuity, bleeding from 
ear), neurological deficit (paresis, dysphasia or other such as cranial nerve damage 
including diplopia, changes in sensibility, asymmetrical reflexes or pathological reflexes, 
coordination problems and ataxia), GCS deterioration 1 hour after presentation. 
Main outcome measures
The primary outcome was any intracranial traumatic finding on CT, defined as a 
subdural hematoma, epidural hematoma, subarachnoid hemorrhage, cerebral 
lesions (hemorrhagic contusion, non-hemorrhagic contusion, diffuse axonal injury), 
intraventricular hemorrhage, and skull fracture. The secondary outcome was any 
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potential neurosurgical lesion, which was defined as an intracranial traumatic finding 
on CT which could lead to a neurosurgical intervention or death. Examples of potential 
neurosurgical lesions are an epidural hematoma, large acute subdural hematoma 
(mass), large contusion(s) (mass), depressed skull fracture, and any lesion with a 
midline shift or herniation. To compare our findings with previous studies we also 
assessed the performance of decision rules for detecting neurosurgical interventions. 
All outcome measures were chosen a priori.
Study procedures
During patient inclusion in the study, neurologists (in training) and emergency 
physicians (in training) followed their local guideline for CT scanning in patients with 
MHI. Most participating centers used the same national guideline based on the CHIP 
rule, two centers followed a slightly adapted guideline (Supplementary Table 2). 
Eligible patients were consecutively included by trained researcher physicians, 
who did not personally interview the patients. Clinical data were collected before 
diagnostic tests as far as possible by using forms the clinicians could fill in for each 
patient. The head CT scans were performed according to a routine trauma protocol at 
each hospital. The CT scans were interpreted by (neuro)radiologists who were aware 
of the patient’s history and clinical findings, but they were not aware of the actual 
score of the CT decision rules. 
The clinical risk factors were collected by taking the patient’s history or information 
from a witness or family member. Characteristics such as injury severity score were 
also collected. All patients’ details about hospital admission, neurosurgical intervention, 
and moment of discharge were collected. If the patient was scanned, details about CT 
findings were recorded. The electronic health records were reviewed 30 days after 
the injury to assess follow-up information about a neurosurgical intervention. All data 
were entered by researcher physicians in the case report forms of the web based 
data management system OpenClinica (LCC, version 3.12.2).
Data management
After patient inclusion and data entering, two authors (KAF and CLvdB) checked the 
database for correct patient inclusion and completeness of data using IBM statistical 
package for social sciences (SPSS) version 21. Missing data were assumed to be 
missing at random; so to avoid bias, missing data were imputed on the basis of all the 
risk factors mentioned above, using multiple imputation (n=5) with the “multivariate 
imputation by chained equations” function in R, version 3.3.2 (R foundation for 
statistical computing).
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Data analysis 
The study population was described in terms of demographic characteristics, risk 
factors, admission to the hospital, and neurosurgical intervention. In patients with a CT 
scan, we also evaluated any intracranial traumatic findings and potential neurosurgical 
lesions on CT. Continuous variables were described as mean and interquartile range, 
categorical variables as frequencies and percentages.
The diagnostic performance of the CHIP, NOC, CCHR, and NICE decision rules for 
detecting intracranial traumatic findings and potential neurosurgical lesions were 
compared. Because the NOC and CCHR rules were developed in a specific patient 
population, we performed the analysis in our entire study population, as well as in 
a subset of the study population (based on the inclusion/exclusion criteria of the 
development studies of the NOC and CCHR; referred to as original NOC and original 
CCHR), and in our entire study population with adjustment of the rules. In the adjusted 
rules, the exclusion criteria of the NOC and CCHR rules were added as additional risk 
factors (referred to as adjusted NOC and adjusted CCHR). For the NOC rule, a Glasgow 
coma scale score of 13 or 14 and presence of neurological deficit were added. Finally, 
for the CCHR rule, use of anticoagulation, post-traumatic seizure, and presence of 
neurological deficit were added. All patients who had a risk factor according to the NOC 
or CCHR rules scored positive on these rules, indicating that they needed a CT scan. 
The sensitivity, specificity, and proportion of patients needing a CT scan (with 95% 
confidence intervals) were assessed for each of the four decision rules. Sensitivity 
was calculated by dividing the number of patients in whom the outcome measure was 
present and the decision rule was positive, by the total number of patients in whom 
the outcome measure was present. Specificity was calculated by dividing the number 
of patients in whom the outcome measure was absent and the decision rule was 
negative, by the total number of patients in whom the outcome measure was absent. 
The Cochran’s Q test was used to directly compare the sensitivities and specificities 
between the four decision rules, but it should be noted that results of this test do not 
automatically imply that any one rule is better than the other.[22] The proportion of 
patients needing a CT scan was calculated by dividing the number of patients in whom 
the decision rule was positive by the total number of patients. Confidence intervals 
were calculated by a bootstrapping method in R, which analyses the performance for 
each rule 500 times and derived the confidence intervals from the results.
In patients without a CT scan the outcomes could not be observed. In these 
patients the expected outcomes (any intracranial traumatic finding and potential 
neurosurgical lesion) were imputed based on their risk factors with multiple 
102
Chapter 6
imputation, in order to avoid selection bias and thus yield unbiased estimates of 
sensitivity and specificity.[23] This imputation was possible for patients from six of 
the nine centers, because the other three centers had not included patients without 
a CT scan. The patients with and without CT scans (with imputed outcomes) from 
these six centers were used for the primary analysis. In addition, we analyzed all 
patients with a CT scan from all the centers in a secondary (sensitivity) analysis, 
which in theory would lead to an overestimation of sensitivity and underestimation 
of specificity of all the rules.
In this decision problem, avoiding false negatives was more important than 
avoiding false positives: a false negative result leads to not performing a CT 
scan and thus potentially misses a lesion, whereas a false positive result leads to 
performing an unnecessary CT scan. The decision rule should identify all patients 
with potential neurosurgical lesions and most with intracranial traumatic findings, 
because of the severe clinical consequences (intracranial surgery, neurological 
sequelae, death).
Net proportional benefit has been proposed to incorporate such weighting in 
calculation of clinical usefulness of decision rules.[24,25] For each rule, we 
expressed the net proportional benefit using the formula: (true positives/total 
number) - weight×(false positives/total number). Over a range of different weights, 
the net proportional benefit was calculated and compared with the scanning of all 
patients. The weight in this formula expresses the ratio of harmful consequences 
due to a false positive divided by the harmful consequences of a false negative, 
and it is equivalent to the odds of a lesion above which one would perform a CT 
scan. At a low threshold for performing CT, we would avoid false negatives of the 
decision rule (that is, maximize true positives) at the cost of performing many CT 
scans: if the threshold is 1%, this level implies performing 100 CT scans to avoid 
one missed lesion. At a higher threshold for performing CT, we would avoid false 
positives of the decision rule: if the threshold is 10%, this level implies performing 
10 CT scans to avoid one missed lesion. We considered an intermediate range of 
thresholds (4-6% for any traumatic finding and 0.5%-1% for potential neurosurgical 
lesion) acceptable from a clinical point of view.[24,26] Net proportional benefit 
expresses the true positives and the decision rule with the highest net benefit 
at the intermediate thresholds has the highest clinical value.[24] All statistical 
analyses were performed using R software, version 3.3.2 (R foundation for 
statistical computing, Vienna, Austria).
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Patient involvement 
No patients were involved in setting the research question or the outcome measures, 
nor were they involved in developing plans for design or implementation of the study. 
No patients were asked to advise on interpretation or writing up of results. There are 
plans to disseminate the results of the research to the relevant patient community. 
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Results
Between March 2015 and December 2016, 5839 consecutive patients with MHI were 
entered in the database in the participating centers (Figure 1). After checking the 
in- and exclusion criteria 322 patients were excluded from the study (GCS score < 
13, age < 16 years or no blunt head injury). In three out of nine centers only patients 
with a CT were included (n=960). The remaining six centers included patients with 
and without a CT (n=4557).
Figure 1. Study flow diagram. 
*Six centers=one university center (trauma level 1) and five non-university centers (trauma levels 
1 (two centers), 2 (one), 3 (two)), including patients with and without CT scans; three centers=two 
university centers (both trauma level 1) and one non-university center (trauma level 2), including 
only patients with a CT scan. CT=computed tomography
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For the primary analysis 4557 patients from six centers were included; 3742 
patients (82.1%) received a CT scan and 815 (17.9%) did not. Compared with patients 
who received a CT scan, more patients without a scan had a Glasgow coma scale 
score of 15 (n=3109 (83.1%) v n=805 (98.8%)), and fewer patients experienced loss 
of consciousness (n=1136 (30.3%) v n=56 (6.8%)) or post-traumatic amnesia (n=1075 
(28.7%) v n=29 (3.5%); Table 1). Some data were unknown to the including physician, 
which was most frequently the case for retrograde amnesia (n=675, 14.8%), loss of 
consciousness (n=651, 14.3%), post-traumatic amnesia (n=502, 11%), and headache 
(n=630, 13.8%; Table 1).
Table 1. Baseline characteristics of 4557 study patients from six centers*. 
All patients 
(n=4557)
Missing Patients 
with CT
(n=3742)
Patients 
without CT
(n=815)
Age mean in years (range) 53.1 (16-101) - 56.9 (16-101) 35.7 (16-96)
Sex, n male (%) 2656 (58.3%) - 2145 (57.3%) 511 (62.7%)
GCS score at presentation -
• GCS 13 143 (3.1%) 141 (3.8%) 2 (0.2%)
• GCS 14 500 (11.0%) 492 (13.1%) 8 (1.0%)
• GCS 15 3914 (85.9%) 3109 (83.1%) 805 (98.8%)
Use of anticoagulation 29 (0.6%)
• None 4045 (88.8%) 3233 (86.4%) 812 (99.6%)
• Coumarin 418 (9.2%) 418 (11.2%) -
• Direct oral anticoagulants 54 (1.2%) 53 (1.4%) 1 (0.1%)
Use of thrombocyte aggregation 
inhibitors
615 (13.5%) 33 (0.7%) 577 (15.4%) 38 (4.7%)
Bleeding disorder 44 (1%) 33 (0.7%) 41 (1.1%) 3 (0.4%)
Mechanism of injury 47(1.0%)
• Road traffic accident 
pedestrian
64 (1.4%) 57 (1.5%) 7 (0.9%)
• Road traffic accident cyclist 162 (3.6%) 152 (4.1%) 10 (1.2%)
• Fall from height 574 (12.6%) 532 (14.2%) 42 (5.2%)
• Other† 3710 (81.4%) 2955 (79.0%) 755 (92.6%)
Ejected from vehicle 150 (3.3%) 56 (1.2%) 135 (3.6%) 15 (1.8%)
Loss of consciousness 651 (14.3%)
• None 2714 (59.6%) 1968 (52.6%) 746 (91.5%)
• 15 minutes or less 1160 (25.5%) 1105 (29.5%) 55 (6.7%)
• More than 15 minutes 32 (0.7%) 31 (0.8%) 1 (0.1%)
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Table 1. Continued
All patients 
(n=4557)
Missing Patients 
with CT
(n=3742)
Patients 
without CT
(n=815)
Retrograde amnesia 675 (14.8%)
• None 3425 (75.2%) 2637 (70.5%) 788 (96.7%)
• 30 minutes or less 312 (6.8%) 303 (8.1%) 9 (1.1%)
• More than 30 minutes 145 (3.2%) 144 (3.8%) 1 (0.1%)
Posttraumatic amnesia 502 (11%)
• None 2951 (64.8%) 2185 (58.4%) 766 (94.0%)
• Up to 2 hours 976 (21.4%) 948 (25.3%) 28 (3.4%)
• 2-4 hours 69 (1.5%) 68 (1.8%) 1 (0.1%)
• More than 4 hours 59 (1.3%) 59 (1.6%) -
Intoxication with drugs or 
alcohol
1031 (22.6%) 85 (1.9%) 922 (24.6%) 109 (13.4%)
Posttraumatic seizure 36 (0.8%) 68 (1.5%) 33 (0.9%) 3 (0.4%)
Headache 1410 (30.9%) 630 (13.8%) 1208 (32.3%) 202 (24.8%)
Vomiting 50 (1.1%)
• Once 158 (3.5%) 148 (4.0%) 10 (1.2%)
• Twice or more 144 (3.2%) 142 (3.8%) 2 (0.2%)
GCS deterioration (after 1 hr) 23 (0.5%)
• 1 point 38 (0.8%) 38 (1.0%) -
• 2 or more points 12 (0.3%) 12 (0.3%) -
Neurological deficit‡ 130 (2.9%) 141 (3.1%) 128 (3.4%) 2 (0.2%)
Signs of skull base fracture 144 (3.2%) 25 (0.5%) 139 (3.7%) 5 (0.6%)
Visible injury of the head 2564 (56.3%) 19 (0.4%) 2208 (59%) 356 (43.7%)
Visible injury of the face 1631 (35.8%) 22 (0.5%) 1315 (35.1%) 316 (38.8%)
Suspicion of open fracture 11 (0.2%) 40 (0.9%) 11 (0.3%) -
Injury Severity Score, mean 
(range)
6.5 (0-75) - 7.1 (0-75) 3.5 (0-29)
Data are number (%) of patients unless stated otherwise. CT=computed tomography.
*These centers refer to those on the left-hand side of figure 1, for the primary analysis.
†Includes patients with mild head injury such as a bumped head against an object.
‡History or suggestive findings on examination (eg, nystagmus, abnormal walking).
In 384 patients (8.4%), CT showed an intracranial traumatic finding, mostly consisting 
of traumatic subarachnoid hemorrhages (n=182; 4.0%) and skull fractures (n=150; 
3.3%; Table 2). Of 74 (1.6%) patients with a potential neurosurgical lesion, 18 (0.4%) 
underwent a neurosurgical intervention for head injury within 30 days after the injury. 
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In 116 of 3742 patients without LOC and in 117 of 3742 patients without PTA an 
intracranial traumatic finding was found (Table 3). In total 20 patients without LOC 
had a potential neurosurgical lesion and four patients underwent a neurosurgical 
intervention. In patients without PTA, 14 had a potential neurosurgical lesion and three 
patients underwent a neurosurgical intervention.
Table 2. Traumatic CT findings in 3742 patients with a CT scan from six centers*
CT finding N (%)
CT finding† 384 (8.4%)
Skull fracture 150 (3.3%)
• Depressed fracture 19 (0.5%)
• Linear fracture 66 1.4%)
• Skull base fracture 68 (1.5%)
Subarachnoid hemorrhage 182 (4.0%)
Contusion
• Small 115 (2.5%)
• Large (mass) 10 (0.2%)
Subdural hematoma
• Small 126 (2.8%)
• Large (mass) 22 (0.5%)
Epidural hematoma
• Small 30 (0.7%)
• Large (mass) 5 (0.1%)
Suspicion of DAI on CT 13 (0.3%)
Basal cisterns compressed or obliterated 11 (0.2%)
CT shift
• 0-4mm 16 (0.4%)
• 5mm or more 9 (0.2%)
CT = computed tomography, DAI = diffuse axonal injury
*These centers refer to those on the left-hand side of figure 1, for the primary analysis.
†some patients had more than 1 CT finding
In a subgroup analysis of the 3914 patients with a Glasgow coma scale score of 15, 
more than half the patients (n=2465, 63%) had no loss of consciousness and no 
post-traumatic amnesia. Ninety-three (3.8%) patients had any intracranial traumatic 
finding, seven (0.3%) had a potential neurosurgical lesion, and one underwent a 
neurosurgical intervention.
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Table 3. Baseline characteristics of 3742 patients with a CT scan from six centers*, according to 
status of CT findings
Normal CT 
(n=3358)
Abnormal CT 
(n=384)
All patients 
with CT 
(n=3742)
Age mean in years (range) 56.6 (16-101) 59.1 (17-98) 56.9 (16-101)
Sex, n male (%) 1901 (56.6) 244 (63.5%) 2145 (57.3%)
GCS score at presentation
• GCS 13 94 (2.8%) 47 (12.2%) 141 (3.8%)
• GCS 14 401 (11.9%) 91 (23.7%) 492 (13.1%)
• GCS 15 2863 (85.3%) 246 (64.1%) 3109 (83.1%)
Use of anticoagulation
• None 2886 (85.9%) 347 (90.4%) 3233 (86.4%)
• Coumarin 387 (11.5%) 31 (8.1%) 418 (11.2%)
• Direct oral anticoagulants 50 (1.5%) 3 (0.8%) 53 (1.4%)
Use of thrombocyte aggregation inhibitors 502 (15.0%) 75 (19.5%) 577 (15.4%)
Bleeding disorder 39 (1.2%) 2 (0.5%) 41 (1.1%)
Mechanism of injury
• Road traffic accident 
Pedestrian
48 (1.4%) 9 (2.3%) 57 (1.5%)
• Road traffic accident cyclist 127 (3.8%) 25 (6.5%) 152 (4.1%)
• Fall from height 451 (13.4%) 81 (21.1%) 532 (14.2%)
• Other† 2691 (80.1%) 264 (68.8%) 2955 (79%)
Ejected from vehicle 120 (3.6%) 15 (3.9%) 135 (3.6%)
Loss of consciousness
• None 1852 (55.2%) 116 (30.2%) 1968 (52.6%)
• 15 minutes or less 943 (28.1%) 162 (42.2%) 1105 (29.5%)
• More than 15 minutes 21 (0.6%) 10 (2.6%) 31 (0.8%)
Retrograde amnesia
• None 2443 (72.8%) 194 (50.5%) 2637 (70.5%)
• 30 minutes or less 251 (7.5%) 52 (13.5%) 303 (8.1%)
• More than 30 minutes 102 (3.0%) 42 (10.9%) 144 (3.8%)
Posttraumatic amnesia
• None 2068 (61.6%) 117 (30.5%) 2185 (58.4%)
• Up to 2 hours 776 (23.1%) 172 (44.8%) 948 (25.3%)
• 2-4 hours 54 (1.6%) 14 (3.6%) 68 (1.8%)
• More than 4 hours 38 (1.1%) 21 (5.5%) 59 (1.6%)
Intoxication * 836 (24.9%) 86 (22.4%) 922 (24.6%)
Posttraumatic seizure 26 (0.8%) 7 (1.8%) 33 (0.9%)
Headache 1086 (32.3%) 122 (31.8%) 1208 (32.3%)
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Table 3. Continued
Normal CT 
(n=3358)
Abnormal CT 
(n=384)
All patients 
with CT 
(n=3742)
Vomiting
• Once 131 (3.9%) 17 (4.4%) 148 (4.0%)
• Twice or more 119 (3.5%) 23 (6.0%) 142 (3.8%)
GCS deterioration (after 1 hr)
• 1 point 33 (1.0%) 5 (1.3%) 38 (1.0%)
• 2 or more points 6 (0.2%) 6 (1.6%) 12 (0.3%)
Neurological deficit ‡ 100 (3.0%) 28 (7.3%) 128 (3.4%)
Signs of skull base fracture 89 (2.7%) 50 (13.0%) 139 (3.7%)
Visible injury of the head 1945 (57.9%) 263 (68.5%) 2208 (59%)
Visible injury of the face 1181 (35.2%) 134 (34.9%) 1315 (35.1%)
Suspicion of open fracture 6 (0.2%) 5 (1.3%) 11 (0.3%)
Injury Severity Score, mean (range) 6.2 (0-54) 15.2 (1-75) 7.1 (0-75)
Data are number (%) of patients unless stated otherwise. CT=computed tomography.
*These centers refer to those on the left-hand side of figure 1, for the primary analysis.
†Includes patients with mild head injury such as a bumped head against an object.
‡History or suggestive findings on examination (eg, nystagmus, abnormal walking).
Of all 4557 patients, 1511 (33.2%) were admitted to the hospital for head injury and 
other reasons. Of the admitted patients, 226 (5.0%) were admitted for two nights 
or longer because of head injury; 52 (1.1%) had neurological deterioration during 
admission, and six (0.1%) were intubated for longer than 24 h. Eleven (0.2%) patients 
died as a result of head injury, and 21 (0.5%) died as a result of a different illness or 
trauma.
Performance of the decision rules
After imputation of outcomes in patients without a CT scan, 23 of 815 patients 
had any intracranial traumatic finding and no patient had a potential neurosurgical 
lesion. None of these 815 patients without a CT scan had undergone a neurosurgical 
intervention in 30 days after injury. The sensitivity for identifying patients with any 
intracranial traumatic finding on CT ranged from 72.5% for the NICE criteria to 98.8% 
for the NOC (Table 4; Supplementary Figure 1). 
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Table 4. Performance of the four decision rules* used for CT in 4557 patients with minor head 
injury presenting at six centers†
 Positive
n
Negative
n
Sensitivity
% (CI) 
Specificity
% (CI)
Positive likelihood 
ratio (CI)
Negative likelihood 
ratio (CI)
CHIP n=4557
Any traumatic finding on CT 94.1 (91.5 to 96.3) 21.6 (20.4 to 22.9) 1.20 (1.16 to 1.23) 0.27 (0.17 to 0.40)
CHIP - Positive 383 3253
CHIP - Negative 24 897
Potential neurosurgical lesion 97.3 (93.1 to 100) 20.5 (19.4 to 21.7) 1.22 (1.17 to 1.26) 0.13 (0 to 0.34)
CHIP - Positive 72 3564
CHIP - Negative 2 919
NICE n=4557
Any traumatic finding on CT 72.5 (67.8 to 77.2) 60.9 (59.3 to 62.5) 1.85 (1.72 to 2.0) 0.45 (0.37 to 0.53)
NICE - Positive 295 1624
NICE - Negative 112 2526
Potential neurosurgical lesion 85.1 (76.4 to 92.9) 58.6 (57.1 to 60.1) 2.06 (1.84 to 2.27) 0.25 (0.12 to 0.40)
NICE - Positive 63 1856
NICE - Negative 11 2627
NOC n=4557 
Any traumatic finding on CT 98.8 (97.6 to 99.8) 4.4 (3.8 to 5.1) 1.03 (1.02 to 1.05) 0.28 (0.06 to 0.53)
NOC - Positive 402 3966
NOC - Negative 5 184
Potential neurosurgical lesion 100 (100 to 100) 4.2 (3.6 to 4.8) 1.04 (1.04 to 1.05) 0 (0 to 0)
NOC - Positive 74 4294
NOC - Negative 0 189
CCHR n=4557 
Any traumatic finding on CT 80.3 (76.1 to 84.2) 44.2 (42.7 to 45.9) 1.44 (1.35 to 1.52) 0.44 (0.36 to 0.55)
CCHR - Positive 327 2314
CCHR - Negative 80 1836
Potential neurosurgical lesion 87.8 (79.7 to 94.9) 42.5 (41.0 to 44.1) 1.53 (1.40 to 1.66) 0.29 (0.12 to 0.47)
CCHR - Positive 65 2576
CCHR - Negative 9 1907
*CHIP=CT in head injury patient rule; NICE=National Institute for Health and Care Excellence 
guideline for head injury; NOC=New Orleans criteria; CCHR=Canadian CT head rule. †These centers 
refer to those on the left-hand side of figure 1, for the primary analysis.
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Table 4. Performance of the four decision rules* used for CT in 4557 patients with minor head 
injury presenting at six centers†
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n
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n
Sensitivity
% (CI) 
Specificity
% (CI)
Positive likelihood 
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Negative likelihood 
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Potential neurosurgical lesion 85.1 (76.4 to 92.9) 58.6 (57.1 to 60.1) 2.06 (1.84 to 2.27) 0.25 (0.12 to 0.40)
NICE - Positive 63 1856
NICE - Negative 11 2627
NOC n=4557 
Any traumatic finding on CT 98.8 (97.6 to 99.8) 4.4 (3.8 to 5.1) 1.03 (1.02 to 1.05) 0.28 (0.06 to 0.53)
NOC - Positive 402 3966
NOC - Negative 5 184
Potential neurosurgical lesion 100 (100 to 100) 4.2 (3.6 to 4.8) 1.04 (1.04 to 1.05) 0 (0 to 0)
NOC - Positive 74 4294
NOC - Negative 0 189
CCHR n=4557 
Any traumatic finding on CT 80.3 (76.1 to 84.2) 44.2 (42.7 to 45.9) 1.44 (1.35 to 1.52) 0.44 (0.36 to 0.55)
CCHR - Positive 327 2314
CCHR - Negative 80 1836
Potential neurosurgical lesion 87.8 (79.7 to 94.9) 42.5 (41.0 to 44.1) 1.53 (1.40 to 1.66) 0.29 (0.12 to 0.47)
CCHR - Positive 65 2576
CCHR - Negative 9 1907
*CHIP=CT in head injury patient rule; NICE=National Institute for Health and Care Excellence 
guideline for head injury; NOC=New Orleans criteria; CCHR=Canadian CT head rule. †These centers 
refer to those on the left-hand side of figure 1, for the primary analysis.
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The sensitivity for identifying patients with potential neurosurgical lesions was 100% 
for NOC, the NICE criteria had the lowest sensitivity (85.1%) for identifying potential 
neurosurgical lesions (Table 4). The NICE criteria would have missed 11/74 patients 
with potential neurosurgical lesions (Supplementary Table 3). The CHIP criteria would 
have missed two patients with potential neurosurgical lesions, these patients both 
had a small epidural hematoma, which did not need neurosurgical treatment and one 
of them had surgery to repair a depressed skull fracture (Supplementary Table 3). 
The specificity for identifying any intracranial traumatic finding was lowest for the 
NOC (4.4%) and highest for the NICE criteria (60.9%). The specificity for potential 
neurosurgical lesions ranged from 4.2% (NOC) to 58.6% (NICE criteria). The sensitivity 
and specificity differed significantly between all the rules (Cochran’s Q P < 0.001). 
Sensitivity and specificity for the original CCHR and NOC were slightly different from 
the adjusted versions (see the methods section for definition of the original and 
adjusted groups; (Supplementary Table 4A, 4B). For the outcome of neurosurgical 
intervention, the NOC rule had the highest sensitivity (100%) and the NICE criteria the 
highest specificity (58.1%; (Supplementary Table 5).
Clinical usefulness
The decision curve of the NOC rule was almost identical to CT scanning all patients 
in both study outcomes (Figure 2). When using a low threshold for performing CT 
(to avoid false negatives of the decision rule), we found that the NOC rule and the 
scanning of all patients had the highest net proportional benefit. When using a 
high threshold for performing CT (to avoid false positives), we found that the NICE 
criteria had the highest net proportional benefit (Figure 2). Over a narrow range of 
intermediate thresholds, the CHIP criteria had the highest net proportional benefit 
(0.038-0.054 for intracranial traumatic findings and 0.008-0.012 for potential 
neurosurgical lesions). For the neurosurgical intervention outcome, the differences 
in net proportional benefit were small (Supplementary Figure 2).
Proportion of patients needing CT
According to the different decision rules the proportion of the study population 
needing CT was 95.9% (95% confidence interval 95.3% to 96.5%) with the NOC; 79.8% 
(78.6% to 80.9%) with the CHIP criteria; 58.0% (56.4% to 59.4%) with the CCHR and 
42.1% (40.6% to 43.6%) with the NICE criteria. To increase the sensitivity of the CHIP 
criteria to the level of the NOC, 733 more CTs would have been needed to identify 
19 more patients with intracranial traumatic findings and two more patients with a 
potential neurosurgical lesion.
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Figure 2. 
Decision curves for study outcomes showing net proportional benefit per CT decision rule
CT=computed tomography; CHIP=CT in head injury patient rule; NICE=National Institute for Health 
and Care Excellence guideline for head injury; NOC=New Orleans criteria; CCHR=Canadian CT head 
rule; scan all=scanning of all patients; scan none=scanning no patients. For each rule, the net 
proportional benefit was calculated with the formula: (true positives/total number) - weight×(false 
positives/total number)
Secondary (sensitivity) analysis in all patients receiving CT scans
In all included centers, 4702 patients received a CT scan (Figure 1). Most of these 
patients had a Glasgow coma scale score of 15 at presentation (n=3798; 80.8%), 
1511 (32.1%) experienced loss of consciousness, and 1480 (31.5%) had post-traumatic 
amnesia (Supplementary Table 6A). We found that 528 (11.2%) patients had an 
intracranial traumatic finding on CT (Supplementary Table 6B). Although the sensitivity 
of all rules was higher and the specificity lower, their ordering was the same. The NOC 
rule had the highest sensitivity (99.1%) and lowest specificity (3.1%) for any intracranial 
traumatic finding, whereas the NICE guideline had the highest specificity (50.3%) and 
lowest sensitivity (77.5%; Supplementary Figure 3). Net proportional benefit analysis 
showed the same pattern as in the primary analysis (Supplementary Figure 3).
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Discussion
Principal findings
In this large, multicenter, external validation study of CT decision rules for MHI 
patients, the NOC had the highest sensitivity and was the only rule with a 100% 
sensitivity for potential neurosurgical lesions. Nevertheless, the high sensitivity of 
the NOC comes at the cost of an extremely low specificity with as consequence that 
practically all patients require a CT scan. The NICE guideline had the highest specificity 
and the lowest proportion that required a CT but at the cost of a low sensitivity. The 
sensitivity of the CHIP criteria was high (97% for potential neurosurgical lesions) with 
an acceptable specificity and a substantial reduction in the proportion requiring CT. 
Of note, the sensitivity for identifying patients with any intracranial traumatic finding 
on CT was less than 100% for all decision rules. 
Which decision rule is the best for the situation depends on several factors. It 
depends not only on its characteristics but also on how many CT scans the physician 
is willing to perform to identify one patient with an intracranial traumatic finding or 
potential neurosurgical lesion. Because a potential neurosurgical lesion could have 
serious consequences, such as a neurosurgical intervention or even death, most 
professionals would agree that the sensitivity of the decision rule should be 100%.[27] 
However, it is less easy to agree on the desired sensitivity for finding any intracranial 
traumatic lesion, because not all small intracranial traumatic findings have clinical 
consequences. If a CT decision rule gives a false positive result, the patient receives an 
unnecessary CT and will be discharged after spending a few hours in the emergency 
department. If the rule gives a false negative result, the patient will be discharged 
without a CT and an intracranial traumatic finding will be missed. If this intracranial 
traumatic finding was a potential neurosurgical lesion and adequate therapy was 
omitted or was given too late, this could have serious consequences.[27] 
The net proportional benefit analysis may help in finding the best decision rule for 
different thresholds, but the interpretation of the curves may be challenging.[24] If a 
low threshold is chosen, the best rule to use in order to identify all patients with any 
lesion is the NOC, but this would imply that practically all patients undergo CT. At a high 
threshold, using the NICE criteria avoids unnecessary scans and has the highest net 
proportional benefit, but important lesions may be missed. For the outcome potential 
neurosurgical lesion a very low net proportional benefit threshold and 100% sensitivity 
is desired. For intermediate thresholds, using the CHIP criteria makes a trade-off 
between avoiding missed lesions while achieving a substantial reduction in CTs of 21%. 
For the outcome intracranial traumatic finding the threshold can be higher, because it 
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is not necessary that all findings are identified. From a societal perspective, not only 
clinical usefulness but also cost-effectiveness is important. A cost-effectiveness 
study showed that a prediction rule needs a sensitivity of at least 97% for identifying 
potential neurosurgical lesions in order to be cost-effective, otherwise performing CT 
in all patients with MHI is more cost-effective.[26] In our study, only the NOC and the 
CHIP criteria fulfilled this criterion. 
Comparison with other studies
Several other studies have validated and compared the sensitivity and specificity of CT 
decision rules for adult MHI patients, but only the NOC, CCHR and NICE decision rules 
have been externally validated.[13-17,28] Our study adds the CHIP rule to externally 
validated decision rules and compares it head-to-head with the other rules. Validation 
studies vary in design and in outcome measures (eg, clinically significant findings 
on CT are not uniformly defined), and are therefore difficult to compare. In addition, 
the case mix of our study is different from previous validation studies because we 
included all patients with blunt traumatic minor head injury, including those without 
risk factors. Our study is in line with earlier findings that the NOC rule has a high 
sensitivity but leads to a high scan rate, whereas the CCHR rule and NICE guideline 
can reduce the number of CT scans substantially, but at the cost of a lower sensitivity. 
However, the potential reduction in CT scans has not been proved in clinical practice 
yet. In terms of sensitivity and specificity, the CHIP rule lies between the NOC and 
CCHR rules.
All the decision rules in this study have been designed for an emergency department 
population. Although only the NICE and CHIP criteria have been designed to apply to 
all patients with minor head injury, in daily practice the NOC and CCHR rules probably 
apply to these patients as well. Therefore, we also investigated adjusted versions of 
the NOC and CCHR rules, which are applicable to all patients with minor head injury. 
The sensitivity and specificity of these two adjusted rules were comparable to the 
sensitivity and specificity of their original versions.
Our study population had a mean age of 53.1 years; by comparison, patients in the 
development studies for the NOC, CCHR, and CHIP rules had a mean age of 36-41 
years. This difference is probably indicative of ageing of the population, but other 
factors such as changed referral patterns or increasing incidence fall accidents might 
contribute as well.[9] The percentage of patients with any intracranial traumatic finding 
(8.4%) was comparable with most other studies (6.9%-12.1%).[6,7,13] The percentage 
of patients who underwent a neurosurgical intervention within 30 days after injury in 
our study (0.4%) was low compared to most other studies (0.4%-1.5%). This difference 
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might be because the indication for neurosurgery not only depends on clinical factors, 
but also differs from country to country and from neurosurgeon to neurosurgeon 
and could have changed over time.[29] We therefore believe that instead of actual 
neurosurgical interventions, it is better to use ‘potential neurosurgical lesions’ as 
outcome measure. The confidence intervals for neurosurgical intervention were wide 
(sensitivity 71%-100%) because of the low prevalence of this outcome. 
Patients with MHI presenting at the emergency department not only reflect the 
ageing of the population but also the result of the decision rules themselves. In the 
Netherlands, use of anticoagulants (coumarines or direct oral anticoagulants) is 
considered a risk factor for intracranial complications and a reason for referral to 
the emergency department in both the ambulance and general practitioner protocols.
[30] The percentage of patients using anticoagulants in our study was higher than in 
the CHIP rule development study (9.2% vs 12.7%).[15]
Limitations 
A limitation of our study was that not all consecutive patients with minor head injury 
were scanned. Following the guidelines for CT scanning at the participating centers 
resulted in patients with 0-1 minor criteria who did not undergo a CT scan. Therefore, 
patients who did not receive a CT scan but had intracranial traumatic findings (that 
is, those with false negative results) could have been missed. To detect this patient 
subgroup and precisely estimate their relative frequency among unscreened patients 
would need many thousands of individuals, which was not feasible. Missing patients 
without a CT scan could have led to a slight overestimation of the sensitivity and an 
underestimation of the specificity. We therefore performed the primary analysis on 
data from six centers which also collected data for patients without a CT scan. For 
all the rules, the new calculated sensitivities were a little lower and the specificities 
higher, as expected. The fact that most centers in our study used CT guidelines based 
on the CHIP rule could have introduced a bias in favor of the CHIP rule, owing to 
possible missed lesions (because the patient was not scanned according to the local 
guideline) that would have been detected by the other rules. However, by imputing 
the outcomes of the patients without a CT scan, we were able to keep this bias to a 
minimum.
Because most physicians used the CHIP rule on a regular basis, they were more likely 
to apply it correctly. However, many risk factors are the same for all rules and the 
validation was performed based on the scored risk factors, not on the physicians’ 
judgment of a rule being positive or negative. In addition, in our centers, it is clinical 
practice to assess not only risk factors from the CHIP rule, but also other risk factors 
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such as headache and retrograde amnesia. In our study, it was unclear how quickly 
patients proceeded to CT and whether lesions appeared after this time. However, 
af Geijerstam et al. concluded in a literature review that the risk for developing an 
intracranial lesion after an early normal CT is very low.[31]
Another limitation was the possibility that we missed patients undergoing a 
neurosurgical intervention in a different hospital. However, because the participating 
centers were all the primary neurosurgery centers of the area, this potential bias is 
highly unlikely. Furthermore, because we used potential neurosurgical lesions as a 
secondary outcome instead of neurosurgical intervention, our main findings would not 
have been affected. In the development studies of the four decision rules, potential 
neurosurgical lesions were not used as an outcome measure.
Conclusions and policy implications
Application of the CHIP, NOC, CCHR, or NICE decision rules leads to a wide variation 
in CT scanning among patients with minor head injury, resulting in unnecessary CT 
scans and missed intracranial traumatic findings. Only the NOC rule did not miss 
potential neurosurgical lesions, but this was at the cost of having to scan nearly all 
patients. Although the NICE guideline had the highest reduction of CT scans (58%), 
missing 15% of patients with potential neurosurgical lesions would be unacceptable 
to most physicians in the emergency department, because it would mean that for 
every 200 patients not be scanned according to the NICE criteria, one patient would 
turn out to have a potential neurosurgical lesion. 
Of the four investigated rules, the CHIP rule performed the best with an acceptable 
sensitivity of 97% for potential neurosurgical lesions according to previous cost 
effectiveness analysis, the highest net proportional benefit at intermediate thresholds, 
and a substantial reduction of CT scans of 21% compared with the scanning of all 
patients. Updating an existing decision rule might increase the sensitivity and 
specificity for detecting potential neurosurgical lesions. Until this update is conducted, 
it is justified to use any of the four rules for patients with minor head injury presenting 
at the emergency department. We recommend use of the CHIP rule because it leads 
to a substantial reduction of CT scans and misses very few potential neurosurgical 
lesions.
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Supplementary Material
Supplementary Table 1. Overview of decision rules CCHR, NOC, CHIP and NICE
Study Patient population Indications for CT
NOC: New 
Orleans 
Criteria 
Haydel et al, 
2000
GCS score of 15, loss 
of consciousness, 
normal findings on 
brief neurological 
examination, >3y
Clinical findings:
• Headache (diffuse or local)
• Vomiting
• Age > 60 years
• Drug or alcohol intoxication 
• Deficits in short-term memory (persistent anterograde 
amnesia in patient with otherwise normal GCS)
• Physical evidence of trauma above clavicles
• Seizure
CCHR: 
Canadian CT 
Head Rule
Stiell et al, 
2001
GCS score 13-15, 
witnessed LOC, 
definite amnesia 
or witnessed 
disorientation, age 
> 16y
Exclusion: use of 
anticoagulation or 
obvious open skull 
fracture
High risk for intervention:
• GCS < 15 at 2 hours after injury
• Suspected open or depressed skull fracture
• Any sign of basal skull fracture
• Vomiting 2 or more episodes
• Age 65 years or older
Medium risk for brain injury on CT:
• Amnesia before impact 30 min or more
• Dangerous mechanism (pedestrian vs vehicle, ejected 
from vehicle, fall from elevation ≥ 3 feet, or 5 stairs) 
CHIP: CT in 
Head Injury 
Patients
Smits et al, 
2007
GCS 13-14 or GCS of 
15 and 1 risk factor, 
age ≥16
CT indicated if ≥ 1 major criterion:
• Pedestrian or cyclist vs vehicle
• Ejected from vehicle
• Vomiting
• PTA of 4 hours or more
• Clinical sign of skull fracture 
• GCS < 15
• GCS deterioration ≥ 2 points (1 hour after presentation)
• Use of anticoagulant therapy
• Posttraumatic seizure
• Age 60 years or older
CT indicated if ≥ 2 minor criteria:
• Fall from any elevation
• Persistent anterograde amnesia 
• PTA of 2-4 hours
• Contusion of skull
• Neurologic deficit 
• LOC
• GCS deterioration of 1 point (1 hour after presentation)
• Age 40-60 years
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Supplementary Table 1. Continued
Study Patient population Indications for CT
NICE: 
National 
Institute 
for Health 
and Care 
Excellence 
guideline: 
Head injury
Adults with head 
injury
Perform CT within 1 hour:
• GCS < 13
• GCS < 15 at 2 hours after injury
• Suspected open or depressed skull fracture
• Any sign of basal skull fracture
• Posttraumatic seizure
• Focal neurologic deficit
• More than one episode of vomiting since head injury
Perform CT within 8 hours:
• Current warfarin treatment
LOC and/or PTA and:
• Age > 65 years
• History bleeding or clotting disorder
• Dangerous mechanism of injury
• More than 30minutes retrograde amnesia of events 
before head injury
CT = computed tomography, GCS = Glasgow Coma Scale, PTA = posttraumatic amnesia, LOC = loss 
of consciousness
A B
Supplementary Figure 1. Performance of the CT decision rules (6 centers, n=4557). 
CT = computed tomography, CHIP = CT in head Injury Patient rule, NICE = National Institute for Health 
and Care Excellence, NOC = New Orleans Criteria, CCHR = Canadian CT Head Rule
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Supplementary Table 2. Overview CT guidelines used in participating centers 
National guideline Local guideline 1 Local guideline 2
Number of centers 7 1 1
1 or more major criteria • GCS < 15 (including persisting PTA)
• 2 or more points deterioration in GCS (1 hour after 
presentation)
• Vomiting
• Posttraumatic seizure
• Signs of skull fracture
• Pedestrian or cyclist versus vehicle
• Ejected from motor vehicle
• PTA ≥ 4 hours
• Use of anticoagulants
• Focal neurologic deficit
• Suspicion of intracranial injury after focal “high impact” 
injury 
• GCS < 15
• 2 or more points deterioration in GCS (1 hour 
after presentation) 
• Vomiting
• Posttraumatic seizure
• Age ≥60 years
• Signs of skull fracture
• Dangerous mechanism (Pedestrian or 
cyclist versus vehicle; Ejected from motor 
vehicle; Fall from more than 1m or 5 stairs; 
Or equivalent mechanism)
• Post traumatic amnesia ≥ 4 hours
• Coagulopathy, e.g. use of coumarin derivate 
(INR >1.7), NOACs, or chronic alcohol abuse
• Focal neurologic deficit
• Intoxication that impairs neurological 
examination
• GCS < 15 (including persisting PTA)
• Deterioration in GCS
• Vomiting > 1 time 
• Posttraumatic seizure
• Signs of skull fracture
• Dangerous mechanism (Pedestrian or cyclist 
versus vehicle; Ejected from motor vehicle; 
Fall from high elevation)
• Post traumatic amnesia > 1 hour
• Use of anticoagulants/coagulopathy 
• Focal neurologic deficit
2 or more minor criteria • Fall from any elevation 
• LOC
• Posttraumatic amnesia 2-4 hours
• Visible injury to the head, excluding the face (without 
signs of fracture)
• 1 point deterioration in GCS (1 hour post presentation) 
• Age > 40 years
• Fall from < 1 m
• LOC
• PTA 2-4 hours
• Persisting PTA (recall deficit)
• Traumatic injury above the clavicles
• 1 point deterioration in GCS (1 hour post 
presentation) 
• Age 40-60 years
• Fall from any elevation
• LOC
• Unclear trauma mechanism 
• Visible injury to the head, excluding the face 
(without signs of fracture) 
• Violence
• Age > 65 years
CT = computed tomography, GCS = Glasgow Coma Scale, PTA = posttraumatic amnesia, LOC =loss 
of consciousness, INR = international normalized ratio, NOACS = novel oral anticoagulants
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Supplementary Table 2. Overview CT guidelines used in participating centers 
National guideline Local guideline 1 Local guideline 2
Number of centers 7 1 1
1 or more major criteria • GCS < 15 (including persisting PTA)
• 2 or more points deterioration in GCS (1 hour after 
presentation)
• Vomiting
• Posttraumatic seizure
• Signs of skull fracture
• Pedestrian or cyclist versus vehicle
• Ejected from motor vehicle
• PTA ≥ 4 hours
• Use of anticoagulants
• Focal neurologic deficit
• Suspicion of intracranial injury after focal “high impact” 
injury 
• GCS < 15
• 2 or more points deterioration in GCS (1 hour 
after presentation) 
• Vomiting
• Posttraumatic seizure
• Age ≥60 years
• Signs of skull fracture
• Dangerous mechanism (Pedestrian or 
cyclist versus vehicle; Ejected from motor 
vehicle; Fall from more than 1m or 5 stairs; 
Or equivalent mechanism)
• Post traumatic amnesia ≥ 4 hours
• Coagulopathy, e.g. use of coumarin derivate 
(INR >1.7), NOACs, or chronic alcohol abuse
• Focal neurologic deficit
• Intoxication that impairs neurological 
examination
• GCS < 15 (including persisting PTA)
• Deterioration in GCS
• Vomiting > 1 time 
• Posttraumatic seizure
• Signs of skull fracture
• Dangerous mechanism (Pedestrian or cyclist 
versus vehicle; Ejected from motor vehicle; 
Fall from high elevation)
• Post traumatic amnesia > 1 hour
• Use of anticoagulants/coagulopathy 
• Focal neurologic deficit
2 or more minor criteria • Fall from any elevation 
• LOC
• Posttraumatic amnesia 2-4 hours
• Visible injury to the head, excluding the face (without 
signs of fracture)
• 1 point deterioration in GCS (1 hour post presentation) 
• Age > 40 years
• Fall from < 1 m
• LOC
• PTA 2-4 hours
• Persisting PTA (recall deficit)
• Traumatic injury above the clavicles
• 1 point deterioration in GCS (1 hour post 
presentation) 
• Age 40-60 years
• Fall from any elevation
• LOC
• Unclear trauma mechanism 
• Visible injury to the head, excluding the face 
(without signs of fracture) 
• Violence
• Age > 65 years
CT = computed tomography, GCS = Glasgow Coma Scale, PTA = posttraumatic amnesia, LOC =loss 
of consciousness, INR = international normalized ratio, NOACS = novel oral anticoagulants
124
Chapter 6
Supplementary Table 3. Overview of missed neurosurgical lesions
Patient characteristics CT result Missed by rule
1 32y, assault blunt instrument, intoxication, 
significant injury to the head, focal high 
impact injury
Small EDH, skull fracture CHIP, NICE, CCHR
2 21y, scooter vs motor vehicle, high energy 
trauma, significant injury to face and head
Small EDH, small ASDH, 
skull fracture
CHIP, NICE, CCHR
3 69y, fall from scooter, headache, significant 
injury to the head
Small EDH NICE
4 52y, fall from standing height, LOC, PTA, 
significant injury to the head
Small EDH, tSAH NICE, CCHR
5 37y, fall from scooter, intoxication, LOC, 
retrograde amnesia < 30 min, PTA 2-4hrs
Small EDH, tSAH, small 
ASDH
NICE, CCHR
6 26y, forklift against head, LOC, PTA, 
headache, significant injury to the head, 
focal high impact injury
Small EDH, tSAH, small 
ASDH, contusion (small), 
skull fracture
NICE, CCHR
7 22y, fall from standing height, LOC, 
retrograde amnesia <30min
Small EDH NICE, CCHR
8 36y, assault blunt instrument, LOC, PTA, 
significant injury to the head, focal high 
impact injury
Small EDH, skull fracture 
(depressed)
NICE, CCHR
9 88y, scooter vs truck, high energy trauma, 
significant injury to the head
Small EDH, skull fracture NICE
10 24y, bicycle vs motor vehicle, high energy 
trauma, significant injury to the face, LOC, 
PTA, headache
Small EDH, contusion 
(small), skull fracture
CCHR
11 40y, bicycle vs bicycle, significant injury to 
the head, PTA, headache
Small EDH, contusion 
(small), skull fracture
NICE, CCHR
12 89y, fall from standing height, significant 
injury to the face
Large ASDH NICE
CT = computed tomography, EDH = epidural hematoma, CHIP = CT in head Injury Patient rule, NICE 
= National Institute for Health and Care Excellence, CCHR = Canadian CT Head Rule ASDH = acute 
subdural hematoma, LOC = loss of consciousness, PTA = posttraumatic amnesia, tSAH = traumatic 
subarachnoid hemorrhage
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Supplementary Table 4A. NOC and CCHR validation in population with in- and exclusion criteria as 
in development cohort (6 centers)
Positive
n
Negative
n
Sensitivity
% (CI) 
Specificity
% (CI)
Original NOC n=1147 (subset of population with in- and exclusion criteria of original NOC study)
Any traumatic finding on CT 98.6 (96.4 to 100) 3.5 (2.4 to 4.5)
NOC - Positive 137 973
NOC - Negative 2 35
Potential neurosurgical lesion 100 (100 to 100) 3.3 (2.3 to 4.2)
NOC - Positive 20 1090
NOC - Negative 0 37
Original CCHR n= 1683 (subset of population with in- and exclusion criteria of original CCHR study)
Any traumatic finding on CT 81.6 (76.8 to 86.2) 42.5 (39.9 to 45.1)
CCHR - Positive 209 821
CCHR - Negative 47 606
Potential neurosurgical lesion 85.1 (74.0 to 94.2) 39.5 (37.2 to 41.9)
CCHR - Positive 40 990
CCHR - Negative 7 646
CI = 95% confidence interval, NOC = New Orleans Criteria, CCHR = Canadian CT Head Rule, CT= 
computed tomography
Supplementary Table 4B. Adjusted NOC and adjusted CCHR validation in entire study population 
(6 centers)
Positive
n
Negative
n
Sensitivity
% (CI) 
Specificity
% (CI)
Adjusted NOC n=4557 (including in- and exclusion criteria of original study as risk factors)
Any traumatic finding on CT 98.8 (97.6 to 99.8) 4.0 (3.4 to 4.5)
NOC - Positive 402 3984
NOC - Negative 5 166
Potential neurosurgical lesion 100 (100 to 100) 3.8 (3.2 to 4.3)
NOC - Positive 74 4312
NOC - Negative 0 171
Adjusted CCHR n=4557 (including in- and exclusion criteria of original study as risk factors)
Any traumatic finding on CT 81.8 (77.6 to 85.7) 42.0 (40.4 to 43.6)
CCHR - Positive 333 2409
CCHR - Negative 74 1741
Potential neurosurgical lesion 87.8 (79.7 to 94.9) 40.3 (38.9 to 41.7)
CCHR - Positive 65 2677
CCHR - Negative 9 1806
CI = 95% confidence interval, NOC = New Orleans Criteria, CCHR = Canadian CT Head Rule, CT= 
computed tomography
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Supplementary Table 5. Performance of rules with outcome neurosurgical intervention (6 centers)
Positive
n
Negative
n
Sensitivity
% (CI) 
Specificity
% (CI)
CHIP n=4557
Neurosurgical intervention 94.4 (81.8 to 100) 20.3 (19.2 to 21.4)
CHIP – Positive 17 3619
CHIP – Negative 1 920
NICE n=4557
Neurosurgical intervention 88.9 (71.4 to 100) 58.1 (56.6 to 59.6)
NICE – Positive 16 1903
NICE – Negative 2 2636
NOC n=4557 
Neurosurgical intervention 100 (100 to 100) 4.2 (3.6 to 4.7)
NOC – Positive 18 4350
NOC – Negative 0 189
CCHR n=4557 
Neurosurgical intervention 88.9 (71.4 to 100) 42.2 (40.7 to 43.8)
CCHR – Positive 16 2625
CCHR – Negative 2 1914
CI = 95% confidence interval, CHIP = CT in head Injury Patient rule, NICE = National Institute for 
Health and Care Excellence, NOC = New Orleans Criteria, CCHR = Canadian CT Head Rule
Supplementary Figure 2. Decision curves showing net benefit for the outcome neurosurgical 
intervention.
CT = computed tomography, CHIP = CT in head Injury Patient rule, NICE = National Institute for 
Health and Care Excellence, NOC = New Orleans Criteria, CCHR = Canadian CT Head Rule. Per rule 
net benefit was calculated using the formula: (true positives/n) – weight*(false positives/n).
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Supplementary Table 6A. Baseline characteristics all patients with a CT scan (9 centers, n =4702)
Normal CT 
(n=4174)
Abnormal CT 
(n=528)
All patients 
with CT (n=4702)
Age mean in years (range) 55.5 (16-101) 58.6 (16-98) 55.9 (16-101)
Sex, n male (%) 2372 (56.8%) 337 (63.8%) 2709 (57.6%)
GCS score at presentation
• 13 138 (3.3%) 69 (13.1%) 207 (4.4%)
• 14 557 (13.3%) 140 (26.5%) 697 (14.8%)
• 15 3479 (83.3%) 319 (60.4%) 3798 (80.8%)
Use of anticoagulation
• None 3581 (85.8%) 474 (89.8%) 4055 (86.2%)
• Coumarin 490 (11.7%) 45 (8.5%) 535 (11.4%)
• NOACS 56 (1.3%) 3 (0.6%) 59 (1.3%)
Bleeding disorder 47 (1.1%) 3 (0.6%) 50 (1.1%)
Mechanism of injury
• RTA pedestrian 60 (1.4%) 12 (2.3%) 72 (1.5%)
• RTA cyclist 164 (3.9%) 36 (6.8%) 200 (4.3%)
• Fall from height 574 (13.8%) 124 (23.5%) 698 (14.8%)
• Other 3325 (79.7%) 348 (65.9%) 3673 (78.1%)
Ejected from vehicle 183 (4.4%) 32 (6.1%) 215 (4.6%)
LOC
• None 2192 (52.5%) 153 (29.0%) 2345 (49.9%)
• 15 minutes or less 1238 (29.7%) 225 (42.6%) 1463 (31.1%)
• More than 15 minutes 30 (0.7%) 18 (3.4%) 48 (1.0%)
Retrograde amnesia
• None 2819 (67.5%) 227 (43.0%) 3046 (64.8%)
• 30 minutes or less 445 (10.7%) 96 (18.2%) 541 (11.5%)
• More than 30 minutes 142 (3.4%) 58 (11.0%) 200 (4.3%)
PTA
• None 2456 (58.8%) 154 (29.2%) 2610 (55.5%)
• Up to 2 hours 970 (23.2%) 200 (37.9%) 1170 (24.9%)
• 2-4 hours 80 (1.9%) 22 (4.2%) 102 (2.2%)
• More than 4 hours 144 (3.4%) 64 (12.1%) 208 (4.4%)
Intoxication * 1075 (25.8%) 117 (22.2%) 1192 (25.4%)
Post-traumatic seizure 31 (0.7%) 11 (2.1%) 42 (0.9%)
Headache 1358 (32.5%) 184 (34.8%) 1542 (32.8%)
Vomiting
• Once 173 (4.1%) 27 (5.1%) 200 (4.3%)
• Twice or more 161 (3.9%) 35 (6.6%) 196 (4.2%)
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Supplementary Table 6A. Continued
Normal CT 
(n=4174)
Abnormal CT 
(n=528)
All patients 
with CT (n=4702)
GCS deterioration 
• 1 point 35 (0.8%) 6 (1.1%) 41 (0.9%)
• 2 or more points 9 (0.2%) 9 (1.7%) 18 (0.4%)
Neurological deficit 104 (2.5%) 29 (5.5%) 133 (2.8%)
Signs of skull base fracture 109 (2.6%) 77 (14.6%) 186 (4.0%)
Visible injury of the head 2237 (53.6%) 338 (64.0%) 2575 (54.8%)
Visible injury of the face 1420 (34.0%) 178 (33.7%) 1598 (34.0%)
Suspicion of open fracture 8 (0.2%) 17 (3.2%) 25 (0.5%)
ISS, mean (range) 6.5 (0-54) 15.3 (1-75) 7.5 (0-75)
CT = computed tomography, GCS = Glasgow Coma Scale, NOACS = novel oral anticoagulants, 
RTA= road traffic accident, LOC = loss of consciousness, PTA = posttraumatic amnesia, ISS = 
Injury Severity Score
*history or suggestive findings on examination (for example nystagmus, abnormal walking, etc.)
**GCS deterioration 2 hrs after presentation
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Supplementary Table 6B. Traumatic CT findings all patients with a CT scan (9 centers, n=4702)
CT finding N (%)
CT finding 528 (11.2%)
Skull fracture 213 (4.5%)
• Depressed fracture 25 (0.5%)
• Linear fracture 103 (2.2%)
• Skull base fracture 89 (1.8%)
Subarachnoid hemorrhage 266 (5.7%)
Contusion
• Small 154 (3.3%)
• Large (mass) 14 (0.3%)
Subdural hematoma
• Small 173 (3.7%)
• Large (mass) 27 (0.6%)
Epidural hematoma
• Small 47 (1.0%)
• Large (mass) 5 (0.1%)
Suspicion of DAI on CT 14 (0.3%)
Basal cisterns compressed or obliterated 13 (0.3%)
CT shift
• 0-4mm 22 (0.5%)
• 5mm or more 13 (0.3%)
CT = computed tomography, DAI = diffuse axonal injury
*some patients had more than 1 CT finding
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General discussion
This thesis describes the epidemiology, risk factors, preventive measures and decision 
rules for diagnostics in patients with head trauma and traumatic brain injury (TBI) in 
emergency departments (EDs) in the Netherlands. 
Interpretation and clinical implications of main findings
Current situation and trends in traumatic brain injury
Chapter 2 of this thesis demonstrated a 75% increase in ED visits and a 95% increase 
in hospitalizations for TBI in the Netherlands between 1998 and 2012. In contrast, TBI-
related mortality remained stable. Similar trends in TBI-related ED visits and mortality 
are observed in other high-income countries.[1,2] 
In most high-income countries the epidemiology of patients with TBI is changing.
[3] Nowadays the average patient with TBI is older and more often female than 
one or two decades ago. This trend was confirmed in our own studies (chapter 6). 
Moreover, the relative and absolute increase in ED visits by elderly TBI patients is 
higher than expected based on ageing of the population alone. Several explanations 
for these changes are: increased awareness of TBI especially in the elderly, changed 
guidelines and increased use of antiplatelet and anticoagulant drugs. Finally, the 
elderly participate in society until a higher age and live longer independently than in 
the past. These developments could lead to more fall accidents. [4-6]
The major changes in epidemiology and causative trauma mechanism we observed 
in our studies have significant clinical implications. Almost all decision rules for 
minor head injury that are being used globally have been based on studies from the 
beginning of this century [7-9]. The results of these studies have been adopted in 
(inter)national guidelines and are still being used in daily practice today. It is highly 
questionable whether the results and decision aids from those studies are still as 
valid today in a totally different population, in comparison with the population two 
decades ago. For example head injury caused by ground level falls leads less often 
to death or severe TBI compared to other (high energetic) trauma mechanisms.[10] 
Nonetheless, given a certain Glasgow Coma Scale (GCS) score the mortality is higher 
in older patients than in young patients with TBI.[11] This implies that identification of 
head injury patients with (intra)cranial lesions is potentially unreliable in guidelines 
that are based on old decision rules. Therefore, guidelines should be validated in the 
current population, as we did for the Dutch population (Chapter 6).
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In chapter 3 of this thesis we demonstrated that the current Dutch guideline did not 
have the desired effect of less CT-scans and/or less hospitalizations. In contrast both 
CT ratio and hospitalizations increased. These effects are not solely the consequence 
of the new guideline. Nonetheless a critical appraisal of the guideline is needed as the 
effects of the introduction of the guideline are the opposite to what was expected. 
Examples of possible adjustments to the guideline that could be considered to limit 
the number of CT-scans are adjustment of the guideline to the current population, a 
higher threshold for performing a CT-scan and more emphasis on clinical judgement 
or the implementation of other diagnostic modalities such as biomarkers. Furthermore, 
a multimodal intervention focusing on physicians could be of importance to reduce 
the number of CT scans and or the number of hospitalizations.[12] 
Prevention of traumatic brain injury
Not only the demographics of patients changed, also causative trauma mechanisms 
changed in our studies. In the ageing population more injuries resulted from ground 
level falls compared to the past when violence and motorized vehicle accidents were 
predominant causative mechanisms (chapters 2,6,7). These changes are in line 
with changes observed in other high-income countries.[1,13] In light of the rapidly 
increasing number of ED visits for TBI in combination with limited treatment options, 
much effort should be made to prevent head injury and TBI. 
As mentioned above, ground level falls, especially in the elderly, are the most important 
and increasing cause of TBI in the Netherlands. Not only are falls the most important 
cause, falls in elderly individuals also lead relatively more often to head/brain injury 
than in the past.[14] Besides a major cause of (head)injury, falls are also a major cause 
of death in the Netherlands.[6] The number of deaths caused by falls is increasing 
rapidly. In 2018 the mortality caused by ground level falls was almost three times 
higher than at the beginning of this century.[15] An important cause for the increase in 
fall-related injury is ageing of the population. However, fall rates in the elderly exceed 
the expected number of falls which would be expected by ageing of the population 
alone.[4,16,17] In the Netherlands increased fall rates in the elderly, amongst other 
explanations such as increased awareness, might be caused by the fact that elderly 
live independently until a higher age than in the past.[18] 
Falls in elderly individuals can be reduced by exercise and fall prevention programs.
[19-25] The increase in the number of fall-related TBIs in older adults suggests an 
urgent need to enhance fall-prevention efforts in that population.[14,26]  
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Besides ground level falls another increasingly important, typically Dutch cause of 
TBI are bicycle accidents. Compared to other countries the use of bicycle helmets is 
low by commuter and recreational cyclists in the Netherlands. While the mortality risk 
(number of traffic deaths per kilometer) of other modes of transportation decreased 
in the past 20 years in the Netherlands, bicycle-related mortality did not decrease.
[27] International studies have shown that bicycle helmet use may decrease TBI.[28] 
In chapter 5 of this thesis we demonstrated that more frequent use of bicycle helmets 
would probably lead to a decrease in TBI in the Netherlands. After a recent appeal 
from a group of physicians, helmets will become obligatory for light mopeds (up to 
25km/h) in the Netherlands.[29], Introduction of helmet laws for bicyclists could lead 
to a reduction of bicycle use and therefore turn out to be counter-productive for public 
health.[30] Hence, provision of good information and stimulation of voluntary bicycle 
helmet use seems to be the best option. 
Risk factors for traumatic brain injury, antiplatelet therapy 
Controversy exists whether antiplatelet therapy should be considered as a risk factor 
for intracranial complications in patients with head injury. Several mostly low to 
moderate quality studies have been conducted that studied the effect of antiplatelet 
therapy on the risk of intracranial complications in head injury. In this thesis we 
conducted a systematic review and meta-analysis of these studies (chapter 4). 
This review suggests that pre-injury antiplatelet therapy, other than acetylsalicylic 
acid (ASA) monotherapy, is associated with an increased incidence of traumatic 
intracranial hemorrhage. However, this should be interpreted with caution given 
the high heterogeneity and methodological flaws of several studies included in the 
systematic review. For patients on ASA monotherapy the available evidence was 
insufficient to establish whether this should be considered as a risk factor as well. 
Besides the fact that patients with antiplatelet therapy seem to have a higher risk of 
intracranial complications, there are indications that these patients also have higher 
risk of an unfavorable outcome. [31-33] Hence, a low scanning threshold is warranted 
for patients on antiplatelet therapy. 
Decision rules for patients with minor head injury and mild traumatic brain injury
Several decision rules have been developed to efficiently identify patients with 
head injury that have intracranial complications. As mentioned before, most of 
these decision rules have been developed at the beginning of this century, when 
the demographics of patients with head injury were quite different from nowadays. 
Four frequently used decision rules were validated and compared in chapter 6 of 
this thesis. The New Orleans Criteria (NOC), the Canadian CT Head Rule (CCHR), the 
National Institute for Health and Care Excellence (NICE) and the CT in Head Injury 
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Patients (CHIP) rule.[7-9,34] We concluded that all four decision rules (NICE, CCHR, 
NOC, CHIP) that were validated could be used. However, all of them have important 
limitations, either scanning almost all patients or missing significant lesions. On the 
one hand the NOC had the highest sensitivity, but at the cost of a low specificity; on 
the other hand the NICE had the highest specificity but at the cost of a low sensitivity. 
Which decision rule is preferred depends on how many unnecessary CT scans you 
are willing to make to prevent one missed traumatic lesion. The clinical implication 
from chapter 6 is clear, the decision rules should be updated.
Consequently we performed an update of the CHIP rule which is described in chapter 
7. The updated CHIP rule consists of 12 variables, compared to 15 in the original CHIP 
rule. Compared to the original CHIP the updated rule could better identify patients 
with (potential) neurosurgical lesions without increasing, or potentially decreasing, 
the CT rate. In accordance with our findings from chapter 4 of this thesis, the use of 
antiplatelet therapy was associated with traumatic findings on CT and was included 
in the decision rule. Surprisingly anticoagulant (e.g. coumarins) use was not identified 
as independent risk factor for traumatic findings. Nonetheless a low threshold for 
scanning these patients is advised both because of potentially worse outcome of 
traumatic intracranial hemorrhage in the presence of anticoagulant use, and because 
these results have not yet been confirmed in a validation study.[31-33]
Instead of a fixed scan threshold we gave insight to an increase or decrease in 
scanning threshold, with subsequently a shift in balance between specificity and 
sensitivity. In this way clinicians or guidelines can tailor their advice depending on 
how many unnecessary CT scans they are willing to make to prevent one missed 
traumatic lesion. 
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Limitations
The limitations of each individual study included in this thesis have been discussed in 
the relevant chapters. Some general limitations will be mentioned here.
Different data sources have been used for different studies included in this thesis. 
Chapters 3, 6 and 7 contain data collected by our own study group, for chapters 2 
and 5 we used data from external sources and chapter 4 is a systematic review. This 
may lead to a difference in interpretation or definition of TBI. As a consequence the 
presented incidence figures have to be interpreted with caution. 
An important limitation of the CREST (CT Refinement Study), presented in chapters 
6 and 7, is that not all consecutive MHI patients received a CT-scan. Participating 
centers followed the applicable guidelines for CT scanning, patients without risk 
factors or with one minor criteria did not have a CT-scan. Therefore, patients who did 
not receive a CT but had intracranial traumatic findings (false negative patients) could 
have been missed. Possible solutions for this problem could have been either scanning 
all participating patients or a follow-up study. Scanning all patients did not seem 
completely ethical and would have led to longer throughput times in the participating 
busy EDs and would therefore probably have jeopardized the completeness of our 
study. Both more CT-scans and a follow-up study would have increased costs of the 
study substantially, this was not feasible considering the available budget. In the 
studies presented in chapters 6 and 7 we solved this problem by using imputation of 
the outcome based on present risk factors. 
All studies included in this thesis have been conducted in a limited number of EDs in 
the Netherlands (except for the systematic review). Circumstances in other countries, 
or other EDs may differ. Therefore, extrapolating results from this thesis should be 
done with caution in other countries or other hospitals. Even more important, all 
studies have been conducted in EDs and results may not be valid for other settings 
such as general practitioners’ practices or emergency medical services. 
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Future perspectives
Future studies will have to externally validate the updated CHIP rule, not only in the 
Netherlands, but preferably also in other countries. Besides that an increasing body 
of evidence exists that blood-based biomarkers for TBI can improve the diagnostic 
accuracy and clinical decision making.[35] In the past decades several potential 
biomarkers have been identified for this purpose. Some promising examples of these 
are: S100B, Glial fibrillary acidic protein (GFAP), Ubiquitin carboxy terminal hydrolase 
L1 (UCH-L1) and NSE (neuron-specific enolase). However, apart from S100B which 
is included in the Scandinavian Neurotrauma Guidelines, the use of biomarkers in 
clinical practice is still very limited at the moment.[36] Future studies should aim to 
study the effectiveness of incorporation of these biomarkers into clinical decision 
rules. For biomarkers to be of added value to current practice they should naturally 
be valid and reliable. Besides, they should be readily available and affordable. Finally, 
biomarkers should offer added value by either increasing precision or reducing costs 
and throughput times. 
We demonstrated that CT rates increased after implementation of new minor head 
injury guidelines. We aimed to increase diagnostic accuracy to improve the existing 
CHIP rule on which the Dutch guideline was based. Nonetheless, it has not been proven 
that clinical decision rules for minor head injury do outperform clinical judgement 
(clinical gestalt). Therefore, future research should also compare clinical judgement 
with existing decision rules for minor head injury. Off course the experience of the 
physician has to be considered in this kind of research as clinical judgement is likely 
to improve with more experience. It is important to mention that guidelines are tools 
to facilitate clinical decision making and are not carved in stone. Whenever possible, 
the patient should be involved in decision making to come to a shared decision.
In the Netherlands, as well as in other countries, there are different guidelines 
for head injury for general practitioners, emergency medical services (EMS) and 
emergency departments (EDs).[37-39] As long as these guidelines are well aligned 
there does not have to be a problem. However, for each of these guidelines a different 
interpretation of available literature is being made. As we discussed in an opinion 
article, this leads to different, not well aligned guidelines and different treatment 
under similar circumstances.[40] Future guidelines for general practitioners, EDs 
and EMS should ideally be made jointly, or at least be harmonized and offer similar 
treatment under similar circumstances.
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In this thesis we used fairly large patient series, nonetheless there are many more 
patients with TBI in the Netherlands than we could possibly include in our study. A 
population-based registry for patients with (mild) TBI could potentially include tens 
of thousands of patients annually in the Netherlands alone. Clinical information from 
such a database could be used to enhance decision making regarding diagnostics and 
the (acute) treatment of TBI. This could be done either by machine learning algorithms 
or by traditional regression models. 
As discussed before we should focus on ways to prevent TBI, especially in the elderly. 
Fall prevention programs should be evaluated and effective fall prevention programs 
should be implemented. Implementation of such programs can be challenging and 
ways to better implement these programs should be studied. 
Finally, the studies presented in this thesis as well as other TBI decision rules focus 
on CT results and short-term outcomes. Naturally, these are not the real outcomes 
of primary interest. It would be very valuable to relate clinical and CT findings in the 
acute setting to long-term outcomes. 
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Summary
Chapter 1 describes the background and aims of this thesis. Each year millions of 
people die and even more become disabled as a result of traumatic brain injury (TBI). 
The incidence of TBI is increasing worldwide. In high income countries TBI falls are 
the most important cause of TBI in an ageing population. 
Computed Tomography (CT) is the most used imaging technique to rule out intracranial 
complications of head injury. To enhance selective use of CT for patients with head 
injury several decision rules have been developed. Most of these rules are applicable 
only for patients who have loss of consciousness, amnesia or confusion. However, 
many patients with head injury do not have any of these and are still at risk for (intra)
cranial lesions. Therefore, the CT in Head Injury Patients (CHIP) decision rule was 
developed in the Netherlands. The CHIP decision rule is applicable to almost all 
patients with head injury and a Glasgow Coma Scale score (GCS) between 13 and 15. 
The Dutch guideline for minor head injury is, regarding CT indications, based on the 
CHIP decision rule with some minor modifications.
There are many uncertainties and controversies regarding the epidemiology, 
diagnostics and acute treatment for (mild)TBI. Therefore, the aim of this thesis 
was to study changes in epidemiology, preventive measures and decision rules for 
diagnostics for patients with head injury and TBI in emergency departments in the 
Netherlands. 
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Part I 
Changing trends in traumatic brain injury
In Chapter 2 a longitudinal study that evaluated trends in TBI related emergency 
department (ED)-visits, hospitalization and mortality in the Netherlands between 
1998 and 2012 is presented. Data from the Dutch Injury Surveillance System (Letsel 
Informatie Systeem; LIS), the National Medical Register (Landelijke Medische 
Registratie; LMR), and Statistics Netherlands (Centraal Bureau voor de Statistiek; 
CBS) were used for ED-visits, hospitalization and mortality respectively.
Between 1998 and 2012 there was a 75% increase in ED visits for TBI, a 95% increase 
for TBI related hospitalization; overall mortality due to TBI did not change significantly. 
Despite the overall increase in TBI related ED visits this increase was not evenly 
distributed among age groups or trauma mechanisms. In patients younger than 65 
years, a declining trend in ED visits for TBI caused by road traffic accidents was 
seen. Among patients 65 years or older, ED visits for TBI caused by a fall increased 
markedly. 
TBI related mortality shifted from mainly young and middle aged (67%) individuals and 
(< 65 years) to mainly elderly (63%) individuals (≥ 65 years) between 1998 and 2012. 
Chapter 3 describes the effect on CT ratio and hospital admission ratio after 
introduction of a new guideline for minor head injury in the Netherlands in 2010. The 
study had an interrupted time series study design. Data selection was performed 
manually, and was done three years before (2007-2009) and several years after 
(2012, 2014, 2015) introduction of the guideline. 
Data collection was performed for 3880 patients. Introduction of the new guideline 
was associated with an increase in CT ratio from 24.6% before to 55% after 
introduction (p<0.001). This increase is both the result of a secular trend and a result 
of the introduction of the new guideline itself. Besides this, hospital admissions 
increased from 14.7% to 23.4% (p<0.001) during the study period, this increase was 
less clearly associated with the introduction of the new guideline. After introduction 
of the guideline there was no significant increase in intra(cranial) traumatic findings 
with 2.6% vs. 3.4% (P = 0.13). Neither did it lead to more neurosurgical interventions 
with 0.1% vs. 0.2% (P = 0.50).
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Part II 
Prevention of- and risk factors for traumatic brain injury
In Chapter 4 we describe a systematic review and meta-analysis, with the objective 
to evaluate whether the pre-injury use of antiplatelet therapy (APT) is associated 
with increased risk of traumatic intracranial hemorrhage (tICH) on CT scan. Pubmed, 
Medline, Embase, Cochrane Central, reference lists and national guidelines on 
traumatic brain injury were used as data sources.
Eligible studies were cohort studies and case-control studies that assessed the 
relationship between APT and tICH. Studies without control group were not included. 
The primary outcome of interest was tICH on CT. Two reviewers independently 
selected studies, assessed methodological quality and extracted outcome data. 
The search resulted in ten eligible studies with 20,247 patients with head injury 
that were included in the meta-analysis. The use of APT in head injury patients was 
associated with significant increased risk of tICH compared to control (odds ratio 
1.87, 95% confidence interval 1.27 to 2.74). There was significant heterogeneity in the 
studies (I2 84%), although almost all showed an association between APT use and 
tICH. This association could not be established for patients on acetylsalicylic acid 
monotherapy. When considering only patients with mild traumatic brain injury (mTBI) 
the odds ratio is 2.72 (95% CI 1.92-3.85). The results were robust to sensitivity analysis 
on study quality. 
In conclusion APT in head injury patients is associated with increased risk of tICH, 
this association is most relevant in patients with mTBI. Whether this association is the 
result of a causal relationship, and whether this relationship also exists for patients 
on acetylsalicylic acid monotherapy could not be established with the review and 
meta-analysis. 
Chapter 5 describes a case-control study with the aim to determine the association 
between bicycle helmet use in adults (16 years and older) and traumatic brain injury 
in EDs in the Netherlands. 
The conducted study was a retrospective case-control study in patients aged 16 
years and older that sustained a bicycle accident and therefore visited the EDs of 
participating hospitals throughout 2016. Cases were patients with traumatic brain 
injury (TBI), controls were patients without TBI but with other trauma. Exposure was 
defined as helmet wearing during the accident. 
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In total 2133 patients were included in the study, 361 cases (patients with TBI) and 
1772 controls (patients without TBI). Within the TBI group (cases) 3.9% of the patients 
wore a helmet compared to 7.7% of patients in the control (non-head injury) group (OR 
0.49, 95% CI 0.28-0.86). No difference in helmet wearing was observed in patients 
that sustained accidents which involved motorized vehicles (OR 0.91; 95% CI 0.29-
2.83).
In conclusion adult patients (≥ 16 years) with TBI had a significantly lower odds for 
wearing a bicycle helmet than adult patients with other trauma (without TBI), adding 
more evidence that wearing a bicycle helmet effectively protects against TBI. 
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Part III 
Decision rules for patients with minor head injury 
and mild traumatic brain injury
Both for chapter 6 and for chapter 7 results from the CREST study were used. The 
CREST study is a prospective cohort study in nine EDs in the Netherlands. The 
participants were consecutive adult (≥ 16 years) patients who presented with minor 
head injury (MHI) at the ED with a GCS score of 13-15 between March 2015 and 
December 2016.
Primary outcome was any (intra)cranial traumatic finding on CT. Secondary outcomes 
were any potential neurosurgical lesion and neurosurgical intervention within 30 days. 
Among 4557 included patients 3742 received a head CT (82%). In 383 patients (8.4%) 
a traumatic finding was present on CT. A potential neurosurgical lesion was found in 
73 patients (1.6%) with 18 (0.4%) actually undergoing neurosurgery.
Chapter 6 describes the external validation of four commonly used computed 
tomography (CT) decision rules for MHI in a prospective cohort study in nine EDs 
in the Netherlands. We compared the sensitivity, specificity and clinical usefulness 
(defined as net benefit, a weighted sum of true and false positive classifications) of 
four CT decision rules: CT in Head Injury Patients (CHIP) rule; New Orleans Criteria 
(NOC); Canadian CT Head Rule (CCHR); and National Institute for Clinical Excellence 
(NICE) guideline for head injury.
The sensitivity for any intracranial traumatic finding on CT ranged between 73% 
(NICE) and 99% (NOC); specificity ranged from 4% (NOC) to 61% (NICE). Sensitivity 
for a potential neurosurgical lesion ranged between 85% (NICE) and 100% (NOC); 
specificity from 4% (NOC) to 59% (NICE). Clinical usefulness depended on thresholds 
for CT scanning: at a low threshold the NOC was preferable and at a higher threshold 
the NICE was preferable; whereas for an intermediate threshold the CHIP rule was 
preferable.
Application of CHIP, NOC, CCHR, or NICE decision rules leads to a wide variation in CT 
scanning among MHI patients, resulting in many unnecessary CTs and some missed 
intracranial traumatic findings. Use of the CHIP rule was recommended because it 
leads to a reduction of CTs while missing very few potential neurosurgical lesions. 
Besides this an update of the CHIP rule (or another decision rule) was recommended. 
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In Chapter 7 we present this update of the CHIP rule. Similar to chapter 6 we 
used data from the CREST study for this chapter. The CHIP model was validated 
and subsequently updated and revised. Diagnostic performance was assessed by 
calculating the c-statistic.
The original CHIP underestimated the risk of traumatic findings in the low-predicted-
risk groups, while in the high-predicted-risk groups the risk was overestimated. The 
c-statistic of the original CHIP model was 0.72 (95%CI 0.69-0.74). The original CHIP 
model would have missed two potential neurosurgical lesions and one patient that 
underwent neurosurgery. The updated model performed better over a wide range of 
predicted risks. The c-statistic of the updated model was 0.77 (95%CI 0.74-0.79). At 
a similar CT rate as the original CHIP, the updated CHIP would not have missed any 
(potential) neurosurgical lesions. 
Chapter 8 constitutes the general discussion and clinical implications of the main 
findings, general limitations and future perspectives. 
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Dutch Summary (Nederlandse Samenvatting)
Hoofdstuk 1 beschrijft de achtergrond en doelen van dit proefschrift. Jaarlijks 
overlijden er miljoenen mensen ten gevolge van traumatisch hersenletsel of lopen 
blijvend letsel op. De incidentie van traumatisch hersenletsel neemt wereldwijd toe. In 
‘westerse’ landen, met een vergrijzende populatie, zijn valongevallen de belangrijkste 
oorzaak van traumatisch hersenletsel. 
Een CT-scan is de meest gebruikte modaliteit om intracraniële bloedingen uit te 
sluiten bij patiënten met hoofd letsel. Om gepast gebruik van CT-scans voor patiënten 
met hoofdletsel te bevorderen zijn verschillende beslisregels ontwikkeld. De meeste 
van deze beslisregels zijn uitsluitend te gebruiken bij patiënten met (doorgemaakt) 
bewustzijnsverlies, posttraumatische amnesie of verwardheid. Veel patiënten met 
hoofdletsel hebben dit echter niet en kunnen desondanks mogelijk wel een intracraniële 
bloeding hebben. Daarom is aan het begin van deze eeuw de CHIP (CT in Head Injury 
Patients) beslisregel ontwikkeld in Nederland. De CHIP beslisregel is toepasbaar bij 
vrijwel alle patiënten met hoofdletsel en een Glasgow Coma Score (GCS) tussen 13 
en 15. De Nederlandse richtlijn voor licht traumatisch hoofd-hersenletsel is voor een 
belangrijk deel gebaseerd op de CHIP beslisregel. 
Er bestaat nog veel onzekerheid en verschil van inzicht rondom de epidemiologie, 
diagnostiek en acute behandeling van (licht) traumatisch hoofd-hersenletsel 
(LTH). Het doel van dit proefschrift is daarom het evalueren van (veranderingen 
in) epidemiologie van traumatisch hoofd-hersenletsel (deel I); het evalueren van 
risicofactoren en preventieve maatregelen voor traumatisch hoofd-hersenletsel en 
tot slot (deel III) het vergelijken, valideren en verbeteren van beslisregels voor licht 
traumatisch hoofd-hersenletsel (LTH).
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Deel I 
Veranderende trends in traumatisch hersenletsel
In Hoofdstuk 2 beschrijf ik een longitudinale studie naar trends in spoedeisende 
hulp (SEH) bezoeken, opnames en overlijdens ten gevolge van traumatisch 
hersenletsel in Nederland tussen 1998 en 2012 gepresenteerd. Voor deze studie 
is data afkomstig van het Letsel Informatie Systeem (LIS), de Landelijke Medische 
Registratie (LMR) en het Centraal Bureau voor de Statistiek (CBS) gebruikt. 
Tussen 1998 en 2012 was er een toename van 75% voor spoedeisende hulp 
(SEH) bezoeken voor traumatisch hersenletsel en een toename van 95% voor 
ziekenhuis opnames ten gevolge van traumatisch hersenletsel. Voor het aantal 
overlijdensgevallen ten gevolge van traumatisch hersenletsel werd geen 
significante verandering gezien in de studieperiode. Alhoewel er over de gehele 
linie dus een toename in het aantal SEH bezoeken voor traumatisch hersenletsel 
werd gezien, was deze toename niet gelijkmatig verdeeld over leeftijdsgroepen 
of traumamechanismen. Bij patiënten jonger dan 65 jaar werd bijvoorbeeld een 
afname gezien in traumatisch hersenletsel ten gevolge van verkeersongevallen. 
Bij patiënten van 65 jaar en ouder werd daarentegen juist een forse toename van 
het aantal SEH bezoeken ten gevolge van valongevallen waargenomen. 
Waar het in 1998 nog overwegend (67%) jongeren en mensen van middelbare 
leeftijd (< 65 jaar) waren die overleden ten gevolge van traumatisch hersenletsel, 
waren het in 2012 juist overwegend (63%) ouderen (≥ 65 jaar) die overleden waren 
aan traumatisch hersenletsel. 
Hoofdstuk 3 beschrijft de ontwikkeling in het aantal CT-scans en het aantal 
opnames voor LTH na de introductie van een nieuwe richtlijn in 2010. In deze studie 
wordt een ‘interrupted time series’ analyse gebruikt. Van drie jaar voor (2007-
2009) en verschillende jaren na (2012, 2014, 2015) introductie van de richtlijn 
werd data verzameld. 
In totaal werden 3880 patiënten geïncludeerd. De introductie van de nieuwe 
richtlijn was geassocieerd met een toename van het percentage patiënten met 
LTH waarin een CT-scan wordt gemaakt van 24,6% voor introductie naar 55% na 
introductie (P < 0,001). Deze toename is echter niet uitsluitend toe te schrijven 
aan de introductie van de nieuwe richtlijn, er is ook sprake van een onderliggende 
trend van steeds meer CT-scans. Naast het percentage CT-scans nam ook het 
percentage opnames toe, van 14,7% naar 23,4% in de studieperiode (P < 0,001). 
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Deze toename was minder duidelijk geassocieerd met de introductie van de nieuwe 
richtlijn. Na introductie van de nieuwe richtlijn was er geen significante toename 
in het percentage traumatische afwijkingen dat werd gevonden (2,6% versus 3,4%; 
P = 0,13). Ook was er geen significant verschil in het aantal neurochirurgische 
ingrijpen (0,1% versus 0,2%; P = 0,50). 
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Deel II 
Preventie van- en risicofactoren 
voor traumatisch hersenletsel
In Hoofdstuk 4 wordt een systematische review en meta-analyse beschreven. 
We onderzochten of patiënten die voorafgaand aan een hoofdletsel 
trombocytenaggregatieremmers gebruikten een hoger risico hadden op een 
traumatische intracraniële bloeding. Voor deze review werden verschillende databases 
(Pubmed, Medline, Embase, Cochrane Central) en nationale richtlijnen geraadpleegd. 
Alleen studies waarbij er ook een controlegroep was werden geïncludeerd. De 
primaire uitkomstmaat was een traumatische intracraniële bloeding op CT-scan. Twee 
reviewers hebben onafhankelijk van elkaar de studies geselecteerd, geanalyseerd en 
de relevante data geëxtraheerd. 
Tien relevante studies met in totaal 20.247 patiënten werden geïncludeerd in de 
meta-analyse. Het gebruik van trombocytenaggregatieremmers bij patiënten met 
hoofdletsel was geassocieerd met een significant verhoogd risico op een traumatische 
intracraniële bloeding (odds ratio 1,87; 95% betrouwbaarheidsinterval 1,27-2,74). Er 
was forse heterogeniteit tussen de studies (I2 84%), maar vrijwel alle studies lieten 
een associatie zien tussen het gebruik van trombocytenaggregatieremmers en de 
aanwezigheid van een traumatische intracraniële bloeding op CT-scan. Deze associatie 
kon niet aangetoond worden voor patiënten die acetylsalicylzuur monotherapie 
hadden. Wanneer uitsluitend naar patiënten met LTH werd gekeken werd een 
soortgelijke associatie gevonden (odds ratio 2,72; 95% betrouwbaarheidsinterval 
1,92-3,85). 
Het gebruik van trombocytenaggregatieremmers voorafgaand aan een hoofdletsel is 
geassocieerd met een verhoogd risico op een traumatisch bloeding. Of dit een causaal 
verband betreft en of deze associatie ook bestaat voor patiënten die uitsluitend 
acetylsalicylzuur gebruikten kon niet worden aangetoond. 
Hoofdstuk 5 beschrijft een case-control studie waarin de associatie tussen het 
dragen van een fietshelm bij volwassenen (16 jaar en ouder) en het optreden van 
traumatisch hersenletsel wordt onderzocht. 
Het onderzoek is verricht in 2016 in deelnemende Nederlandse SEH afdelingen. 
Patiënten van 16 jaar en ouder die de SEH bezochten in verband met een fietsongeval 
werden geïncludeerd. Cases waren patiënten die de SEH bezochten wegens 
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traumatisch hersenletsel. Controles waren patiënten zonder traumatisch hoofd-
hersenletsel die de SEH bezochten in verband met ander letsel. De ‘exposure’ die 
onderzocht werd betrof het al dan niet dragen van een fietshelm gedurende het 
fietsongeval.
In totaal werden 2133 patiënten geïncludeerd in de studie. Er waren 361 patiënten met 
traumatisch hersenletsel en 1772 patiënten zonder traumatisch hersenletsel. In de 
groep patiënten met traumatisch hersenletsel (cases) had 3,9% een helm gedragen 
tijden het ongeval, in de groep zonder traumatisch hersenletsel (controles) droeg 7,7% 
een helm tijdens het ongeval. Dit resulteert in een odds ratio van 0,49 voor het dragen 
van een fietshelm tussen cases en controles, met een 95% betrouwbaarheidsinterval 
van 0,28-0,86. Bij patiënten die een ongeval hadden gehad waarbij een gemotoriseerd 
voertuig betrokken was werd geen verschil gezien tussen het gebruik van fietshelmen 
tussen cases en controles (odds ratio 0,91; 95% betrouwbaarheidsinterval 0,29-2,83).
Patiënten met traumatisch hersenletsel droegen minder vaak een fietshelm dan 
patiënten met ander letsel (zonder hersenletsel). Dit versterkt het bewijs dat een 
fietshelm effectief beschermt tegen traumatisch hersenletsel. 
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Deel III 
Beslisregels voor patiënten 
met licht traumatisch hoofd-hersenletsel 
Voor zowel hoofdstuk 6 als voor hoofdstuk 7 is gebruik gemaakt van resultaten van 
de CREST studie. Het betreft hier een prospectieve cohort studie op negen SEH 
afdelingen in Nederland. Deelnemers aan de studie waren patiënten van 16 jaar en 
ouder die een van de deelnemende SEH’s bezochten in verband met LTH tussen maart 
2015 en december 2016. 
De primaire uitkomstmaat was de aanwezigheid van een traumatische (intra)craniële 
afwijking op CT. Secundaire uitkomstmaten waren de aanwezigheid van een afwijking 
die potentieel neurochirurgisch behandeld moest worden en neurochirurgische 
interventie binnen 30 dagen. Van de 4557 patiënten die zijn geïncludeerd in de studie 
kregen 3742 (82%) een CT-scan van het hoofd; 383 (8,3%) hadden traumatische 
(intra)craniële afwijkingen op CT. Bij 73 patiënten (1,6%) was er sprake van een 
potentieel neurochirurgische afwijking en bij 18 patiënten (0,4%) is daadwerkelijk 
neurochirurgisch ingegrepen. 
In Hoofdstuk 6 wordt de externe validatie van vier veel gebruikt CT beslisregels voor 
patiënten met LTH beschreven. De primaire uitkomstmaat was de aanwezigheid van 
een traumatische (intra)craniële afwijking op CT. De secundaire uitkomstmaat was 
de aanwezigheid van een afwijking die potentieel neurochirurgisch behandeld moest 
worden.
Specificiteit, sensitiviteit en klinisch nut (gedefinieerd als ‘net benefit’, een gewogen 
som van echt en vals positieve classificaties) van vier beslisregels werden geëvalueerd: 
CT in Head Injury Patients (CHIP); New Orleans Criteria (NOC); Canadian CT Head Rule 
(CCHR); en de National Institute for Health and Care Excellence (NICE) richtlijn voor 
hoofdletsel. 
De sensitiviteit voor een traumatische afwijking op CT-scan varieerde van 73% (NICE) 
tot 99% (NOC). De specificiteit varieerde van 4% (NOC) tot 61% (NICE). De sensitiviteit 
voor potentieel neurochirurgische afwijkingen varieerde van 85% (NICE) tot 100% 
(NOC); en de specificiteit van 4% (NOC) tot 59% (NICE). Het klinisch nut hangt af van 
de (zelf bepaalde) drempel voor een CT-scan. Bij een lage drempel voor het maken 
van een CT-scan is de NOC te verkiezen, bij een hoge drempel de NICE. Voor het 
tussengelegen spectrum (een intermediaire drempel) is de CHIP te verkiezen.
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Concluderend kan gesteld worden dat de toepassing van verschillende beslisregels 
leidt tot een grote variatie in het aantal CT-scans dat gemaakt wordt bij patiënten 
met LTH. Dit resulteert in veel onnodige CT-scans en enkele gemiste traumatische 
afwijkingen. Omdat de CHIP slechts enkele potentieel neurochirurgische afwijkingen 
miste en leidde tot een aanzienlijke reductie in CT-scans werd het gebruik van de CHIP 
geadviseerd. Daarnaast werd geadviseerd om een update van de CHIP uit te voeren. 
In Hoofdstuk 7 wordt deze update van de CHIP gepresenteerd. Ook voor deze update 
is gebruik gemaakt van data van de CREST studie. Het CHIP model werd gevalideerd 
en vervolgens geupdate en gereviseerd. De diagnostische prestatie werd beoordeeld 
door de ‘c-statistic’ te berekenen. 
De oorspronkelijk CHIP onderschatte het risico op traumatische afwijkingen in de 
groep patiënten met een laag voorspeld risico, voor de groep patiënten met een hoog 
voorspeld risico werd het risico juist overschat. De c-statistic van de oorspronkelijke 
CHIP was 0,72 (95% betrouwbaarheidsinterval 0,69-0,74). Het oorspronkelijke CHIP 
model zou twee potentieel neurochirurgische afwijkingen gemist hebben, waarvan 
één patiënt daadwerkelijk neurochirurgisch ingrijpen onderging. Het geupdate model 
presteerde beter over een grote range van voorspelde risico’s. De c-statistic van 
het geupdate model was 0,77 (95% betrouwbaarheidsinterval 0,74-0,79). Bij een 
vergelijkbaar aantal CT-scans als de oorspronkelijke CHIP zou het geupdate model 
geen patiënten met (potentieel) neurochirurgische afwijkingen gemist hebben. 
Hoofdstuk 8 bevat de algemene discussie, klinische implicaties van de belangrijkste 
bevindingen, algemene beperkingen en een perspectief voor toekomstig onderzoek.
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AABB formerly American Association of Blood Banks
ACEP American College of Emergency Physicians
APT Antiplatelet Therapy
ASA Acetylsalicylic acid
CBS Statistics Netherlands (Centraal Bureau voor de Statistiek)
CCHR Canadian CT Head Rule
CHIP CT in Head Injury Patients
CI Convidence Interval
CREST CT Refinement Study
CRF Case Report Form
CSF Cerebro Spinal Fluid
CT Computed Tomography
DAI Diffuse Axonal Injury
DOACs Directly acting Oral Anticoagulants (synonym NOAC)
ED Emergency Department
EMS Emergency Medical Services
GCS Glasgow Coma Scale
GFAP Glial Fibrillary Acidic Protein
ICD International Classification of Disease
INR International Normalized Ratio
ITS Interrupted Time Series
LIS Dutch Injury Surveillance System (Letsel Informatie Systeem)
LMR National Medical Register (Landelijke Medische Registratie)
LOC Loss Of Consciousness
LOESS Locally Estimated Scatterplot Smoothing (or locally weighted regression 
curve)
LTH Licht Traumatisch Hoofd-hersenletsel
MHI Minor Head Injury
MICE Multivariate Imputation by Chained Equations
MOOSE Meta-analysis Of Observational Studies in Epidemiology
mTBI Mild Traumatic Brain Injury
MVC Motorized Vehicle Collision
NICE National Institute for Health and Care Excellence (formerly National 
Institute for Clinical Excellence)
NOACs Non vitamin K (or Novel) Oral Anticoagulants (synonym DOAC)
NOC New Orleans Criteria
NOS Newcastle-Ottawa assessment Scale
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NSE Neuron-Specific Enolase
OR Odds Ratio
PTA Post Traumatic Amnesia
RTA Road Traffic Accidents
SEH Spoedeisende Hulp
SPSS Statistical Package for Social Sciences 
TBI Traumatic Brain Injury
tICH Traumatic Intracranial Hemorrhage
UCH-L1 Ubiquitin Carboxy Terminal Hydrolase L1
VKA Vitamin K Antagonsist
WMO Medical Research Involving Human Subjects Act (Wet Medisch-
wetenschappelijk Onderzoek met mensen)
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Dit proefschrift had niet tot stand kunnen komen zonder de hulp van velen zowel 
professioneel als privé. Ik wil iedereen hiervoor hartelijk danken. Dit geldt zeker ook 
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Prof. dr. M.G.M. Hunink, beste Myriam, wij hebben elkaar leren kennen bij aanvang 
van dit promotietraject. Zeer waardevol en inspirerend was jouw bijdrage aan 
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besliskunde en jouw ervaring als PI van de CHIP studie hebben mij erg geholpen 
bij de totstandkoming van dit proefschrift. Veel dank hiervoor, heel mooi om op ons 
beider verjaardag dit traject af te sluiten!
Prof. dr. P. Patka, beste Peter, alhoewel je niet meer officieel mijn promotor bent ben je 
dat gevoelsmatig zeker nog wel. Jij was betrokken bij de start van dit promotietraject 
en bracht me in contact met Myriam. Ik wil je zeer bedanken voor de mogelijkheid die 
je me hebt geboden om te promoveren op dit onderwerp en de manier waarop je me 
hiermee op weg hebt geholpen.
Dr K. Jellema, beste Korné, jij stond aan de wieg van dit proefschrift. Toen ik je jaren 
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en opperde jij of ik niet zou willen promoveren op dit onderwerp. Gedurende mijn 
hele promotie ben jij zeer nauw betrokken geweest, stond me bij met raad en daad 
en kwam je steeds met mooie nieuwe plannen. Als ik je een manuscript stuurde ter 
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Prof. dr. J. van der Naalt, Prof. dr. M. Smits, Prof. dr. E.W. Steyerberg, Prof. dr. D. 
Dippel, Prof. dr. V.A. de Ridder, dr. K.E. Jie, veel dank dat jullie dit proefschrift hebben 
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dr. J.S. Huff, thank you very much for your willingness to evaluate this thesis and to 
participate in the opposition committee. 
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bijdrage geleverd aan dit proefschrift, veel dank voor wat ik van jullie heb mogen leren. 
Christien, jouw aanstekelijke enthousiasme voor het doen van onderzoek heeft ook 
mij geholpen in het doen van onderzoek en de lol ervan in te zien. 
Ik ben al mijn oud collegae uit het HMC veel dank verschuldigd. In het bijzonder wil ik 
de vakgroep spoedeisende geneeskunde erg bedanken voor de mogelijkheid die jullie 
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Ernie de Deckere, Toeba Ghafuri-Taheri, Marjolein Koen, Maartje de Kort, Merel van 
Loon, Susan Mollink, Dafni Papathanasiou, Karen Pelka-van Doorn, Annelijn Rambach, 
Resi Reijnen, Ingrid Scholtes, Mischa Veen, Alice Vis, Geesje van Woerden en Berbel 
Würth, zonder jullie steun hierin en jullie flexibiliteit was dit niet gelukt. 
Ook mijn huidige collegae bij DICA wil ik natuurlijk hartelijk bedanken voor jullie 
interesse en alles wat ik van jullie heb mogen leren op het gebied onderzoek en 
kwaliteit van zorg. 
Menno Gaakeer, jij was mijn voorganger als voorzitter van de NVSHA. Samen hebben 
we gebouwd aan het mooie vak spoedeisende geneeskunde. Ik heb veel van je geleerd 
en heb veel bewondering voor je gedrevenheid, je creativiteit en je enthousiasme. Ik 
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onderzoek zijn blijven doen. Eind 2019 mocht ik jouw paranimf zijn, ik ben heel blij dat 
jij nu ook mijn paranimf bent! 
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Lieve familie en vrienden, ik zal jullie niet allemaal bij naam noemen, maar ben 
bevoorrecht met zulke mensen om me heen! Veel dank voor alle steun in tijden van 
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schoonfamilie wat fijn dat ik jullie als familie erbij heb gekregen. Dank voor jullie 
warme bad!
Lieve Machteld, als klein jongetje was jij al mijn suikertante, ik keek er altijd erg naar 
uit als je weer uit Zwitserland op bezoek kwam. Een generatie verder prijs ik me nog 
steeds heel gelukkig met mijn suikertante. Dank voor alles.
Eva, Igor, Jurriaan, Mischa, Charlotte, Jan, Ellen, Suzanne, Anniek, Alex, lieve neven en 
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Lieve broers en zussen ik prijs me gelukkig dat jullie ook tijdens mijn promotie, in de 
persoon van Igor, naast mij staan. Ik omhels jullie. 
De koetjes op de kaft zijn een knipoog naar het beeld dat ik kreeg van mijn ouders bij 
mijn afstuderen. 
Lieve papa, lieve Marcel, helaas heb jij dit eindresultaat niet kunnen zien. Gelukkig 
heb je een groot deel van de totstandkoming van dit boekje wel meegekregen. Je was 
heel betrokken en appte me trots als je ergens een artikel over hoofdletsel zag. Jouw 
promotie was de eerste waar ik bij was en voor mij ook de meest indrukwekkende. 
Samen in de keuken berekeningen maken voor jouw proefschrift. Ik weet niet meer of 
we eruit zijn gekomen, maar vond het leuk om onze berekeningen onlangs weer terug 
te zien. Dank voor alles wat je me geleerd hebt, maar vooral dank voor alle liefde die 
je me hebt gegeven. 
Lieve mama, lieve Duuf, ook jij hebt de afronding van dit proefschrift helaas niet mee 
kunnen maken. Toen je wist dat je de promotie zelf niet mee zou maken heb je alvast 
een cadeau voor mijn promotie laten maken en kort voordat je overleed kreeg ik een 
schitterend schilderij van Josephine. Ik koester alle dierbare herinneringen en dank 
je voor je onvoorwaardelijke liefde, steun en vertrouwen. Dankzij jou ben ik geworden 
wie ik ben.
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Joanne, liefste, samen is alles mooier. De afgelopen jaren zijn een rollercoaster van 
emoties geweest. Jij was er altijd voor me en gaf me af en toe een broodnodig zetje 
om nou toch die promotie eens af te ronden. Veel dank voor al je steun en al je liefde, 
ik hou zielsveel van je en bewonder je om wie je bent. 
Lieve Josephine en Mathilde, jullie zijn de zonnestralen op mijn pad, ik ben er trots op 
jullie vader te mogen zijn. 
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